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ABSTRACT 
carbohydrates are among the most ubiquitous and complex types of biomolecules in nature. 
Their interplay with a number of receptor families including lectins, antibodies, enzymes and 
viruses, triggers a variety of responses related to physiological and pathological events. Thus, 
knowledge on the forces that govern these interactions at atomic detail is essential for a 
thorough understanding of many vital processes and to open the possibility of their 
modulation. 
At the same time, the high structural variability and functional versatility of glycans call for 
developing new tools to probe carbohydrate conformation and recognition features by 
receptors. 
In this Thesis, we have made extensive use of NMR spectroscopy methods to gain structural 
insight into the interactions of a series of protein-carbohydrate systems of biomedical 
relevance. In addition, we present an innovative approach for conformational characterization 
of sugars and structural aspects of their recognition by receptors, based on the exploitation of 
paramagnetic effects arisen from lanthanide-binding carbohydrate conjugates. 
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RESUMEN 
Los carbohidratos constituyen uno de los tipos de biomoléculas más complejos y ubicuos, cuyo 
reconocimiento por parte de receptores proteicos pertenecientes a diversas familias (lectinas, 
anticuerpos, enzimas y virus) determina una variedad de respuestas relacionadas con procesos 
fisiológicos y patológicos. El conocimiento, a nivel atómico, de la estructura de los 
carbohidratos y de sus interacciones con proteínas es esencial para una completa comprensión 
de muchos procesos vitales, así como abrir la puerta a su modulación. 
Al mismo tiempo, la gran variabilidad estructural y versatilidad funcional de los glicanos 
impone la necesidad de desarrollar nuevas herramientas que permitan ampliar nuestro 
conocimiento sobre la estructura de estas moléculas y su reconocimiento por parte de 
receptores. 
En esta Tesis se ha hecho un uso exhaustivo de métodos de espectroscopía por resonancia 
magnética nuclear (RMN) para obtener información estructural sobre procesos de 
reconocimiento molecular en una serie de sistemas carbohidrato-proteína de interés 
biomédico.  
En distintos capítulos, esta Tesis aborda el estudio del reconocimiento molecular entre 
glicanos y los cuatro tipos principales de receptores de carbohidratos: lectinas, anticuerpos, 
enzimas y virus. 
- Capítulo 1. Introducción 
La introducción de esta Tesis centra su atención en la gran variabilidad estructural de los 
carbohidratos, que dota a estas moléculas de un elevado potencial para codificar información 
biológica, así como los distintos tipos de receptores proteicos de carbohidratos y sus 
características más notables. 
Asimismo, se presenta una revisión comprensiva de los métodos de RMN más utilizados en la 
actualidad, con especial énfasis en su aplicación al estudio estructural de los carbohidratos y 
de sus interacciones con receptores. Dichos métodos incluyen experimentos basados en la 
observación de las señales de RMN de los ligandos, así como en la observación de las señales 
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de RMN de las proteínas. De entre los primeros, destacamos el experimento de diferencia de 
transferencia de saturación (STD, por sus siglas en inglés). Esta técnica se basa en la 
transferencia de magnetización entre el receptor, que es objeto de irradiación selectiva 
mediante pulsos de radiofrecuencia, y aquellos ligandos que, en exceso y en régimen de 
intercambio rápido, se unan al receptor. Entre los métodos basados en la observación de las 
señales de la proteína, debemos destacar los experimentos basados en la correlación 
heteronuclear de cuanto simple protón-nitrógeno-15 (1H-15N HSQC, por sus siglas en inglés). 
También se profundiza en otros tipos de experimentos de RMN, tales como los destinados a la 
asignación de moléculas pequeñas y de proteínas, métodos basados en difusión traslacional o 
en la observación de núcleos distintos de protón, especialmente flúor-19. Asimismo, se 
presenta el concepto de descubrimiento de fármacos basado en fragmentos (FBDD, por sus 
siglas en inglés), así como aspectos prácticos del uso de RMN aplicado a este procedimiento. 
- Capítulo 2. El reconocimiento entre determinantes de tipo carbohidrato y un conjunto de 
proteínas fibrilares víricas 
En este capítulo se presenta el estudio del reconocimiento entre una serie de proteínas 
fibrilares de distintas especies víricas y sus ligandos sacarídicos, utilizando experimentos 
basados en la observación de las señales de ligando. En concreto, se han llevado a cabo 
experimentos de diferencia de transferencia de saturación (STD) para detectar la unión 
reversible entre estos receptores y sus ligandos, así como la obtención de información de 
epítopo desde el punto de vista del ligando.  
En concreto, se ha estudiado las capacidades de interacción de tres de estos receptores virales: 
la proteína gp37 del fago T4, la proteína gp17 del fago T7, y el receptor fibrilar del adenovirus 
de pavo 3 (TAdV-3). 
- Capítulo 3. Las propiedades de interacción de un anticuerpo monoclonal contra el 
-glucano de la cápsula de Mycobacterium 
xviii 
En el Capítulo 3 se presenta el estudio de la interacción entre un anticuerpo monoclonal y el 
polisacárido glucógeno, así como una serie de oligosacáridos pequeños relacionados 
estructuralmente. Estos estudios han conducido a la identificación del epítopo del 
carbohidrato responsable de la unión al anticuerpo. 
Asimismo, se han llevado a cabo experimentos de RMN en células de Mycobacterium 
smegmatis destinados a obtener información estructural de su -glucano capsular. 
- Capítulo 4. Estudios sobre la UDP-glucosa pirofosforilasa de Streptococcus pneumoniae, un 
candidato a diana terapéutica 
El Capítulo 4 aglutina distintos estudios en torno a la UDP-glucosa pirofosforilasa (UGP) de 
Streptococcus pneumoniae (spUGP), una enzima que cataliza la transformación reversible de 
UTP y glucosa-1-P en UDP-glucosa y pirofosfato. En primer lugar, se ha desarrollado una serie 
de experimentos destinados a  adquirir información de carácter mecanístico sobre esta 
enzima. Mediante experimentos de STD, se ha obtenido información respecto al modo 
secuencial en que los sustratos se unen a la enzima: en primer lugar se produce la unión de 
UTP al centro activo, seguido de glucosa-1-P, siendo el Mg2+ esencial para la unión de los 
sustratos. 
También se ha desarrollado un ensayo de actividad enzimática basado en RMN, mediante el 
seguimiento de la interconversión entre el H1 de glucosa-1-P y el H1 de UDP-glucosa. Este 
ensayo representa una estrategia directa para el seguimiento de la actividad UGP, y es 
ventajoso sobre el método más utilizado actualmente, basado en la medición indirecta de la 
actividad UGP mediante su acoplamiento con la oxidación de la UDP-glucosa seguida por 
procedimientos espectrofotométricos. 
Finalmente, se llevó a cabo un cribado de fragmentos preliminar contra spUGP, encontrándose 
una serie de compuestos estructuralmente relacionados que se unían con moderada afinidad 
al subsitio de unión de UTP de spUGP. 
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Capítulo 5: Galectinas 
El Capítulo 5 presenta diferentes estudios relacionados con galectinas, una familia de lectinas 
animales con capacidad de unión a -galactósidos. En términos estructurales, se distingue 
entre tres tipos de galectinas: (i) prototipo, que constan de un dominio de reconocimiento de 
carbohidratos (CRD) que usualmente dimeriza; (ii) en tándem, que constan de dos CRDs 
distintos en la misma cadena polipeptídica; y (iii) quimera, que constan de un CRD y una 
porción no-CRD. Hasta la fecha, la única galectina quimera identificada es galectina-3 (gal-3). El 
Capítulo centra su atención en gal-3 y en galectina-7 (gal-7), una galectina prototipo.  
Los estudios sobre gal-7 se iniciaron con la asignación completa de sus señales de RMN 
mediante experimentos bi y tridimensionales. Dicha asignación reveló la existencia de dos 
confórmeros de la proteína en disolución, en proporciones aproximadas 55:45, en equilibrio de 
intercambio lento en la escala de tiempo del desplazamiento químico, que posteriores 
estudios atribuyeron a la isomerización cis-trans del enlace peptídico V3-P4. También se llevó a 
cabo un cribado de fragmentos, hallándose una serie de compuestos pequeños que se unían a 
gal-7 en dos epítopos distintos: uno, previamente desconocido, homólogo estructural del sitio 
de galectina-1 de unión a farnesil-Ras, y un segundo en la interfaz de dimerización de gal-7. La 
unión de fragmentos en la interfaz de dimerización mostró capacidad para inhibir la 
autoasociación de gal-7, a la vez que contribuyó a demostrar el efecto estabilizador del dímero 
de gal-7 promovido por su unión a lactosa. 
Asimismo, los estudios sobre gal-3 se iniciaron por la asignación de las señales de RMN de la 
proteína completa. Se llevó a cabo estudios de interacción de pequeños oligosacáridos, así 
como polisacáridos (keratan sulfato y keratan desulfatado) con el CRD de gal-3. Finalmente, se 
estudió la capacidad de interacción entre el CRD de gal-3 y péptidos derivados del dominio 
N-terminal de gal-3, sin y con fosforilación en posiciones fisiológicamente relevantes. Los 
resultados mostraron la capacidad de algunos de estos péptidos de interaccionar con el CRD 
de manera dependiente de su estado de fosforilación.
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- Capítulo 6. Nuevos desarrollos: aplicación del paramagnetismo para la estudiar la 
conformación de azúcares y su interacción con receptores 
Finalmente, el Capítulo 6 presenta el desarrollo de nuevas metodologías relacionadas con el 
aprovechamiento de efectos paramagnéticos en el campo de los carbohidratos. Dichas nuevas 
metodologías están destinadas a la obtención de información de tipo estructural sobre la 
conformación de oligosacáridos y aspectos estructurales de su unión a receptores. 


1 
CHAPTER 1 
INTRODUCTION 
1.1 Carbohydrates and Glycoscience  
1.1.1 General aspects 
All cell surfaces and most proteins are coated by carbohydrates that intrinsically contain 
structural information used in recognition processes relevant in health and disease.  These are 
secondary gene products that are entirely missed by the current screening techniques relying 
solely on genomics. Glycans (carbohydrates, sugars) are expressed on glycoproteins, 
glycolipids, proteoglycans and free complex carbohydrates and the entire category of these 
structures, known as the glycome, is probably the least studied and most complicated and 
biologically important molecular classifications in humans.  
In particular, carbohydrates are among the most ubiquitous and complex types of 
biomolecules in nature. They are composed of smaller units, called monosaccharides, which 
are linked in the form of linear sequences, with or without sophisticated branches [1-3], 
allowing for a high potential for overall structural diversity. In addition, the introduction of 
substituents at the hydroxyl groups, such as phosphate, sulfate [4] and/or acetyl [5] groups, 
greatly increases carbohydrates' potential for complexity. This structural diversity allows 
carbohydrates to be specifically recognized by receptors with exquisite selectivity, making 
them very suitable for encoding biological information [6].  
Carbohydrates, especially when conjugated as glycoproteins or glycolipids at the periphery of 
the cell, thus play a very important role in molecular recognition processes by establishing 
specific interactions that trigger a variety of intra-, extra-cellular physiological and pathological 
events (fig. 1). Thus, modifications of cell-surface glycosylation may lead to or be involved in 
pathological phenomena, such as inflammation and cancer [7-9]. In this context, knowledge at 
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the maximum resolution possible on the 3D structure of carbohydrates, and characterization 
of their recognition features by different entities, such as lectins, enzymes, viruses, and 
antibodies, are essential for a thorough understanding of many vital processes and to open the 
possibility of their modulation. Therefore, glycoscience, a discipline lying at the interface 
between chemistry, biology, and biomedicine is today a challenging and active field of 
research. Glycoscience represents a fruitful and innovative source of novel therapeutics that is 
relatively untapped.  In fact, there is a current need to produce innovative therapeutic 
solutions based on the exploitation of the emerging opportunities that exist in this emerging 
field.  
Figure 1: The importance of protein-carbohydrate interactions. Cell-surface carbohydrates are recognized by a 
diversity of protein families, including lectins, enzymes, antibodies and viruses, triggering a variety of physiological 
and pathological responses. 
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1.1.2 Structure of carbohydrates 
1.1.2.1 Monosaccharides 
Carbohydrate molecules are built from small building blocks, called monosaccharides. Many 
different monosaccharides exist in Nature. They may have different number of carbon atoms, 
usually from five to seven, although other possibilities also exist.  
The high potential for diversity displayed by carbohydrates is originated, at the 
monosaccharide level, by a number of sources of structural variability. First, due to the 
presence of different substituents for every carbon atom, these become stereogenic centers 
(fig. 2). The absolute configuration at each chiral center of the sugar backbone defines the type 
of sugar (e.g. glucose, galactose, mannose). In addition, the orientation of the substituent in 
the anomeric position, i.e. axial or equatorial in respect to the plane containing the sugar ring, 
defines the  or  anomers, respectively.  
Finally, the sugar ring conformation introduces another source of structural variability [10] 
which is of special relevance for the molecular recognition of sugars by receptors, since it 
determines the orientation of functional groups in the three-dimensional space. For the 
common pyranose rings, the regular geometry is one of the possible chair conformations, 
which minimizes steric congestion and accounts for the anomeric effect. However, 
monosaccharide rings may populate a number of additional, distinct three-dimensional 
shapes, at relative ratios that depend on the free energy of the different conformers. This, in 
turn, depends heavily on the orientation, nature and number of substituents at the sugar ring. 
For certain sugars in solution, rapid interconversion may occur between the major chair 
conformations and some other minor geometries [11], which may  include envelope, boat and 
skew ring puckers, as well as alternative chairs (fig. 2). 
1.1.2.2 The anomeric effect 
The anomeric effect was first described in the 1950s by J. T. Edward and R. U. Lemieux [12]. In 
carbohydrate chemistry, the anomeric effect describes the tendency of the electronegative 
substituents at the anomeric carbon (C1) of a pyranose ring to adopt the axial rather than the 
equatorial orientation. This is in contrast to what would be expected based solely on terms of 
steric factors. Normally, for D-sugars, the  isomer is more stable than expected (fig. 2).  
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The origin of the anomeric effect has been a matter of historical controversy. Over the last 
decades, modeling approaches including ab initio calculations and molecular mechanics 
studies [13-14] have permitted to gain insight into all factors that come into play to produce 
this phenomenon. On the basis of these studies, the anomeric effect is now understood as the 
result of multiple steric, electrostatic and stereoelectronic interactions. Although the anomeric 
effect is a well-known phenomenon for carbohydrate chemists, it is not exclusive of the sugar 
field, appearing also in many other types of molecules. 
Figure 2: Structural variability of a monosaccharide: glucose. Schematic representation of D-glucose in its open-
chain form. The absolute configuration is labeled with either the (R) or (S) descriptors for each stereocenter. The 
substituents at each carbon atom can be at axial or equatorial disposition with respect to the imaginary plane 
containing the C2, C3, C5 and O5 atoms. In -D-glucose, the orientation of the hydroxyl group in C1 is equatorial, 
while in the  anomer it is axial (shadowed in blue). Both anomers can coexist, but one of them is usually preferred. 
The energetically privileged chair conformations of the cyclic sugar ring are labeled as 4C1 or 
1C4, depending on the 
position of carbons 1 and 4, i.e. above or below the sugar ring plane (shadowed in red), respectively. Many other 
ring puckers can coexist in conformational equilibrium, populating boat, skewed and envelope forms. 
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Figure 3: Torsion angles F, Y and w in a 
model oligosaccharide, which determine 
the relative orientation of the different 
sugar ring planes (shadowed in red). All O-
glycosidic linkages are defined by F and Y. 
In addition, 1-6 linkages demand to 
determine an additional angle (w) around 
C5-C6 to provide the relative orientation of 
the two sugar planes.  
1.1.2.3 Disaccharides. The glycosidic linkage
One given monosaccharide is attached to other one through a glycosidic linkage. The anomeric 
oxygen of one particular monosaccharide is attached to a hydroxyl group of the second sugar 
moiety to build one disaccharide. The conformations around the glycosidic linkage are defined 
by the torsion angles F and Y (fig. 3). Obviously, not every possible combination of these 
angles is permitted from the energetic viewpoint, as certain geometries would give rise to 
steric clashes, while others provide stabilizing inter-residue van der Waals interactions. The 
glycosidic torsion angle F is restricted by the exo-anomeric effect, which favors a value of F of 
ca. +50° in the case of -D- and -L-hexopyranosides, and -50° in -D- and -L-hexopyranosides 
[15]. The origin and implications of the exo-anomeric effect to define the geometry of 
oligosaccharides and their mimetics remain a matter of investigation [16] Finally, 1-6 linkages 
demand the determination of an additional angle (w) around C5-C6 to provide the relative 
orientation of the two sugar planes (fig. 3). 
1.1.2.4 Increasing complexity: oligosaccharides to polysaccharides 
As the number of sugar units increase, so does carbohydrate complexity. Depending on the 
nature and the position of the sugar substituents, different oligosaccharides may adopt a 
variety of shapes and display distinct dynamic features. For instance, they may resemble chain-
like structures, as in chitooligosaccharides, which are linear (1-4) linked N-acetylglucosamine 
(GlcNAc) oligomers (fig. 4A) [17], or branched structures, with special mention to the blood 
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group determinant oligosaccharides (the ABH-system), and the GM1 oligosaccharide (fig. 4B), 
the sugar part of the corresponding ganglioside. Their conformational properties, adaptability 
and recognition features have been and still are deeply analyzed [15]. 
Further increase in carbohydrate size leads to polysaccharides. They are one of the most 
important classes of biological polymers, adopting a variety of functions, from energy storage, 
as in glycogen or starch, to structural composition of plant (cellulose) or fungal cells (chitin).   
The physical properties of polysaccharides may differ substantially from those of their 
monosaccharide building blocks. Often, they are amorphous and insoluble in water, or may 
display viscoelastic properties [18]. They may also differ in chemical complexity, as they can be 
composed of one single repeating unit (e.g. amylose) or incorporate many different types of 
sugar building blocks, and even aglyconic parts, such as the bacterial lipopolysaccharides (LPS) 
(fig. 4C, D). 
Another important class of oligo- and polysaccharides are glycosaminoglycans (GAGs), a term 
which encompasses a variety of sulfated amino-containing glycans. They include heparin, 
heparan sulfate, hyaluronic acid and keratan sulfate, which perform important structural 
functions, and whose recognition by different receptors triggers a plethora of biological 
responses, such as inflammation, cell adhesion, and regulation of cell growth and proliferation 
[19-20]. 
In summary, carbohydrates are structurally complex molecules, whose diversity emerges from 
a number of sources of variability at different levels of hierarchy. Carbohydrates potential for 
structural diversity surpasses those of proteins and nucleic acids [21-22]. This endows them 
with the capacity to store biological information. Through molecular recognition, carbohydrate 
messages are interpreted by sugar receptors, which translate them into biological function. 
7 
Figure 4: Oligo- and polysaccharides. A: Formula and 3D structure of chitopentaose as a linear oligosaccharide. B: 
Formula and 3D structure of the GM1 pentasaccharide as a branched oligosaccharide. C: Schematic structure of 
lypopolysaccharide. D: Schematic 2D cross-sectional view of glycogen, including a core molecule of glycogenin. The 
whole glycogen granule may contain more than 30,000 units of glucose [23]. 
1.2 Molecular recognition of carbohydrate and their receptors 
The notion of carbohydrates being specifically recognized by proteins dates back to the lock-
and-key principle used by Emil Fisher as early as 1894 [24] to illustrate the complementarity 
between a glucoside and an enzyme that permits the one to fit into the other. Today, 
knowledge on the intrinsic flexibility and variability of carbohydrates has reformulated the 
older paradigm as a bunch of keys, [25] each of which may be selected by one or more among 
a bunch of locks. This concept unifies the existing possibilities of induced-fit- or 
conformational-selection-based molecular recognition processes. 
The advent of modern techniques devoted to the structural elucidation of biomolecules have 
permitted to gain detailed insight into the mechanisms governing the phenomenon of  
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molecular recognition, providing a thorough understanding of the physicochemical bases 
underlying the receptor-ligand interaction. 
1.2.1 The Nature of the Carbohydrate-Protein Interaction 
In general, glycans bind at domains defined by shallow pockets on the hydrophilic surface of 
lectins and other receptors. As a consequence, affinity regimes of monovalent interactions 
between lectins and their ligands tend to be rather weak. Overall, sugar binding to proteins is 
made possible via a number of attractive forces including polar and hydrophobic interactions. 
Despite the phylogenetic and structural diversity of carbohydrate-binding proteins, the 
signature of the protein-carbohydrate interaction can be seen in different protein families and 
all throughout the evolutionary tree. 
1.2.1.1 Hydrogen bonding 
The establishment of hydrogen bonds between sugars and their receptors constitutes perhaps 
the most evident protein-carbohydrate bonding potential due to the existence of numerous 
OH groups in all saccharides (fig. 5A). Furthermore, hydrogen bonding is made possible not 
only thanks to the hydroxyl groups, but also to the presence of amine and carboxyl groups of 
many substituted carbohydrates. Hydroxyl groups may participate in hydrogen bonds both as 
donors and as acceptors, by means of their lone electron pairs. In some instances, the same 
OH group simultaneously acts as donor and acceptor, a characteristic phenomenon in sugar-
protein interactions, known as cooperative hydrogen bonding. Sugar hydroxyl groups establish 
hydrogen bond contacts with the side chains of polar residues, most often aspartic and 
glutamic acid, asparagine, glutamine, arginine and serine, as well as backbone amine and 
carbonyl groups. A characteristic feature of sugar-protein interactions commonly seen in 
lectins and enzymes are bidentate hydrogen bonds established between two adjacent hydroxyl 
groups of a sugar and both carboxylate oxygens of either aspartic or glutamic acids [26]. Of 
course, hydrogen bonding not only contributes to affinity but also to selectivity, being, in many 
cases, the characteristic stereochemical arrangement of hydroxyl groups what gives a protein 
its specificity towards a given sugar type. Our group has studied the implications of hydrogen 
bonding on selectivity by approaching the phenomenon from both perspectives, i.e. those of 
the proteins and of the sugars, by studying the effect of mutation of key residues of the 
9 
receptors [27], and using engineered sugars deleterious for hydroxyl groups via the synthesis 
of monodeoxy [28] and fluoro-monodeoxy derivatives [29-30] of natural lectin ligands.  
1.2.1.2 Apolar interactions 
In some sugars, the clustering of three or more adjacent CH groups caused by the 
characteristic steric disposition of hydroxyl groups creates hydrophobic patches on the sugar 
surface that can establish apolar interactions with hydrophobic epitopes in proteins, most 
notably the aromatic rings of Trp, Tyr and Phe residues (fig. 5B). Although the fine details of 
the nature of such interactions are currently subject to investigation, it is thought that 
attractive forces are due to both an entropic contribution, arising from the mutual shielding of 
both apolar surfaces from the bulk water, and the enthalpic contribution of non-conventional 
hydrogen bonds established between the partially positively charged CH groups and the 
quadrupole created by the -system of the aromatic ring [31]. Our group has contributed to 
the understanding of CH- interactions using a multidisciplinary approach combining NMR 
spectroscopy and molecular mechanics calculations. Using simple models involving 
monosaccharides and small aromatic compounds, such as free aromatic amino acids, it was 
possible to detect and quantify the magnitude of their interaction in water by simple NMR 
experiments [32]. In addition, experimental evidence for the hydrophobic component to the 
interactions was provided, finding that they were absent in aprotic solvents [33]. Theoretical 
results obtained in our laboratory also indicated that the carbohydrate-aromatic interaction is 
enthalpically stabilized by weak electro-attractive forces between the sugar hydrogens and the 
aromatic ring [34], a hypothesis that was confirmed experimentally [35]. 
1.2.1.3 Other interactions 
Further forces involved in the recognition of some carbohydrates by their protein receptors 
include electrostatic interactions between charged residues of some saccharides, such as sialic 
acid, and protein residues of opposite charge [36] (fig. 5C). Another type of interaction 
involves the coordination of a divalent cation bridging certain sugar hydroxyls and negatively 
charged aspartates or glutamates. Such interaction is displayed by proteins belonging to the 
C-type family of lectins, which require the presence of Ca2+ ions to bind their carbohydrate 
ligands [21] (fig. 5D). 
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Figure 5: Different types of protein-carbohydrate interactions (shown in yellow-dashed lines). A: Hydrogen bonds. 
Crystallographic structure of lactose-bound human galectin-7 (PDB: 4GAL) [37]. B: CH- interactions. NMR structure 
of hevein in complex with chitobiose (PDB: 1T0W) [38]. C: Electrostatic interactions. Crystallographic structure of 
the fibroblast growth factor in complex with a heparin pentasaccharide (PDB: 2AXM) [36]. D: Ca2+-mediated. 
Crystallographic structure of codakine, a C-type lectin, in complex with a biantennary complex-type N-glycan (PDB: 
2VUZ) [39]. 
1.2.2 Lectins and other carbohydrate-receptor proteins 
Carbohydrates interact with partners belonging to a number of protein families including 
lectins, antibodies, viruses and enzymes. The latter catalyze the synthesis of activated sugar 
donors [40], as well as the transfer of sugar residues from these donors to other carbohydrates 
or aglycans [41], and thus they are responsible for the genesis of the whole cellular glycan 
repertoire. For their part, anti-glycan antibodies are generated by the immune system and play 
a role in the defense against pathogens and cancer cells [42]. In contrast to antibodies, lectins 
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are not products of the immune system and they display structural diversity [43-44]. 
Furthermore, and unlike enzymes, they lack catalytic activity. Finally, viruses are non-living, 
infectious particles which specifically recognize surface protein and glycan determinants of 
their hosts through fibrous multi-domain receptors [45]. 
Etymologically from the Latin legere [8], meaning, among other things, to select, lectins 
recognize and bind selectively and specifically to carbohydrate epitopes of glycoproteins, 
glycolipids and free oligosaccharides without modifying them. First discovered in plants, lectins 
are now known in all domains of life.  
Lectins act as central mediators of the transfer of information in biological systems through 
their interactions with glycans, both as free carbohydrates in solution and presented by 
glycolipids or glycoproteins [8, 44]. These interactions mediate a number of important 
functions, including host-pathogen recognition [46],  protein trafficking [47], lymphocyte 
homing [48], fertilization and early development [49]. The key involvement of lectins in these 
processes offers the potential of exploiting them for therapeutic use, both as pharmacological 
targets [21], or as carriers to deliver drugs to their site of action [50].  
Lectins are diverse proteins according to structure, specificity and function. Although no 
absolute classification of lectins has been made, it is useful, in some contexts, to classify lectins 
according to their origin, hence distinguishing mainly between animal and plant lectins. 
1.2.2.1 Plant lectins 
Many plant lectins are involved in defense against parasites or predators, being sometimes 
secreted in large quantities as highly toxic agents, such as ricin [51]. Thanks to the easy 
disposal and purification of legume lectins, many of which are available in a commercial basis, 
plant lectins find themselves among the best characterized systems.  
Plant lectins are often found in the oligomeric state, e.g. as dimers or tetramers, which confers 
them the ability to precipitate multivalent carbohydrates and agglutinate cells. This makes of 
lectins a family of biologically relevant study systems, not only from the perspective of 
protein/sugar, but also of protein/protein interactions. 
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1.2.2.1.1 Hevein domains 
Hevein domains are common to plant lectins of different origins. They are specific for 
(1-4)GlcNAc-containing glycans,  notably chitin, a polysaccharide found in fungal cell walls 
and in the exoskeleton of insects and other invertebrate parasites. Lectins containing hevein 
domains are secreted by many plant species as a defense mechanism.  
The hevein domain is a structural motif containing 40-50 amino acids, characterized by the 
presence of 6 or 8 cysteine residues, at conserved positions, establishing three or four 
intramolecular disulfide bonds that highly stabilize the structure. Hevein domains are found in 
many legume lectins, such as hevein itself, a small protein of 43 amino acids isolated from the 
rubber tree (Hevea brasiliensis).  
The main driving force of the recognition of chito-oligosaccharides by hevein domains are CH- 
interactions (fig. 5B). Thanks to the very convenient properties of hevein, which are related to 
its small size and high stability, our group has profusely employed this lectin as a model system 
to study protein-carbohydrate interactions in solution [31], with a focus on the nature of the 
CH- interaction. Using NMR spectroscopy, our group has obtained detailed information on 
affinity and binding geometry for several hevein/(GlcNAc)n complexes, and provided the first 
structure of a lectin/ligand complex solved by NMR [52].  
Other proteins bearing hevein domains include the stinging nettle lectin (Urtica dioica
agglutinin, UDA), which is composed of two hevein domains [53], and the wheat germ 
agglutinin (WGA), a dimeric protein in which each subunit is an assembly of four hevein 
domains [54]. 
1.2.2.2 Animal lectins. Galectins 
Animal lectins are expressed in a variety of tissues, where they perform disparate functions. 
They are generally divided into two main groups, according to their function and cellular 
location. The first one comprises intracellular lectins, such as the calnexin family and M-, L- and 
P-type lectins. Acting in different compartments along the cellular secretory pathway, they are 
mainly involved in glycoprotein sorting, trafficking and quality control [55-57] The second 
group includes extracellular lectins, such as C- and R-type lectins, siglecs and galectins, which 
may be membrane-bound or secreted to the extracellular medium, playing important roles in 
cell adhesion, cell signaling and recognition of pathogens [58]. 
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Galectins [59] are a family of animal lectins defined by a shared consensus of amino acid 
sequences and a carbohydrate recognition domain (CRD) of around 130 amino acids, with 
affinity for -galactose (Gal) containing oligosaccharides. The more than 30 solved 3D 
structures of many galectin family members show a highly-conserved -sandwich fold (fig. 6), 
slightly bent forming a concave groove on the side opposite to the sugar-binding site. 
Although, in some instances, galectins have been recognized to have intracellular functions, 
they are best known for their extracellular activities, being found on the cell surface or 
deposited in the extracellular matrix. There, galectins specifically recognize glycan moieties of 
glycolipids and glycoproteins on the surface of various cell types, triggering a number of cell 
responses both in developmental stages and in the adult tissue. In general, galectins have been 
associated with cell-cell and/or cell-matrix adhesion and migration, signal transduction, cell 
growth and proliferation and apoptosis [60]. Up to now, 15 members of the galectin family 
have been identified in mammals (Table I), although this number might increase [61]. Galectins 
are also known to other animal groups, such as birds [62] and invertebrates [63-64].  
Galectins are classified in three groups according to their structure (fig. 7). Prototype galectins 
are composed of a single CRD, which can be monomeric or, more often, self-associate to form 
homodimers (gal-1, -2, -5, -7, -10, -11, -13, -14 and -15). Tandem-repeat galectins consist of 
two distinct CRDs connected by a linker peptide domain (gal-4, -6, -8, -9 and -12). Finally, 
chimera-type galectins are composed of one CRD attached to a non-lectin part. At present, the 
only chimera-type galectin identified is gal-3, which consists of a CRD and an N-terminal 
domain (ND), including several collagen-type repeats rich in glycine and proline, and an 
N-terminal peptide region, which can be phosphorylated [65]. The ND of gal-3 is involved in 
pentamerization of the lectin [66]. Of note, in vitro and in vivo enzymic cleavage of full length 
gal-3 by extracellular metalloproteases yields a truncated, monomeric version of gal-3 
consisting of only its CRD [66]. 
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Figure 6: Galectin fold and interactions. Crystallographic structure of a lactose-bound human gal-1 (PDB: 1GZW) [67] 
monomer, showing the characteristic galectin -sandwich fold. The expanded view shows the network of contacts 
with lactose, including hydrogen bonds between sugar hydroxyl groups and the side-chains of conserved residues 
H44, N46, R48, E71 and R73, and a CH- interaction established between W68 and the apolar face of the galactose 
reside. 
1.2.2.2.1 Recognition features of galectins 
The ability of galectins to bind -galactoside-containing glycans has been well documented 
both in vitro and in vivo [68]. Galectin family members do not appear to have specific 
individual receptors, but rather they can bind to a set of cell-surface or extracellular matrix 
glycoproteins containing suitable oligosaccharides [68]. The minimal saccharide unit 
recognized by galectins is the galactose residue, linked to another monosaccharide in the 
-configuration. Although many structural aspects of the galectin/galactoside interaction have 
been explored by using simple sugars down to the level of disaccharides (see, for example, [69-
70]), galectins perform their biologically relevant functions by binding to -galactosides 
incorporated in larger, more complex ligands, such as N-acetyl lactosamine (Gal-(1-4)GlcNAc) 
residues found in N-linked complex type glycans and O-linked glycans on glycoproteins [71]. 
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Figure 7: Structural types of galectins: prototype, tandem-repeat and chimeric, with examples. 
Galectin Type Location Function 
Gal-1 Prototype Ubiquitous 
Induction of apoptosis in activated T cells, 
cell growth, mRNA splicing, regeneration of 
nerve axon [72].
Gal-2 Prototype Gastrointestinal tract Induction of apoptosis in T cells. 
Gal-3 Chimera Ubiquitous 
Pro- or anti-apoptotic, cell adhesion, mRNA 
splicing, macrophage chemotactic factor, 
regulation of genes including JNK1 [73]. 
Gal-4 Tandem Gastrointestinal tract Activation of intestinal CD4+ cells 
Gal-7 Prototype 
Keratinocytes (stratified 
epithelium) 
Pro-apoptotic effector, differentiation of 
keratinocytes, wound healing [74].  
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Gal-8 Tandem Ubiquitous 
Cell adhesion through binding to integrins, 
regulation of neutrophil function. 
Gal-9 Tandem 
Immune cells, lung, kidney 
gastrointestinal tract 
Induction of apoptosis in activated T cells 
and cancer cells, eosinophil chemotaxis, 
urate transporter in kidney [75]. 
Gal-10 Prototype Eosinophils, basophils Suppression of T cell proliferation. 
Gal-12 Tandem Adipose tissue Induction of apoptosis in adipocytes. 
Gal-13 Prototype Placenta Lysophospholypase activity [76]. 
Table I: Structure, location and function of the principal human galectins. 
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Figure 8: Intra- and extra-cellular functions of galectins. A: Subcellular localization and secretion. From the cytosol, 
galectins can be translocated into the nucleus or vesicles, or stay in the cytosol. In addition, and although galectins 
lack a canonical secretion signal peptide, they can be exported across the plasma membrane by non-classical 
mechanisms through vesicle transport. Once in the extracellular space, they can bind to cell surface glycans and 
cross-link them to glycans of the extracellular matrix. B: Extracellular roles of galectins. By cross-linking glycans on 
neighboring cells, either directly or via the extracellular matrix, galectins can mediate cell adhesion. Also, by binding 
to cell surface glycans in cis, they can form homogenous lattices on cell surfaces, which can trigger the activation of 
signaling pathways of functional relevance. Adapted from [60].
As sugar receptors, the affinity of galectins toward simple saccharides is rather low. For 
example, the KD of gal-3 for lactose, the pan-galectin ligand, is around 170 µM [77]. Binding 
affinities can be modulated by substitutions at the -galactoside core, resulting from subtle, 
but significant differences in the architecture of the sugar binding site of each galectin 
member. For example, N-acetylation of galactose significantly reduces the affinity of gal-1 for 
this residue, whereas it increases that of gal-3 [78]. In addition, (2-6)-sialylation notably 
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decreases affinity for gal-1 and gal-3. This modification has been shown to be of functional 
relevance, being crucial for the gal-1-dependent skewing of T cells toward a T-helper cytokine 
profile, both in mice and in humans [79]. For its part, (2-3)-sialylation greatly boosts binding 
affinity to some galectins, notably the tandem-repeat type gal-8 [80], down to the nM range. 
The main driving force responsible of this strong interaction, hardly found in other monovalent 
lectin-sugar systems, is an electrostatic contact with the Arg59 side-chain of the gal-8 N-CRD. 
In contrast, the gal-8 C-CRD does not interact with (2-3)-sialylated ligands, showing 
preference toward LacNac-containing oligomers instead [81]. Thus, gal-8 is an example of how 
tandem-repeat galectins may display different recognition features at each individual sugar-
binding site. 
In any case, monovalent interactions of galectin CRDs with their glycan ligands are lower than 
typical protein-protein interactions [78]. In order to increase their avidity toward their ligands, 
most galectins, as other lectins, self-associate to form higher-order, multivalent glycoclusters. 
For example, truncated gal-3, which lacks the ND needed for oligomerization, also lacks the 
ability to tightly bind to the glycocalix of endothelial cells, in contrast to the full-length protein 
[82]. Similarly, dimeric gal-1 binds with considerably higher affinity to extended glycans 
containing terminal N-acetyllactosamine (LacNAc) sequences than a monomeric gal-1 mutant 
[83]. Thus, higher avidities of soluble galectins are achieved by oligomerization of monovalent 
galectin monomers, which is essential for these proteins to perform their functions. 
1.2.2.2.2 Galectins in protein-protein interactions 
A number of studies have shown that some galectins can play a role inside the cell, 
participating in protein-protein interactions in a manner independent of their sugar-binding 
capabilities. For instance, gal-1 and -3 are known pre-mRNA-splicing factors, and gal-3, -7 and 
-12 have been shown to regulate cell-growth and apoptosis intracellularly [84]. In some cases, 
the protein interacting partners of galectins mediating these intracellular processes are known. 
For instance, physical interaction has been demonstrated between gal-7 and at least two non-
glycosylated partners: the apoptotic regulator Bcl-2 [85] and the transcription factor Smad2/3 
[86]. Of note, the gal-7/Bcl-2 interaction was shown to be independent of carbohydrate 
binding. Furthermore, non-glycosylated protein partners are also known to other galectins, 
such as Bcl-2 itself for gal-3 [87] and farnesyl-Ras for gal-1 [88]. In the latter case, the binding 
epitope on gal-1 was delineated by the construction of a mutant (gal-1 L11A) which retained 
normal carbohydrate-binding abilities, but inhibited Ras-GTP, giving rise to an attenuated pro-
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oncogenic activity of H-Ras(G12V) [89]. Taken together, all these data evidence the interacting 
capabilities of galectins beyond the carbohydrate recognition site. 
1.2.2.2.3 Role of galectins in the immune response  
Galectins are widely expressed in mammalian tissues, including most cells responsible for both 
the innate (dendritic cells, macrophages, mast cells, natural killer cells and B1 cells) and 
adaptive (activated B and T cells) immune responses [60]. 
Galectins are involved in the adaptive response through regulation of immune cell 
development and homeostasis at different levels. For example, galectins can modulate B cell 
maturation and differentiation [90]. Galectins are also bivalent modulators of apoptosis. Gal-1 
is pro-apoptotic on T cells depending on the developmental stage and activation status of the 
cell, as well as on the microenvironment [79]. On the other hand, the effect of gal-3 on T cell 
survival varies depending on its location: it is anti-apoptotic when intracellular, and pro-
apoptotic when outside the cell [91]. Also, galectins are known to exert important regulatory 
functions in T cell homeostasis. Signaling cascades triggered by their binding and lattice 
formation at the surface of T cells have implications in a range of downstream events 
modulating their differentiation, activation, and production of pro- and anti-inflammatory 
cytokines [68, 92].
Recently, galectins have been discovered to also play a role in innate immunity, by binding 
glycans at the surface of different types of pathogens [60, 93]. For instance, gal-1 is able to 
inhibit the fusion of the Nipah virus with endothelial cells by binding to N-linked 
oligosaccharides of the virion envelope [94]. Also, gal-3 has been reported to be a receptor for 
bacterial LPS in a species-dependent manner, with at least two independent binding sites for 
LPS [95]: its CRD binds to -galactoside-containing groups in the glycan domain of LPS, and its 
ND binds the lipid A moiety of LPS, which is essential for LPS-mediated neutrophil activation 
[96-97]. GalNAc-(1-4)GlcNAc (LacdiNAc)-containing glycans constitute a parasite pattern for 
gal-3-mediated immune recognition of various invertebrates, such as helminths [98]. Also, 
gal-3 can bind to Gal-(1-3)-Gal, a Leishmania virulence factor [99-100], the Gal-(1-3)-Gal-(1-
4)-GlcNAc-R xenoantigen [101-102], and A/B-histo-blood group tetrasaccharides [103]. In 
addition, the recent demonstration that galectins 4 and 8 are able to kill E. coli bacteria 
expressing blood group B antigen [104] has reinforced the idea that innate immunity functions 
are widespread among the galectin family. 
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1.3 Nuclear Magnetic Resonance Spectroscopy (NMR) 
Over the last years, numerous investigations have looked deeply into the fine structural details 
of carbohydrates and their recognition by receptors. Advances in different biophysical and 
spectroscopic techniques, such as X-ray crystallography and Nuclear Magnetic Resonance 
spectroscopy (NMR), complemented by quantitative data obtained through isothermal 
titration microcalorimetry (ITC), [105] have allowed for the gathering of information on 
protein-carbohydrate complexes [106] at atomic resolution, and permitted to deduce the role 
of the different forces involved in their interactions.  
Among these, NMR is one of the most widely used techniques to characterize molecular 
recognition events, [107] thanks to its versatility, and a spectacular progress that it has 
experienced in recent times, with advances in distinct areas to generate an improvement in 
the resolution and sensitivity of NMR experiments. Also, the developments of procedures for 
structural determination, as well as the study of the conformation and dynamics of complex 
oligosaccharides have permitted key advances in the expansion of NMR [108]. Also of note, 
NMR techniques provide the possibility to work in solution, i.e. in conditions akin to those 
physiological. 
Nuclear magnetic resonance [109-110] is an intrinsic property of atomic nuclei having a non-
zero spin quantum number, I. Such nuclei possess an associated magnetic moment,  via the 
relation  = gI, where g is the gyromagnetic ratio, which is characteristic for each nucleus. The 
angular momentum associated with nuclear spin is quantized, e.g. both the magnitude and 
orientation of the angular momentum can only adopt a limited number of values. For a given 
nucleus with spin I, there exist 2I+1 possible angular momentum states, taking values from -I
to +I. Thus, for nuclei with spin I = ½, such as 1H, 13C or 15N, there are two possible sublevels, or 
spin states: m = +½ and m = - ½. In the absence of an external magnetic field, these levels are 
degenerate, which means that both states have the same energy, and the number of nuclei in 
both states will be approximately equal. However, if an external magnetic field (B0) is applied, 
the degeneracy is broken, being the difference between both states as shown in eq. 1. As a 
result, a slightly larger fraction of the nuclei is present in the lower energy spin state, following 
the Boltzmann distribution (eq. 2). 
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Figure 9: Nuclear magnetic resonance. Left: precession of a m = ½ nucleus with an associated magnetic moment 
around the external magnetic field B0. Center: two possible momentum states of a nucleus with spin I = ½ under an 
external magnetic field B0. Right: energy difference (E) between both momentum states and its dependence on 
the external magnetic field strength. 
where k is the Boltzmanns constant. The signal in NMR spectroscopy results from the 
difference between the energy absorbed by the spins which make a transition from the lower 
energy state to the higher energy state, and the energy emitted by the spins which 
simultaneously make a transition from the higher energy state to the lower energy state. The 
NMR signal, therefore, is proportional to the population difference between both states. 
Noteworthy is that, given the small energy difference between both spin states even at very 
high magnetic fields, the population bias towards the lower energy state is always tiny, making 
NMR a rather insensitive spectroscopy. 
The magnetic moment of each nucleus precesses around B0 (fig. 9). The frequency of this 
precession is called the Larmor frequency (w0), which is the frequency of resonance for each 
nucleus, and is equivalent to the energy difference between the two levels: 
 (3) 
The Larmor frequency for each nucleus depends thus on the gyromagnetic ratio and the 
strength of the magnetic field, as shown in eq. 3. However, there exist local perturbations of 
the magnetic field experienced by each nucleus, mainly due to the shielding exerted by nearby 
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electrons. As a result, nuclei within different chemical environments precess at slightly 
different frequencies (eq. 4), which permits the use of NMR as a spectroscopy technique. 
 (4) 
For practical reasons, NMR spectroscopists prefer the use of chemical shifts (d, expressed in 
ppm) instead of Larmor frequencies. The relation between both is shown in eq. 5. 
 (5), 
where w is the Larmor frequency for a given nucleus, and wref, is the Larmor frequency of a 
nucleus in a reference compound, usually tetramethylsilane (TMS) or trimethylsilylpropionate 
(TSP) in proton NMR. 
1.3.1 NMR spectroscopy of carbohydrates 
For decades, NMR spectroscopy has been the preferred biophysical technique for structural 
characterization of carbohydrates. Reasons for this include the intrinsic flexibility of glycans, 
which makes them difficult to crystallize, hampering its study by X-ray diffraction, and the 
possibility to work in solution. In addition, NMR spectroscopy offers a great variety of 
methods, which permit the gathering of very useful information regarding the fine structure of 
carbohydrates, their conformational and dynamic properties, and their recognition features by 
receptors. 
Among several experimental restraints that can be gathered for structural determination of 
carbohydrates, vicinal 1H-1H coupling constants (3JHH) are particularly useful, as they permit to 
determine the relative configuration of the sugar nuclei. Additionally, nuclear Overhauser 
enhancement (NOE) spectroscopy (NOESY) is employed for conformational analyses around 
the glycosidic linkage [107, 111]. 
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1.3.1.1 Coupling constants 
In the late 1950s, Nobel Laureate Martin Karplus described a relationship between the 
dihedral torsion angle established between vicinal hydrogens and the 3JHH coupling constant, 
by using a theoretical approach [112]: 
3JHHABcosFCcos2F                                           (6) 
Where F is the dihedral angle between the two protons. According to eq. 6, for dihedral 
angles of 0º or 180º the observed coupling constant is large; while, conversely, dihedral angles 
around 90, lead to cos2F values close to zero, and thus the observed coupling constant is 
small or null.  For its part, coefficients A, B and C are parameterized for each particular kind of 
molecules, atoms and substituents. In this regard, and for instance, eight new Karplus 
relationships have recently been refined for use in conformational studies of saccharide 
N-acetyl side-chains [113].  
A practical example of the usefulness of the Karplus equation to determine the relative 
configuration of the chiral centers is provided by the differentiation between two 
monosaccharides, such as -glucose and -mannose, which are epimers at C2. The dihedral 
angle between H1 and H2 is around 180º in -glucose and 60º in -mannose. Subsequently, the 
3JHH value is large in glucose, of around 10-15 Hz, and small in mannose, of around 3-5 Hz. 
Also, the absolute configuration of the anomeric function in glycosides can be obtained with 
the same approach: in -glucose, the 3JH1H2 is small due to the small angle established 
between these two protons, while their trans-type di-axial disposition in -glucose entails a 
larger J-coupling value. 
1.3.1.2 The Nuclear Overhauser Effect (NOE). NOE spectroscopy (NOESY) 
The 3D molecular geometry of glycans becomes more intrincated as the number of saccharide 
units increases. Knowledge on the spatial relationships among nuclei belonging to different 
units can be provided by both nuclear Overhauser enhancement (NOE) spectroscopy (NOESY) 
studies. This source of structural information is based on its dependency on the interproton 
distance through space. 
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The NOE is defined as the change in intensity of a nucleus' signal when the spin transitions of 
another nucleus cause a perturbation of its equilibrium populations. The two nuclei do not 
share a scalar (through bond) coupling; instead, they are sufficiently close in space to share a 
dipolar coupling. Thus, the NOE originates from dipolar cross-relaxation between pairs of 
protons, and depends on the proton-proton distance and on the molecular motion of the 
interproton vector:
INOE1/r6f tc     (7) 
where INOE is the NOE intensity, r is the proton-proton distance, and f is a function that 
depends, among others factors, on the correlation time (c) that describes the motion of the 
interproton vector. The inverse-sixth relationship in eq. 7 implies that the NOE only develops 
between nuclei that are close in space, usually within 5 Å. In 2002, Kurt Wüthrich was awarded 
the Nobel Prize in Chemistry for demonstrating that two-dimensional NOE spectroscopy could 
be used to determine the 3D structures of biological macromolecules in solution [114-115]. In 
2D NOESY experiments, a map of the NOE relationships of every hydrogen nucleus is obtained, 
thus allowing for a thorough structural characterization of the molecule. 
Of course, not only homonuclear NOESY, but also heteronuclear studies are possible. For 
instance, 19F-1H heteronuclear NOE spectroscopy (HOESY) may be employed to estimate 
fluorine-proton distances [116]. 
1.3.1.3 Spectral assignment of carbohydrates 
Among all biophysical techniques, NMR is unique in that it permits the monitoring of individual 
nuclei, allowing for complete structural elucidation of biomolecules, as well as epitope-fine 
mapping of their interactions at atomic resolution. To initiate these studies, the first step is 
thus to obtain the complete or partial spectral assignment of the molecules of interest. A 
palette of NMR experiments can provide such information, usually when used in conjunction.  
Correlation spectroscopy (COSY) is a 2D homonuclear experiment used to identify spins which 
are directly J-coupled to each other, thus allowing for the identification of neighboring 
protons. Total correlation spectroscopy (TOCSY) experiments are conceptually similar to COSY-
type methods. However, they allow for the identification of nuclei that are not only directly 
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coupled, but also indirectly coupled through a chain of J-couplings, i.e. belonging to the same 
spin system. Thus, in carbohydrates, TOCSY experiments allow for the identification of spins 
belonging to the same sugar residue. For their part, NOESY experiments allow for the 
establishment of inter-residue connectivities. 
Finally, heteronuclear experiments are useful for achieving the splitting of signals that are 
overlapping in the 1H dimension, something not unusual in carbohydrates due to their poor 
spectral dispersion. The most commonly used is 1H-13C heteronuclear single-quantum 
coherence (HSQC), which provides a 2D mapping of pairs of directly bound C-H nuclei. 
NMR spectral elucidation can often be aided by assignments reported in the literature or 
stored in databases (notably, the Biological Magnetic Resonance Data Bank BMRB [117]) or 
computationally simulated, e.g. with CASPER [118]. 
1.3.2 NMR methods for the study of protein-carbohydrate interactions 
In addition to those suitable for the study of isolated carbohydrate molecules, a variety of 
NMR techniques are also available for studying protein-ligand interactions. These methods, 
usually assisted by computational protocols, permit to elucidate the structural features of the 
binding entities, as well as to characterize the kinetic and thermodynamic parameters of the 
free-bound equilibrium.  
NMR techniques devoted to the study of molecular recognition processes encompass both 
ligand- and receptor-detected experiments. Receptor-based methods are based on the 
monitoring and comparison of the receptor signals in the presence and absence of compounds 
of interest. By identifying perturbations of specific protein resonances, their binding sites can 
be delineated. These methods demand physicochemical properties of the protein target that 
are often challenging. First, they are usually applicable to relatively small receptors (< 40 kDa). 
Also, milligram quantities of soluble, non-aggregated protein must be expressed and purified. 
Thus, suitable expression hosts must be found that permit isotope enrichment (e.g. 13C, 15N, 
and sometimes also 2H) needed for resonance assignment of the heteronuclear NMR spectrum 
of the macromolecule. In addition, it must be ensured that samples are stable for the time 
required for sequential resonance assignment (weeks).  
For their part, ligand-detected methods are based on the monitoring of the NMR parameters 
of ligands in the presence and absence of the receptor. Saturation transfer difference (STD), 
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WaterLOGSY and transferred NOE spectroscopy (trNOESY) are used for detecting binding 
based on either changes in the motional properties of the saccharides upon binding to large 
macromolecular receptors, or the transfer of magnetization via their binding to the receptors. 
In contrast to protein-detected methods, these approaches render the size of the protein not 
an issue. In fact, most ligand-based experiments become more sensitive when working with 
larger and multiple site receptors. Additionally, ligand observation bypasses the need to 
produce milligram quantities of isotopically labeled protein.  
An obvious setback of ligand-based approaches is the impossibility to identify their binding site 
on the receptor surface. Also, ligand-based approaches rely on the exchange-mediated 
transfer of bound state information to the free state. This requirement biases ligand-detected 
methods toward the study of weakly binding ligands (i.e. in fast exchange) and the use of large 
ligand molar excesses.  
In short, both receptor- and ligand-based approaches have distinct advantages and 
disadvantages, but they can be used together to provide a thorough vision on all the structural 
aspects that govern the sugar-protein interaction. 
1.3.2.1 Ligand-detected methods 
With certainty, the most powerful ligand-detected NMR techniques for probing binding 
activities are those based on the transfer of magnetization, such as saturation transfer 
difference (STD) and WaterLOGSY. The common mechanism underlying both techniques is the 
detection of dipole-dipole interactions between the spins of the ligands and those of the 
receptor, being their main difference the target of the irradiation: in STD experiments, the 
magnetization is transferred from the irradiated protein to the binding ligands, while in the 
WaterLOGSY experiment, the bulk water is selectively excited, and the magnetization is 
transferred from the water molecules lying at the receptor-ligand interface to the ligand 
nuclei. 
1.3.2.1.1 Saturation transfer difference (STD) 
The STD experiment [119] involves the comparison of two 1H-NMR spectra of the same 
sample, acquired either with (on-resonance spectrum) or without (off-resonance spectrum) 
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saturation of the protein. In the on-resonance experiment, a subset of the protein protons are 
selectively irradiated by a train of pulses directed towards frequencies of the 1H-NMR 
spectrum devoid of ligand signals. Typically, the irradiation frequency is set between -1 and 1 
ppm, thus being side-chain protons of Ile, Val and Leu residues the target of irradiation. 
Alternatively, if the ligand lacks signals in the aromatic region, irradiation can be set at 6-8 
ppm. The magnetization then quickly propagates, via 1H-1H cross-relaxation pathways, from 
the irradiated protons to the rest of the protein, and from there to any ligands in direct contact 
to the protein. This will lead to a spectrum where the intensity of the signals belonging to 
saturated molecules (both the receptor and binding ligands) is decreased, but leaving signals of 
non-binding molecules unaffected. 
In parallel, an off-resonance spectrum, equivalent to a reference 1H-NMR spectrum of the 
complex, is obtained by irradiating the sample at spectral regions devoid of either receptor 
and ligand resonances (e.g. 100 ppm). The difference between the reference and the on-
resonance spectra yields a saturation spectrum, in which the signals of the saturated nuclei are 
represented, thus allowing the discrimination of ligands with binding activities in a compound 
mixture (fig. 10).   
Typically, the sample is irradiated with a total saturation time of between 0.5 and 4 s. During 
this time, the ligand molecules can enter the binding site, become saturated, and leave it. If 
the ligand is in excess versus the receptor, this process can take place for many times for 
different individual ligand molecules, provided that their binding exchange kinetics is fast 
enough. Thanks to the slow longitudinal relaxation of the ligands, the saturated state largely 
persists when ligands dissociate, giving rise to a pool of unbound saturated ligands, which are 
ultimately responsible for the STD signal. On the basis of this, two considerations can be made. 
First, the STD experiment is most sensitive to ligands binding strongly enough to become 
effectively saturated, but weakly enough to be in fast exchange between the bound and the 
unbound states so that a large population of unbound, saturated molecules is generated. Put 
into numbers, the optimal range of dissociation constants is about 10-3-10-8 M [120]. Second, 
the method enables a large excess of ligand to be used, typically 20:1 to 100:1. Thanks to the 
efficient saturation of proteins, the concentration of receptor can be kept as low as 1 M in 
favorable cases, which means that concentrations between 50 M and 200 M of ligands can 
be used. Of course, this is also highly dependent on the water solubility of the screened 
compounds. 
28 
The small amounts of protein needed for the STD experiment, added to the simplicity of its 
read-out and the possibility to screen several compounds at a time, make of it the preferred 
NMR-based method for screening a large number of putative ligands. Moreover, in its more 
than 10 years of history, the STD has proven versatile and useful for the pharmaceutical 
industry far beyond its role as a screening technique, being today routinely utilized for the 
characterization of the ligand epitopes and determination of affinity constants.  
The STD experiment was originally designed to screen a library of carbohydrate compounds 
against the wheat germ agglutinin (WGA) [119]. In the same study, however, it was realized 
that this technique was not only useful to detect binding events, but also to map the parts of 
the ligand making a major contribution to the binding. Indeed, in complex molecules, the 
ligand epitopes establishing tighter contacts with the protein receive a higher amount of 
magnetization, which is translated into stronger signals in the STD spectrum. This information 
facilitates the discrimination between parts of the molecule with major importance for binding 
(pharmacophore), and those with less relevance, which can be subject to chemical 
development in order to achieve better affinities or improved properties for the overall drug.  
In addition, STD experiments allow to measure binding affinities, thus enabling the ranking of 
bioactive compounds. For this purpose, STD-titration curves are built in the presence of 
variable amounts of the ligand. Special care must be taken to keep the protein concentration 
constant, as it is an important factor affecting the intensity of the STD signal. Measuring of KDs 
by STD experiments must be executed carefully, as there are a number of factors which can 
introduce biases in the estimations, such as rebinding events and the longitudinal relaxation of 
the ligands. To overcome these sources of error, KDs are determined by STD titration curves at 
zero saturation time, since, at these conditions, neither rebinding nor relaxation occurs. Curves 
at zero saturation time are extrapolated from titration experiments performed at different 
saturation times. Affinity data estimated this way have proven to be in agreement with those 
obtained by other biophysical techniques, such as calorimetric studies [121]. 
STD experiments have been successfully applied to whole, living cells, enabling the study of 
ligand binding to membrane proteins, such as G-protein coupled receptors (GPCRs), which are 
often difficult to isolate and manipulate. A typical problem arising when STD experiments are 
performed on whole cells is the observation of crowded STD spectra due to the saturated cell 
components, which can preclude the identification and epitope mapping of the ligand signals. 
In such cases, a variant technique known as saturation transfer double difference (STDD) is 
applied. According to this method, the STD spectrum of a control performed in the presence of 
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the cells is subtracted from the STD spectrum performed in the presence of the cells and the 
ligand, leading to the exclusive observation of signals corresponding to the ligand STD effects 
in the STDD spectrum [122].
1.3.2.1.2 WaterLOGSY 
In the second magnetization transfer experiment, the magnetization of the bulk water is 
selectively transferred, via the protein-ligand complex, to the ligand in the unbound state. 
In essence, the WaterLOGSY (Water-Ligand Observed via Gradient SpectroscopY) experiment 
[123] can be understood as a NOESY experiment, in which the magnetization of the water 
molecules is selectively inverted, and during a long mixing time of up to several seconds, the 
magnetization is transferred, via 1H-1H cross-relaxation, to the ligand spins at the protein-
ligand interface. There are essentially two pathways by which this transfer of the 
magnetization occurs: (i) via direct cross-relaxation from the water molecules tightly bound at 
the protein-ligand interface, and (ii) via chemical exchange between the water protons and the 
labile protons of amine and hydroxyl groups in the protein, which in turn cross-relax with the 
protons of the bound ligand. In either case, an inversion of the NOE sign takes place during the 
mixing time, since both the protein protons and those of the water molecules bound to the 
protein adopt the motional and NMR relaxation properties of the receptor, with a slow 
tumbling rate and therefore, a long correlation time. For their part, non-interacting ligands 
receive the magnetization only in the free state, via water molecules involved in their solvation 
sphere, and the sign of the NOE stays unaltered. As a result, the WaterLOGSY experiment 
yields a spectrum in which ligands with binding activity are manifested by positive signals, 
whereas non-binding ligands are represented by negative signals (fig. 11). 
In practical terms, the same considerations regarding the use of a ligand excess and low 
protein requirements can be made with respect to STD experiments. The sensitivity and range 
of applicability of both methods is comparable, and the WaterLOGSY can also be used to 
obtain affinity data [124]. For KD determination by WaterLOGSY, a parallel series of control 
experiments in the absence of the receptor must be performed. Since each signal in the 
WaterLOGSY experiment is a weighted combination of the negative NOEs of the hydrated 
unbound ligand and the positive NOEs of the ligand in the bound state, the WaterLOGSY 
signals must be normalized by subtracting the signals of the reference spectrum from those of 
the WaterLOGSY spectrum. Titration curves are then built by plotting the resulting intensities 
against the respective ligand concentration values.  
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In addition, it has been shown that WaterLOGSY experiments can also provide information on 
the ligand orientation in the bound state, given the different degrees of bulk water 
accessibility to parts of the ligand facing the protein (giving rise to positive NOEs) and those 
protruding from the protein (giving rise to negative NOEs) [125].  
Figure 10: The STD experiment. Top panel: schematic 
representation of the STD experiment, with arrows 
representing the transfer of magnetization from the 
irradiated protons in the macromolecule to the ligand 
protons. Middle panel: Simulated STD experiment. (a) 
Reference (off-resonance) spectrum; (b) On-resonance 
spectrum; (c) Difference spectrum (up-scaled). Bottom 
panel: illustration of the STD epitope mapping effect 
Figure 11: The WaterLOGSY experiment. Top panel: 
schematic representation of the WaterLOGSY 
experiment. White circles represent water molecules 
causing negative NOEs, and filled circles represent 
water molecules causing positive NOEs or labile protons 
in the protein exchanged from the irradiated water. 
Bottom panel: Simulated WaterLOGSY experiment. (a) 
Reference spectrum; (b) WaterLOGSY spectrum. 
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A practical drawback of the WaterLOGSY experiment is that samples must be prepared in 
protonated H2O as a solvent, which requires the introduction of an efficient means to suppress 
the water signal. On the other hand, its lesser dependence on spin diffusion makes 
WaterLOGSY the preferred option when dealing with receptors of low proton densities, such 
as nucleic acids [126]. 
1.3.2.1.3 Transferred NOESY (trNOESY) 
Since its introduction by Bothner-By in the early 1970s, trNOE spectroscopy [127-128] has 
been thoroughly used to study receptor-ligand interactions. This technique focuses on the 
change of sign in the ligand NOE peaks upon binding to the receptor. This is due to the 
dependence of the NOE sign on the correlation time of the molecule, which in turn is related 
with its size. As a result, fast moving small molecules show positive NOEs, while slow tumbling 
macromolecules exhibit negative NOEs.  
The trNOESY experiment is a regular 2D NOESY experiment in which the cross-peaks of the 
ligand change their NOE sign by virtue of the fact that, in the bound state, they adopt the 
motional properties of the macromolecule. As a result, non-binders show no NOE sign change 
upon the presence of receptor and their NOEs remain positive, while binders show negative 
NOE cross-peaks. Of note, the observed NOE is a contribution of both the free (positive NOE) 
and the bound ligand (negative NOE), but the cross-relaxation rate of the bound ligand is much 
larger than that in the free state. Thus, the observed NOEs show a predominance of the 
contribution arisen by the bound form [129]. As a result, the trNOESY experiment not only 
permits to detect interactions, but also provides information on the conformation of the ligand 
in the bound state. 
1.3.2.1.4 Employing other nuclei (19F)  
The hydrogen-1 nucleus (1H) accounts for the overwhelming majority of all NMR observations 
of (bio)organic compounds. This privileged position of the proton is due to a sum of factors 
that made the observation of this nucleus very convenient. With a natural isotopic abundance 
close to 100% and the highest gyromagnetic ratio among natural nuclei, 1H is the most 
sensitive nucleus of the periodic table. It has a spin I = ½, which enormously simplifies its NMR 
signals, and is present in virtually all organic molecules. 
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The virtues of the proton are in contrast with a majority of the other elements of ubiquitous 
presence in organic compounds. Carbon and oxygen have the disadvantage that their most 
abundant isotopes, 12C and 16O, are null-spin nuclei, and hence are NMR inactive, as is the case 
for 32S. The majority nitrogen isotope, 14N, has a spin I = 1, which causes its NMR signals to be 
significantly broadened by quadrupolar interactions, to the extent that they become often 
unobservable in high-resolution NMR spectrometers. For their part, 13C and 15N are stable, 
magnetically active nuclei with a spin I = ½, but their low natural isotopic abundance (1.1% and 
0.37%, respectively) and poor sensitivity in comparison to 1H preclude their use for routine 
NMR studies such as compound screening. However, their use in receptor-detected methods, 
especially in isotopically enriched samples, is of great usefulness in the drug discovery process, 
as will be discussed later.   
Phosphorous-31 has a spin I = ½ and a 100% isotopic abundance. Depending on its oxidation 
state, phosphorous nuclei can adopt a broad range of chemical shifts, being the typical 31P 
chemical shift dispersion in organic compounds of about 100 ppm. In addition to the many 
important enzymatic reactions involving phosphorous-containing reactants, phosphorous plays 
a role in many protease inhibitors by mimicking the tetrahedral intermediate of a peptide 
bond hydrolysis. With these considerations, 31P-NMR has been regarded as a tool for 
compound screening [130], but the otherwise limited presence of phosphorous in drug 
candidates has restricted the use of 31P-NMR mainly to clinical or in vivo applications, e.g. to 
assess metabolites such as phospholipids, ATP and inorganic phosphate. 
Fluorine-19, on the other side, exhibits a number of properties that make the NMR 
spectroscopy of this nucleus very attractive for drug research, while at the same time being 
suitable for a wide range of compounds of pharmaceutical interest. Indeed, around 20% of the 
currently marketed drugs contain one or more fluorine atoms, a number which is steadily 
increasing [131]. Fluorinated analogues have long been regarded in the pharmaceutical 
industry for their high metabolic stability and increased membrane permeability. At the same 
time, fluorinated drugs are very amenable to trace in order to determine its absorption, 
distribution, metabolism and excretion (ADME) properties, given the virtual absence of 
endogenous fluorine in living organisms. 
From the NMR viewpoint, 19F is a I = ½ nucleus with a 100% isotopic abundance and a 
gyromagnetic ratio comparable to that of proton, being the relative sensitivity of 19F 83% with 
respect to 1H. Moreover, 19F displays a much broader span of chemical shifts than 1H does, 
ranging from -272 ppm in the CH3F molecule to over +85 ppm in pentafluorosulfanyl (SF5) 
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substituents [132], which minimizes the probability of signal overlapping and, added to the 
absence of fluorine in biological molecules and in most solvents and buffer components, 
accounts for very clean 19F-NMR spectra.  
Furthermore, and owing to its large chemical shift anisotropy, 19F signals are highly perturbed 
by local changes, such as binding to a receptor. Indeed, thanks to the exquisite sensitivity of 
the fluorine nuclei to changes in their microenvironment, and to the potentially large 
difference between the 19F chemical shifts in the free and bound states, even weak binding 
between fluorine-containing compounds and a target of interest can be easily detected in 
simple 1D experiments, by monitoring chemical shift perturbation of the 19F signals after the 
addition of the receptor. In addition, appreciable changes in transverse relaxation rates (T2) 
upon binding to a macromolecule enables binding of fluorinated compounds to be assessed by 
substantial broadening of the 19F signals or by changes in their intensity when a relaxation filter 
is applied.  
The possibility to straightforwardly detect protein-ligand interactions in 19F-NMR 1D 
experiments makes it a very efficient tool vis-à-vis 1H-NMR for the high-throughput screening 
of chemical libraries. In addition, other usual screening procedures well-established for 1H-
NMR, such as STD, are also feasible by detecting 19F [133]. Of course, the use of NMR 
spectrometry of fluorine-19 also enables structural characterization of fluorochemicals by a 
wide span of multidimensional experiments, both homonuclear (19F-19F) and heteronuclear 
(19F-1H and e.g. 19F-13C), such as COSY, TOCSY, NOESY, HOESY, HMBC or 3D triple resonance 
HCF experiments [134]. 
Obviously, a requisite is that the studied compounds contain at least one atom of fluorine. 
While the increasing interest towards 19F-NMR over the recent years has prompted the release 
of chemical libraries composed entirely of fluorine-containing compounds, there are 
methodologies that allow exploiting the advantages of fluorine NMR for the screen and 
binding assessment of non-fluorinated compounds, e.g. through the use of fluorinated spy 
molecules [135]. According to this strategy, a reference experiment is first performed in the 
presence of the spy molecule and the target receptor. Next, the spy molecule is made to 
compete with a compound or mixture of compounds, and changes in the spectral properties of 
the spy molecule (i.e. 19F chemical shift or transverse relaxation) are monitored. If the affinity 
data for the spy molecule are known, which can be reliably determined through 19F-NMR 
titration experiments, competition methods also allow measuring binding constants for the 
screened compounds. 
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1.3.2.2 Receptor-detected methods: 1H-15N HSQC 
The above mentioned techniques are useful to study the phenomenon of molecular 
recognition from the ligands perspective, to detect binding events, and to providing insights 
into the structure of the bound saccharide. When it comes to study binding from the viewpoint 
of the other partner involved, i.e. the macromolecule, another set of methodologies focusing 
on monitoring the protein signals can provide information on the receptor binding epitopes. 
Given the high spectral overlap of proteins in the proton dimension, most protein-detected 
methods are 2D experiments (notably 1H-15N heteronuclear single-quantum coherence, HSQC), 
among which heteronuclear experiments require isotopic labeling, and thus protein expression 
in suitable systems, which poses a limitation to the size of the receptors studied, usually not 
exceeding a size of 40 kDa [129], although current advances are pushing this limit further. In 
addition, detailed study on receptor/ligand interactions focusing on the protein signals require 
a full or partial assignment of the protein 1H, 13C and 15N resonances, which is often very time- 
and material-consuming. However, these setbacks are compensated by the amount of 
information that these techniques provide. 
In its simple version, the interaction between ligands and peptides, very small proteins or 
domains thereof can be studied from the receptors perspective by monitoring of their 1H 
signals in mono- or two-dimensional (e.g. NOESY) experiments with unlabeled receptor. In 
such cases, the assignment of the receptors 1H-NMR signals can be achieved with the 
standard strategies used for spectral assignment of small ligands. While these instances 
constitute only an exiguous minority of all sugar/protein systems, these mono-nuclear 
strategies have long been applied, for example, to study the interaction between hevein and 
(14) linked N-acetylglucosamine oligosaccharides, a model system of protein-carbohydrate 
interactions. [21, 31] 
For a majority of the sugar-protein systems, however, 2D heteronuclear experiments are 
required. By far, the most widely used protein-detected technique is 1H-15N HSQC. 
Heteronuclear coherence experiments are based on the transfer of magnetization between 1H 
and a bonded heteronucleus via scalar couplings. The result of a 1H-15N HSQC experiment is a 
two-dimensional spectrum [136] showing a number of cross-peaks close to the number of 
residues. Prolines, which lack an amide proton, are not represented in the spectrum, while 
side-chain amines of nitrogen-containing residues (i.e. asparagine, glutamine, arginine, lysine 
and histidine) provide additional cross-peaks. If the cross-peaks are assigned to their 
respective residues, 1H-15N HSQC experiments can provide valuable information on the protein 
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epitopes for binding ligands, since cross-peaks belonging to residues located at the binding site 
become shifted upon the addition of the ligand (fig. 12). 
Figure 12: Left: 1H-15N HSQC spectrum of human galectin-7 in the absence (blue) and presence (red) of lactose, with 
labels indicating some of the most shifted peaks, according to its full spectral assignment [137]. Right: 
crystallographic structure of lactose-bound galectin-7 (PDB: 4GAL [37]), with labels indicating some of the residues 
with the most perturbed cross-peaks upon addition of the ligand in the 1H-15N HSQC experiment. 
Fast relaxation of the protein 1H-15N signals becomes an issue when dealing with high 
molecular weight macromolecules (> 35 kDa). However, technological advances in hardware 
and novel developments in pulse sequences, such as transverse relaxation optimized 
spectroscopy (TROSY), [138] are pushing this limit further. TROSY-edited experiments permit 
the obtaining of high-resolution spectra (e.g. 1H-15N TROSY-HSQC) of proteins up to 100 kDa, 
[139] by selectively recording the most slowly relaxing signal component of the 15N-1H 
correlation. 
Lastly, a variety of experiments that can be collectively referred to as selective labeling 
methods, are also utilized to gather insight into the ligand/protein binding from the 
perspective of the receptor. They all have in common the simplification of the protein NMR 
spectrum via selective spin-labeling of only a fraction of its nuclei, and are especially useful 
when they constitute an important part of the binding site. For instance, selective 13C-labeling 
of Val, Ile and Leu side-chain methyl groups can be achieved by bacterial culturing in the 
presence of labeled versions of their biochemical precursors, [140] and information is obtained 
through 1H-13C-HSQC experiments. Also, the virtues of fluorine-19 NMR [141] can be exploited 
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by 19F-labeling of proteins using fluorine-containing analogs of natural amino acids, such as 
fluorophenylalanine [142], and information is obtained through clean, mono-dimensional 19F-
NMR spectra. Finally, other strategies for selective labeling that do not require manipulation at 
the pre-translational level have been reported. Such is the case of solvent exposed-amines 
(SEA)-HSQC [143] or SEA-TROSY, [144] which allow for the selective detection of solvent-
exposed NHs, and are useful for screening of interactions, since binding mainly occurs on the 
surface of a protein. 
1.3.2.2.1 Protein NMR assignment 
As already mentioned, obtaining 1H-15N HSQC data requires the use of 15N isotopically-enriched 
protein and the spectral assignment of at least most 15NH resonances, which is achieved by 
sequential assignment of the protein backbone in 3D triple 1H/13C/15N resonance NMR 
experiments. For this purpose, proteins are usually expressed in bacterial hosts cultured in 
minimum media containing 13C-glucose and/or 15N-ammonium as sole carbon and nitrogen 
sources, respectively. Also, deuterated water can be included in culture media for proteins to 
be also labeled with 2H at non-exchangeable hydrogens. [145] While this usually leads to a 
decrease in bacterial growth and protein harvest efficiency, it is used for assigning large 
proteins, as deuterium enrichment of the protein side-chains helps to minimize 1H-mediated 
relaxation pathways that produce signal broadening and loss of intensity [146]. 
Full NMR assignment of proteins is carried out as a two-step strategy involving assignment of 
the backbone and, optionally, of the side-chains.  
Assignment of the protein backbone is usually approached through a combination of 3D NMR 
experiments correlating intra- and inter-residue 1H, 15N, 13C and 13C resonances. For example, 
the HN(CO)CACB experiment correlates the 15NH signal of an amino acid (i) with the  13C and 
13C resonances of the preceding residue (i-1) [147], while the HNCACB experiment establishes 
the intra-residue 15NH-13C-13C connectivities [148] (fig. 13). Several other possibilities exist, 
including CBCANH, i.e. the reversed version of HNCACB; HNCO [149] and HN(CA)CO 
experiments, to name a few.  
Then, additional experiments are performed to assign side-chain resonances. 1H-13C HSQC 
experiments provide the 1H-NMR resonances of the protons attached to carbons 13C and 13C, 
and other experiments (e.g. 1H-1H NOESY and H13C13CH-TOCSY [150]) allow for assignment of 
side-chain nuclei beyond these.  
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Besides, homo- and heteronuclear 2D experiments can be used alone for full assignment of 
small peptides or protein fragments, similarly to carbohydrates. 
Figure 13: Examples of backbone spectral assignment experiments. Red and yellow arrows show the magnetization 
transfer pathway in HNCACB and HN(CO)CACB experiments, respectively. In the HNCACB experiment, the 
magnetization is transferred from Hi to 
15Ni, and then via the 
15N-13C J-coupling to the 
13C,i, and then from 
13C,i to 
13C,i. Then, the magnetization is transferred back to 
15NHi for detection. Usually, transfer from 
13C,i also occurs to 
15Ni-1, becoming visible in the spectra with lower intensity than that of the intra-residue connectivity. In the 
HN(CO)CACB experiment, the magnetization is transferred from Hi to 
15Ni, then to 
13COi-1, and then to 
13C,i-1 and 
13C,i-1 and their bound protons, for detection.
1.3.2.3 Paramagnetism-based NMR methods 
Paramagnetism arises from the presence of unpaired electrons in atomic or molecular orbitals 
of certain chemical species, notably metal ions and organic radicals. An emerging family of 
methods taking advantage of paramagnetic effects, including Residual Dipolar Couplings 
(RDCs), Pseudo Contact Shifts (PCSs), and Paramagnetic Relaxation Enhancements (PREs) [151] 
are currently starting to be applied for structural characterization of glycans and their 
interactions with receptors. 
RDCs, which originate from dipolar interactions between a pair of nuclei (e.g. 1H13C, 1H1H), 
causing a splitting in the signal of each nucleus involved, permit to correlate the relative 
geometrical orientation between structural fragments (e.g. sugar rings), independently of how 
apart they are in the molecule [152-155]. RDCs are particularly useful to deduce the geometry 
of the glycosidic linkages, which has a major influence on the conformation of glycans and 
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their overall shape [156]. RDC measurements require the partial alignment of the molecule 
under study. [157-158] Several alignment media have been tested for carbohydrates, using 
both external alignment systems [159-160] and paramagnetic tags [161]. 
Pseudo Contact Shifts (PCSs) [162-163] also arise from a dipolar interaction, in this case 
between the unpaired electrons of a paramagnetic entity and the nuclei in its vicinity. PCS-
derived information is analogous to NOE restraints in the sense that it is distance-dependent. 
The main advantage of PCS effects is their longer-range effect, due to the favorable r-3 distance 
dependency, instead of r-6 in the case of NOEs. 
Finally, PREs are due to enhancements of dipolar relaxation of nuclei caused by the presence 
of a paramagnetic species in its vicinity. PREs also show the typical r-6 distance dependence, 
and may be employed to obtain information on the distance between the paramagnetic center 
and the monitored nuclear spins. 
In the context of carbohydrate-protein interactions, it is worth mentioning the application of 
nitroxide spin-labels for mapping the sugar binding sites on protein surfaces, thanks to PREs 
arisen from the nitroxide moiety. Perturbations in the 1H-15N HSQC spectrum of galectin-3 
were monitored and used to identify protein residues proximate to the binding site for N-
acetyllactosamine [151]. 
RDCs have also been successfully employed for the study of protein-carbohydrate complexes. 
In this regard, RDCs have been applied to determine the glycan conformation in the bound 
state [164], the location of the sugar binding site and the structure of the complex, in 
combination with PCS-derived information [165]. 
1.3.2.3 Diffusion-based methods: DOSY 
Diffusion-ordered spectroscopy (DOSY) is based on a pulse-field gradient spin-echo NMR 
experiment, in which the different components of a sample mixture experience diffusion. As a 
consequence, the signals of each component decay at different rates as the gradient strength 
varies. Thus, it is possible to obtain a 2D NMR spectrum, in which the first dimension is the 
regular NMR chemical shift, and the additional dimension is related to the diffusion coefficient. 
This allows for the obtaining of virtually deconvoluted NMR spectra, with many potential 
applications, such as identifying individual components and impurities in complex mixtures. 
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Importantly, self-diffusion of a molecule is related to its size, as it is deduced from the Stokes-
Einstein equation: 
         (8) 
where D is the diffusion coefficient, kB is the Boltzmann constant, T is the temperature, and f is 
the friction coefficient. If the molecule is considered as a spherical particle with an effective 
hydrodynamic radius (i.e. the Stokes radius) rS in a solution of viscosity h, then the friction 
coefficient is given by:   6       (9) 
Of course, the hydrodynamic radius of a molecule is related to its molecular weight [166]. This 
can be exploited for estimating the size of chemical species through DOSY experiments, most 
commonly by extrapolating obtained D values from calibrated data [167]. 
1.3.3 Assisting NMR observations with computational protocols 
During the past decades, the development of molecular modeling techniques has allowed for 
successful prediction of the structure of ligands, as well as their interactions with receptors. 
Indeed, the award of the Nobel Prize in Chemistry 2013 to M. Karplus, M. Levitt, and A. 
Warshel for the development of multiscale models for complex chemical systems shows the 
increasing importance that computer models have gained through the years. 
The combination of computational protocols with NMR experimental data has proven 
extremely useful to deduce the conformational and dynamic properties of free and bound 
carbohydrate molecules [168]. Molecular modeling of saccharides can be performed at 
different levels of complexity. The most employed protocols are based on force fields, which 
are used for performing molecular mechanics (MM) and dynamics (MD) calculations. In 
glycoscience, GLYCAM parameters [169] are the most commonly employed for reproducing 
dynamic and electronic properties of sugars. Nevertheless, more sophisticated computational 
chemistry methods based on quantum chemistry may also be employed. Ab initio calculations 
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are used to solve the Schrödinger equation through a series of approximations, and have also 
been employed to model a variety of systems in the carbohydrate field [168]. 
In addition, the combination of NMR experiments with docking and MD protocols can be used 
for obtaining the 3D structure of carbohydrate-protein complexes [170]. Ideally, experimental 
information from ligand-based and receptor-based NMR experiments is available, thus 
providing full empirical information on the recognition process that can be used as input for 
computational studies. Docking protocols are used to explore the possible interactions of a 
given carbohydrate ligand with a particular receptor (fig. 14A). These programs (e.g. AutoDock 
[171]) evaluate the free energy of the interaction for different possible binding modes, in 
which the conformation of the sugar and/or the receptor may change. Further refinement of 
the proposed docking poses may be accomplished through molecular dynamics simulations 
(fig. 14B), and may take into account the available experimental information as knowledge-
based restrictions (i.e., through NMR). 
Other computing methods have been conceived to predict or interpret specific NMR 
phenomena, such as the simulation of STD events by the CORCEMA (Complete relaxation and 
conformational exchange matrix) package, which permits to assess the agreement of the 
predicted docking based on trNOESY [172] and/or STD [173] experimental data. 
Finally, for carbohydrate-processing enzymes, methods combining quantum mechanics with 
molecular dynamics (QM/MM) have been developed [174]. They permit to define the region of 
the catalytic site (the ligand and protein residues of interest) to be studied through ab initio
calculations, leaving the rest of the protein subject to standard molecular mechanics. Catalytic 
processes or reaction pathways can thus be modeled [175-176]. 
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Figure 14: Computational protocols. A: AutoDock [171] calculation using the crystallographic structure of human 
galectin-3 (PDB: 1A3K) and the structure of N,N-diacetyllactosamine, treated as a flexible ligand, allowed to explore 
a 34 Å × 34 Å × 34 Å cubic box around the sugar binding site. B: MD calculation, in explicit solvent (water), on the 
binding of cellotetraose to the carbohydrate-binding module of a Clostridium cellulosic enzyme [177]. 
1.3.4 Screening. Fragment-based drug discovery 
The screening of a battery of compounds against a macromolecular target of biomedical 
interest is the fuel that feeds the drug discovery engine. Regardless of the many biochemical 
and biophysical techniques used for the detection and evaluation of binding hits, two different 
philosophies of compound screening coexist in the current pharmaceutical landscape: high-
throughput screening (HTS) and fragment-based drug discovery (FBDD). The aim of HTS, which 
has dominated the drug discovery activity for much of its history, is the evaluation of large 
numbers of heavy, drug-like molecules. Typically, hundreds of thousands to several millions of 
compounds are screened for each target, and high potency inhibitors are sought. For its part, 
FBDD is based on the screening of small libraries of low molecular weight compounds, called 
fragments, in pursuit of hits with low, but efficient binding activity, which are then combined 
or developed into more potent inhibitors via different strategies, as illustrated in fig. 15. Over 
the last decade or so, FBDD has gained increasing acceptance both in the industry and in the 
academia. The success of this new drug discovery paradigm is illustrated by the recent 
approval of the first fragment-based drug (Vemurafenib) [178] by the FDA. 
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Figure 15: Two strategies for lead generation following a fragment-based approach: (a) Fragment growth; (b) 
Fragment linking. 
From the beginning, NMR has represented by far the preferred biophysical technique in FBDD 
programs, due to its reliability and versatility. Indeed, thanks to the wide variety of NMR 
experiments available, the use of this spectroscopy can guide the whole process (fig. 16), from 
the initial screening of compounds, to the ranking of the hits according to their affinity or 
efficiency and the characterization of the binding modes, both from the ligand and the 
receptor viewpoints [179].  
Figure 16: Flow scheme for an NMR-driven fragment-based screening. 
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1.3.4.1 Fragment screening and ranking 
1.3.4.1.2 Magnetization transfer experiments: STD and WaterLOGSY 
Most usually, fragments are screened by using a magnetization transfer-based technique, 
namely STD or WaterLOGSY. These methods present the advantage that their detection range 
is suitable to the weak affinities expected for fragment-receptor interactions. To speed up the 
process and minimize protein consumption, experiments are performed on cocktails of 
fragments, in a number such that signal overlapping does not preclude the identification of the 
compounds and their solubility is not compromised. Normally, 6 to 10 fragments are assayed 
in each experiment. The composition of the mixtures might be entirely random, although it is 
more advisable to bring together fragments as chemically different as possible, in order to 
easily identify hits by inspection of the 1H-NMR spectrum without need to deconvolute the 
mixture. Alternatively, mixtures can be made up of similar fragments, if one wishes to identify 
structural features or scaffolds with binding activities toward the target. 
Ranking of the fragment hits can be undertaken by determining the dissociation constants with 
either STD or WaterLOGSY titration experiments, as described in previous units. Sometimes, 
fragment hits are ranked by their ligand efficiencies (LE), rather than their dissociation 
constants. The LE (eq. 10) is defined as the free energy of binding per heavy atom (N), and its 
measurement is useful for comparing ligands with different potencies and different sizes, as it 
normalizes the affinity of a given compound to its size [180]: 
(10) 
1.3.4.1.3 Transverse relaxation rates 
Another popular and fast technique for fragment screening is based on monitoring the 
changes in T2 relaxation of the fragment signals upon binding to the target. Ligands that bind 
to a macromolecular receptor experience an enhancement of their T2 relaxation, which is 
translated into a broadening of their signals. In the practice, however, rather than directly 
measuring the line-width of the ligand signals, a relaxation filter is applied by setting a spin-
lock between the 90º excitation pulse and the signal acquisition, and a comparison of spectra 
N
KRT
N
G Dbind lnLE 
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recorded in the presence and in the absence of the target will reveal a change in the intensity 
of signals corresponding to binding compounds. Depending on the duration of the spin-lock 
filter, a detection cut-off can be tuned in order to scope for stronger or weaker-binding 
fragments, with longer spin-lock times enabling to detect weaker interactions. This possibility 
also introduces a way to qualitatively rank fragment hits, i.e. by comparing series of 
experiments performed with different spin-lock times. 
1.3.4.1.4 Paramagnetic labeling of proteins: SLAPSTIC 
Paramagnetic tagging of proteins has been also used for compound screening. According to 
this method, dubbed SLAPSTIC (Spin Labels Attached to Protein Side chains as Tool to identify 
Interacting Compounds) [181], a paramagnetic label is covalently attached to a specific site of 
the target (e.g. a Cys thiol group), and hits are detected by the transmission of paramagnetic 
effects (mainly PREs) to the binding fragments, most usually through a transverse relaxation 
filter. The paramagnetic label should be judiciously placed, so that it lies relatively close to the 
active site, as paramagnetic effects decrease with the distance, but its attachment does not 
alter the structure and recognition properties of the protein. Therefore, it is required not only 
a previous knowledge of the structure of the target, but also to perform genetic engineering in 
the case that a suitable tagging site does not exist in the natural protein. 
A modification of this strategy, involving the use of a paramagnetic derivative of a fragment 
with demonstrated binding activity toward the target, can be used to discover fragments 
binding to different sites [182]. At saturating concentrations of this fragment, a screening is 
performed looking for second binders, which will be detected by the transmission of 
paramagnetic effects from the first fragment. This event only is possible if both molecules are 
bound at the same time to the protein. This method presents notorious advantages in 
comparison to other procedures, which are essentially based on performing any of the 
mentioned NMR screening experiments (e.g., STD) in the presence of saturating 
concentrations of a first binder, since, for weakly-binding compounds, such as fragments, it is 
often difficult to achieve saturating concentrations before reaching their solubility limit, and 
false positives can arise. 
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1.3.4.1.5 Competition approaches 
Finally, for compound screening, indirect approaches, in the shape of competition experiments 
involving a spy molecule, can be employed. According to this strategy, the NMR properties of a 
known ligand for a given target are monitored before and after the addition of the screened 
compounds, using any of the NMR experiments presented here. If the spy molecule is 
fluorinated, 19F-NMR experiments can be carried out.  
Competition approaches present the advantage that, if the binding parameters of the spy 
molecule are well-determined, those of the competitors can be easily derived applying 
mathematical models. For example, assuming a competitive inhibition model between a 
fragment hit and a spy molecule for binding to a target, the dissociation constant (KD) for the 
spy molecule (F) is shifted to an apparent value (KDap) in the presence of non-zero 
concentrations of a fragment hit (F) displaying an inhibition constant KI. 
(11) 
Therefore, the relation between the observed values for an NMR property of the spy molecule 
S (e.g. the intensity of a signal applying a T2 relaxation filter) after (I) and before (I0) the 
addition of the competitor fragment can be represented as: 
          (12) 
And, for selected experimental conditions where [S] = KD, 
(13) 
The principal drawbacks associated with competition methods are the impossibility to identify 
the active compounds if screened within mixtures containing a very high affinity ligand, and 
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the occurrence of false-negatives when fragments bind to sites different from that of the spy 
molecule. 
1.3.4.3 Binding mode characterization 
When it comes to get a detailed picture on the geometry of the ligand-receptor complex, the 
versatility of NMR offers the scientist a wide variety of experiments, both ligand- and receptor-
detected, providing valuable information from different points of view. 
1.3.4.3.1 Protein-detected techniques: 1H-15N HSQC experiments 
Competition experiments themselves represent a first insight into the characterization of the 
binding mode, since, taking allosteric effects aside, if the binding site of the spy molecule is 
known, so is that of the studied fragment.  
In order to delineate in more detail the binding epitope of the protein, changes in the 
resonances of the latter are monitored upon the addition of the fragment, usually in 1H-15N 
HSQC experiments. By doing so, amide groups closest to the ligand are identified by the strong 
perturbation of the chemical shifts of their respective cross-peaks in the spectrum. This 
information is given as input to computational modeling programs in order to get a 3D view of 
the binding. Understanding the mode of binding of the hits in the three-dimensional context of 
the protein is of great importance to design potentially stronger binding compounds (fig. 15A). 
1.3.4.3.2 Ligand-detected techniques: Inter-ligand NOEs, STD, trNOESY 
When two or more fragments bind to different, but adjacent sites on the target surface, 
knowledge on their relative orientation and distance becomes essential in order to attempt 
the connection of the fragments (fig. 15B) via a suitable linker to create a larger, more potent 
compound. In this regard, NOESY experiments can provide valuable information in the shape 
of inter-ligand NOEs (iLOEs) [183] given rise to by pairs of protons belonging to different 
fragments, but located close in space when docked at the binding site. 
It has been already explained how one can take advantage of STD and trNOESY experiments to 
obtain information on the ligand epitopes more exposed to the protein surface and the 
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conformation of the bound ligand, respectively. While for fragments, as relatively simple and 
small molecules, such experiments might not provide decisive information, they can be of 
usefulness for the study of the bound structure of lead compounds in more advanced stages. 
1.4 Objectives  
The general objectives of this Thesis are the study of interaction processes between 
carbohydrates and a series of protein receptors of different types, and the development of 
novel NMR procedures which permit to advance in the knowledge of carbohydrate structure 
and recognition features. 
This Thesis is divided into different Chapters, which have the following specific objectives: 
Chapter 2:  
- Explore, at atomic detail, the interaction features of an array of viral fiber receptors toward 
small oligosaccharides, using ligand-detected NMR experiments. 
Chapter 3: 
- Characterization of the interaction between glycogen and related oligosaccharides and a 
monoclonal antibody through ligand-detected experiments. 
- Structural characterization of the -glucan envelope of Mycobacterium smegmatis through 
2D heteronuclear NMR experiments. 
Chapter 4: 
- Exploration of the catalytic mechanism of the UDP:glucose pyrophosphorylase (UGP) of 
Streptococcus pneumoniae. 
- Development of a direct, NMR-based assay to measure UGP activity. 
- Targeting of the UGP of Streptococcus pneumoniae through fragment-based drug discovery. 
Chapter 5: 
- Full NMR assignment of galectin-3 (gal-3) and galectin-7 (gal-7). 
- Understanding of the conformational duality of gal-7 and structural characterization of the 
minor conformer thereof. 
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- Targeting of gal-7 through fragment-based drug discovery. 
- Characterization of the interaction between gal-3 and a series of glycan ligands, using both 
ligand- and protein-detected NMR methods, assisted by molecular modeling. 
- Provide insight into the interacting capabilities of the N-terminal domain of gal-3 toward the 
gal-3 carbohydrate recognition domain. 
Chapter 6: 
- Developing novel methods for the application of paramagnetic effects to the study of 
carbohydrate conformation and recognition features by receptors 
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CHAPTER 2 
THE RECOGNITION OF SUGAR DETERMINANTS BY AN ASSORTMENT OF VIRAL FIBER 
PROTEINS 
2.1 Introduction 
Viruses are intracellular parasites of all forms of life, which take over the metabolic machinery 
of the organism they infect to make multiple copies of themselves through self-assembly. Lying 
at the boundary between life and the inanimate, viruses are generally considered as non-living 
entities, due to the lack of a metabolism and the requirement of a host cell to produce new 
progeny. Yet, viruses are the most abundant organisms in the biosphere [1], and are 
responsible for the greatest selective pressure on the rest of the organisms [2]. In addition, 
viruses are now widely used as tools in molecular and cellular biology [3], and seen as 
promising vehicles for the development of novel applications of industrial or therapeutic 
relevance, such as insecticides [4], antibiotics [5], or vectors for gene therapy [6]. 
Morphologically, viral particles are assemblies of different components. They consist of a 
capsid, or head, which is a protein coat that contains the viral genome and may adopt a rich 
variety of symmetrical shapes. The viral genome is a nucleic acid, which can be single-strained 
or double-strained DNA or RNA. The size of the viral genome is highly variable, ranging from 
only 2 genes in porcine circoviruses [7], to more than 900 in mimiviruses [8]. Optionally, the 
capsid may be surrounded by a lipid envelope derived from the host cell membrane. Finally, 
viruses possess a series of fibrous appendices, which project receptor proteins involved in the 
specific recognition of the host precluding infection. 
Viruses are highly polymorphic organisms whose ultimate origin is a matter of controversy [9]. 
Several types of classifications of viruses exist, the simplest of which takes into consideration 
the type of cell they infect. Hence, there are animal viruses, plant viruses and bacteriophages, 
also called phages. In addition, viruses can be classified according to the chemical nature of 
their genetic material, their shape and their life cycle. 
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Regardless of virus type, one of the most important steps in the biology of viruses is infection, 
which is triggered by the binding of the virus to the surface of the host cell. This process 
involves the specific recognition, by viral receptor proteins, of protein or carbohydrate 
determinants of the host. To this end, some viruses have developed protein structures that 
project viral receptors away from the viral capsid surface, usually in the shape of fibrous 
proteins. The general organization of fiber proteins appears constant: they are trimers, with a 
N-terminal capsid-binding domain, a core shaft domain of a certain length, and a globular C-
terminal receptor domain. 
Understanding the host-virus interactions is key to get insight into the biology of infection and 
to explain the exquisite selectivity of viral strains toward their host species. At the same time, 
understanding these phenomena opens the door for their modulation. In this context, 
bacteriophages are regarded as potential antibacterial tools against resistant organisms [10-
11], while adenoviruses have gathered significant interest as vectors for gene therapy or 
antitumor vectors in humans [12-13]. 
The work presented in this chapter has been performed in collaboration with the group of Dr. 
Mark J. van Raaij (CNB-CSIC). Dr. van Raaij provided a selection of viral fiber proteins of 
different sources, whose recognition properties toward an array of biologically relevant sugar 
determinants were investigated. In many cases, microarray data were available supporting the 
interaction of these receptors with several types of sugars. NMR studies on these systems 
were designed to obtain a confirmation of binding in solution, also attempting to provide the 
fine structural details on the interaction from the ligand point of view. 
From the methodological perspective, the work presented in this chapter makes extensive use 
of STD as a straightforward ligand-detected NMR technique for the screening and epitope-fine 
dissection of sugar-protein interactions. 
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2.2 Phage T4 fiber protein gp37 
2.2.1 Introduction 
The phage T4 is a virus belonging to the family Myoviridae, which infects Escherichia coli cells. 
It is a relatively large virus, of approximate dimensions of 200 nm × 90 nm. Its icosahedral head 
hosts the double-stranded DNA genome, which encodes 289 proteins, and is connected 
through the tail to the base plate, from which a series of tail fibers emerge: long fibers, which 
are involved in reversible binding to the host, and short fibers, which non-reversibly bind to 
the bacterium surface (figs. 1, 2). 
The first step in the infection of T4 involves non-covalent binding of gene product 37 (gp37), a 
trimeric fibrous protein of the long tail fibers (fig. 3), to glucosyl-(1-3)glucose (Glc (1-3)Glc) 
residues of the bacterial lipopolysaccharide (LPS) [14], and to the outer membrane protein C 
(OmpC) [15]. When at least six of the long fibers have interacted with their receptors, the 
signal is transduced to the basal plate, triggering an extension of the short fibers, which 
irreversibly bind to the host cell surface. Then, an internal tube of the tail penetrates into the 
bacterium and the viral DNA is ejected into the cell (fig. 2) [16]. 
Figure 1: Electron micrographs of Phage T4. A: with labels indicating the different phage components. B: Thin 
section of T4 phages infecting a microcolony of E. coli K12. Courtesy of John Wertz (Yale University) 
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Figure 2: The gp37 tip domain. A: Schematic representations of bacteriophage T4 attached to a bacterial membrane 
before (left) and after (right) expansion of the short tail fibers. The gp37 tip domain is boxed. Adapted from [17]. B: 
Electron micrograph of recombinantly expressed gp37 tip domains. Bar size: 50 nm. Courtesy of M. van Raaij (CNB-
CSIC). 
Figure 3: Structure of the gp37 trimer, with each subunit shown in a different color. A: Ribbon representation. Each 
10th residue is highlighted. Iron ions are shown as yellow balls. B: Surface representation, with labels showing the 
collar domain, the core needle domain and the head domain, which includes the receptor motif for LPS binding. 
Adapted from [17]. 
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2.2.2 Results 
In order to demonstrate and characterize the recognition of Glc(1-3)Glc units by gp37, STD 
experiments were performed on mixtures of this protein and the simple disaccharide model 
nigerose (3-O--D-glucopyranosyl-D-glucopyranose). 
STD peaks were clearly observed in the corresponding spectrum, indicating that the 
disaccharide binds to the protein (fig. 4A). Inspection of the STD spectrum revealed differences 
in the degree of saturation between the two glucose residues. Specifically, most of the protons 
at the reducing glucose unit showed considerably smaller STD responses than their 
counterparts at the non-reducing moiety, suggesting that binding of nigerose to gp37 occurs 
mainly at the level of the non-reducing glucose. The highest degree of saturation was 
registered at H4 of the non-reducing end, suggesting that the recognition of nigerose by gp37 
occurs mainly around this area. Finally, no significant differences were found between the two 
anomeric species of nigerose. 
These observations are in agreement with previous data suggesting that the initial recognition 
of E. coli cells by phage T4 involve Glc(1-3)Glc motifs in the E. coli lipopolysaccharide [14]. 
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Figure 4: A: STD experiment performed on nigerose in the presence of gp37. Top spectrum: Off-resonance 
(reference) spectrum, with labels indicating the assignment for a number of representative signals [18-19] . Bottom 
spectrum: STD spectrum (up-scaled), with a label (100%) indicating the signals that display the highest degree of 
saturation (4-protons of the non-reducing unit). The asterisks show the signals with the lowest STD responses (those 
belonging to the reducing unit). B: Epitope mapping obtained with the STD data for nigerose. Chemical structure of 
nigerose, with labels indicating the notation for each hydrogen atom, and colors representing the STD intensities of 
each signal, relative to the STD intensities of the most saturated signal. Red circle: 100%, orange circles: 50% > I > 
30%, yellow circles:  30% > I > 15%.
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2.3 Phage T7 fiber protein gp17 
2.3.1 Introduction 
The phage T7 is a virus belonging to the family Podoviridae. T7 infects rough strains of 
Escherichia coli, i.e. those lacking the O-antigen chain in their LPS. Its icosahedral capsid, made 
out of gp10, contains the DNA genome, which codes for 55 proteins. The capsid is linked at 
one of its vertices, through a connector, to a tail encompassing six tail fibers, each composed 
of three copies of the fibrous protein gp17 (fig. 5).  
Figure 5: Phage T7 fiber gp17 protein. A: Scheme of T7, with gp17 fibers boxed. Adapted from [20]. B: Negatively 
stained electron micrograph of the tail complex of phage T7, showing six tail fibers. The boxed region corresponds 
to the gp17(371-553) fragment used in this chapter. The tip and pyramid domains are distinguishable. C: Structure 
of the gp17(371-553) fragment, showing its tip and pyramid domains (PDB: 4A0T). Adapted from [21]. 
Gp17 forms elongated homotrimers (fig. 5C), which are involved in the first specific, albeit 
reversible, attachment to the E. coli LPS [22]. A second, irreversible interaction with the 
bacterial membrane, followed by inoculation of the viral genetic material is likely mediated by 
binding of one or more of the tail proteins to an unknown receptor [23]. 
Each gp17 subunit consists of a N-terminal tail-attachment domain, a core shaft region and a 
C-terminal domain [21]. The structure of the most C-terminal portion of gp17, i.e. gp17(371-
553) was elucidated by the group of M. van Raaij using X-ray crystallography [21]. This distal 
part of the fiber, which is likely involved in virus-host recognition, encompasses two distinct 
structural domains, which are also apparent under the electron microscope (fig. 5B): an N-
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terminal pyramid domain, formed by a mixed -sheet made up by -strands of the three 
different subunits, and a C-terminal globular tip domain (fig. 5C). 
The most important part of the LPS for binding to T7 fibers has been suggested to be the first 
glucose and the terminal glucose/heptose of the LPS  outer core [24]. Fittingly, microarray data 
obtained by the group of M. van Raaij suggested binding between the gp17(371-553) fragment 
to kojibiose (2-O--D-glucopyranosyl-D-glucopyranose, (Glc(1-2)Glc), a motif which is present 
in the outer core of the E. coli LPS. This fact prompted the NMR study of the interaction, in 
solution, between gp17 and the aforementioned disaccharide. 
2.3.2. Results 
STD experiments performed on kojibiose in the presence of the gp17(371-355) fragment gave 
rise to peaks in the corresponding spectrum, indicating that the disaccharide binds to the 
protein (fig. 6). Inspection of the STD spectrum revealed subtle differences in the degree of 
saturation between the two glucose residues, as well as between the two different species of 
kojibiose that coexist in solution, due to the / mutarrotation process at the reducing 
glucose. Specifically, several protons at the reducing glucose showed smaller STD responses 
than their counterparts at the non-reducing moiety. These differences became especially 
apparent for the -anomer (fig. 6, fig. 7). These results suggest that binding of kojibiose to the 
gp17.371 fragment occurs mainly at the level of the non-reducing glucose, and that the -
anomer of the reducing unit is in looser contact to the protein surface than the -anomer. 
However, the differences in the degree of saturation between the two glucose units were only 
minor (for comparison, significantly larger differences between the glucose monomers were 
obtained with the gp37/nigerose system, see fig. 4 above). It is thus likely that both sugar units 
of kojibiose are accommodated in the gp17 binding site. 
To complement these observations, we also explored the ability of gp17(371-533) to recognize 
the simple monosaccharide, glucose. STD signals were obtained, although they were 
significantly less intense than those obtained for kojibiose (fig. 6). These results point towards 
considerable differences in affinity between the monosaccharide and kojibiose and support 
the hypothesis that both glucose units are accommodated in the binding site.  
In rough E. coli strains, the LPS outer core bears heptose-(1-2)glucose-(1-2)glucose-
(1-3)glucose termini. [25]. In the past, the terminal glucose residues have been shown to be 
important for the T7/LPS interaction [24]. Our results indicate that gp17 also binds to the 
Glc(1-2)Glc disaccharide. Therefore, more structural details on the actual epitope that is 
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recognized by the virus fibers have been presented herein. Further experiments with 
elongated ligands incorporating the heptose unit should clarify whether the terminal heptose 
is also involved in the recognition by gp17. 
Figure 6: STD experiments performed on kojibiose and glucose in the presence of the gp17.371 fragment. Top 
spectrum: Off-resonance (reference) spectrum of kojibiose, with labels indicating the assignment for a number of 
representative signals [18-19]. Middle spectrum: STD spectrum of kojibiose (up-scaled 100X), with a label (100%) 
indicating the signals showing the highest degree of saturation (H4-protons of the non-reducing unit), and asterisks 
indicating the signals with the lowest STD responses (those belonging to the -anomer of the reducing unit). Bottom 
spectrum: STD spectrum of glucose (up-scaled 100X).
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Figure 7: Epitope mapping obtained with the STD data for kojibiose. Chemical structures of kojibiose with the 
reducing end in - (left) and -configuration (right), with labels indicating the notation for each hydrogen atom, and 
colors showing the STD intensities of each signal, relative to the STD intensities of the most saturated signals. Red 
circles: 100% > I > 80%, orange circles: 80% > I > 60%, yellow circles:  I < 60% (for uncircled protons the 
corresponding  relative STD values could not be calculated due to signal overlapping).
2.4 Turkey adenovirus 3 fiber head protein 
2.4.1 Introduction 
Adenoviruses are a family of animal viruses with a large, non-enveloped icosahedral capsid and 
a double-stranded DNA genome. Thanks to its efficient infection and high loading capacity, 
adenoviruses are regarded as promising tools for gene therapy [13]. 
The adenovirus capsid consists of three major structural proteins: the hexon, the penton base 
and the fiber. The hexon is the major coat protein forming the icosahedral structure. The 
penton is bound to the hexon protein at each vertex of the icosahedron, serving as the base 
for the insertion of the fiber (fig. 8) [26]. The specific attachment of adenoviruses to their host 
cells occurs with high affinity and at the level of the fiber knob [27], whose primary receptor in 
humans is the widely expressed coxsackievirus and adenovirus receptor (CAR) [28]. Other 
subtype-specific receptors for adenovirus reported in humans include CD46 [29] as well as the 
sialic acids presented by gangliosides and glycoproteins [30].  
In addition, most human adenoviruses bear the tripeptide sequence Arg-Gly-Asp (RGD) in the 
fiber knob, which has been reported as the binding site of the virus to cellular integrins, 
causing endocytosis of the virus by the cell [31].  
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Figure 8: Adenovirus structure. A: Scheme showing the three main protein components of the adenoviral capsule: 
the hexon, the penton base and the fiber. B: Negatively stained electron micrograph of adenovirus particles isolated 
from Pipistrellus pipistrellus bat. Scale bar: 100 nm. From [32]. 
Turkey adenovirus 3 (TAdV-3) belongs to the genus Siadenovirus. With the smallest genomes in 
the family, the taxon is named after a genus-specific open-reading frame, whose putative gene 
product bears a high sequence similarity to bacterial sialidases [33]. 
TadV-3, which carries a small genome coding for 16 genes  [34], causes hemorrhagic enteritis 
in turkeys and marble spleen disease in pheasants [35]. The general organization of the virus is 
highly similar to that of other members of the adenovirus family. Sequencing of the TadV-3 
genome revealed a high degree of sequence similarity between most of its putative gene 
products and their homologues throughout the family [33]. The predicted fiber protein 
consists of an N-terminal virus-attachment domain, a central shaft domain and a C-terminal 
knob (head) domain. Interestingly, the head domain has no sequence similarity to any 
previously known analogue [36], nor it carries the RGD sequence, as in other mammalian and 
avian adenoviruses [33].  
The lack of sequence homologues raises the intriguing possibility that the TadV-3 fiber head 
domain might bear novel recognition capabilities. In any case, the identification of the receptor 
for this protein is interesting either from the perspective of a novel sequence leading to a 
novel activity, or to convergent recognition properties. In this regard, microarray data 
obtained by Dr. van Raaij suggested binding to both 3- and 6-sialyllactose, as well as to xylose, 
for the fiber head domain of TAdV-3. NMR-based test of binding to these three sugars is 
presented in this section.  
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The structure of the head domain has recently been solved by the group of M. van Raaij (PDB: 
3ZPE). The structure shows a trimeric arrangement, in which each monomer consists of a -
sandwich, plus a protruding -hairpin akin to a flap embracing the neighboring monomer 
(fig. 9). Of note, structure-based searches could not correlate the structure of TadV-3 fiber 
head protein with any previously known structure. 
Figure 9: Structure of the turkey 
adenovirus 3 fiber C-terminal head domain 
(PDB: 3ZPE), as solved by the group of M. 
van Raaij. The structure adopts a trimeric 
arrangement (each monomer is shown in a 
different color), in which each monomer 
consist of a -sandwich, plus a protruding 
-hairpin which embraces the neighboring 
monomer.
In addition to the virulent strains of TadV-3, naturally occurring avirulent strains are known, 
producing splenomegaly and immunosupression in turkeys, although not resulting in mortality 
[37].  Intriguingly, the sequence identity of both virulent and avirulent strains is very high, with 
only a few non-silent point mutations found in genes ORF1, E3 and fib, i.e. the one coding for 
the fiber. Different mutations appearing in avirulent strains have been suggested to result in 
alteration of cell tropism or affinity to receptors [37]. To test this hypothesis, we have 
investigated herein the effect of two point mutations in the fiber head domain (354M®I and 
376M®T) found in a naturally occurring avirulent strain [37], by studying the recognition 
abilities of both the virulent and the avirulent versions of the fiber head protein toward sialic 
acid-containing oligosaccharides. 
2.4.2 Results 
STD peaks were observed for 3'-sialyllactose and 6'-sialyllactose in the presence of either the 
virulent or the avirulent versions of TAdV, indicating that both ligands are recognized by these 
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proteins in solution (figs. 9-10). In contrast, the more intriguing interaction with xylose, 
suggested by the microarray data, could not be detected by NMR in solution (not shown). 
In all instances, the highest degree of saturation was observed at the sialic acid signals, and to 
a much lesser degree, at the galactose signals (fig 11). Very similar degrees of saturation were 
found between both virulent and avirulent proteins, as well as between both ligands. 
Figure 10: STD experiment performed on 3-sialyllactose in the presence of the virulent version of TAdV. Top: Off-
resonance (reference) spectrum, with labels indicating the assignment for a number of representative ligand 
signals. Bottom: STD spectrum (up-scaled 100X). B: Epitope mapping deduced from the STD data. Chemical 
structure of 3'-sialyllactose, with labels indicating the STD intensity for each signal, relative to the STD intensity for 
the 5''-N-acetyl peak. Red circles: I > 50%, orange circles: 50% I > 30%, yellow circles: 30% > I > 10%. 
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Figure 11: STD experiment performed on 6-sialyllactose in the presence of the virulent version of TAdV. Top: Off-
resonance (reference) spectrum, with labels indicating the assignment for a number of representative ligand 
signals. Bottom: STD spectrum (up-scaled 100X). B: Epitope mapping deduced from the STD data. Chemical 
structure of 6'-sialyllactose, with labels indicating the STD intensity for each signal, relative to the STD intensity for 
the 5''-N-acetyl peak. Red circles: I > 50%, orange circles: 50% I > 30%, yellow circles: 30% > I > 10%. 
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Figure 12: STD experiment performed on 3-sialyllactose in the presence of the avirulent version of TAdV. Top: Off-
resonance (reference) spectrum, with labels indicating the assignment for a number of representative ligand 
signals. Bottom: STD spectrum (up-scaled 100X). B: Epitope mapping deduced from the STD data. Chemical 
structure of 3'-sialyllactose, with labels indicating the STD intensity for each signal, relative to the STD intensity for 
the 5''-N-acetyl peak. Red circles: I > 50%, orange circles: 50% I > 30%, yellow circles: 30% > I > 10%. 
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Figure 13: STD experiment performed on 6-sialyllactose in the presence of the avirulent version of TAdV. Top: Off-
resonance (reference) spectrum, with labels indicating the assignment for a number of representative ligand 
signals. Bottom: STD spectrum (up-scaled 100X). B: Epitope mapping deduced from the STD data. Chemical 
structure of 6'-sialyllactose, with labels indicating the STD intensity for each signal, relative to the STD intensity for 
the 5''-N-acetyl peak. Red circles: I > 50%, orange circles: 50% I > 30%, yellow circles: 30% > I > 10%.
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2.4.2.1: Avirulence may be caused by an impaired trimer formation 
The virulent and the avirulent versions of the fiber head protein did not show any significant 
difference in the recognition processes of different sialyllactose derivatives. Provided that sialic 
acid is, in fact, the receptor for this protein, this observation rules out the possibility that 
avirulence is caused by a defect in the recognition of the receptor.  Thus, we further 
investigated what the causes for the difference in avirulence phenotype for both protein 
variants might be. As depicted in Fig. 14, one of the mutated residues (354M®I) lies at the 
interface between each pair of trimer subunits, within the beta hairpin moiety that embraces 
the neighboring monomer. We thus raised the question whether the 354M®I substitution 
might alter the stability of the trimer. DOSY (diffusion-ordered NMR spectroscopy) 
experiments performed on both protein versions revealed the existence of a smaller apparent 
size for the avirulent protein, in a concentration-dependent manner. Extrapolation of the 
obtained D values to a calibration line (fig. S1 in Appendix) permitted to estimate apparent 
molecular weights of 20-45 kDa for samples of the avirulent protein version at concentrations 
ranging from 3 M to 40 M , in contrast with the inferred size of 64 kDa for the virulent 
version. Thus, these data support that the loss of virulence in the avirulent protein might, at 
least in part, be explained by an impeded trimer formation.  
Figure 14: Structure of the turkey adenovirus 3 fiber C-terminal head domain (PDB: 3ZPE), as solved by the group of 
M. van Raaij, highlighting the position of M354 in the virulent protein (in sticks, in the green monomer). This amino 
acid, involved in monomer-monomer interactions, is substituted by an isoleucine residue in the avirulent protein. 
72 
Figure 15: DOSY titration with different concentrations of the avirulent versión of the TadV fiber head protein. 
Stacked DOSY spectra of either the virulent protein (red), or different concentrations of the avirulent protein 
(green: 40 M, blue: 20 M, and orange: 3 M). Signals of water and 3-sialyllactose are indicated for reference. 
2.5 Methods 
STD spectra were acquired at 298 K in a Bruker AVANCE 600 MHz spectrometer equipped with 
a cryoprobe. STD experiments were performed in fully deuterated phosphate 20 mM buffer, 
pD 7.8. Samples contained 2 mM of the screened sugar compounds, and 15 to 30 M of the 
correspondent viral fiber proteins. Proteins were provided by M. van Raaij (CNB-CSIC): TadV-3 
fiber head protein [36], phage T7 gp17 (371-553) fragment [21] and phage T4 g37 [17] were 
recombinantly produced as previously reported. 
The protein signals were selectively saturated on-resonance at 0.5 ppm with a train of 
Gaussian-shaped pulses of 50 ms each, totaling an irradiation time of 2 s. The off-resonance 
frequency was set at 100 ppm. A T2 relaxation filter consisting of a 15 ms 5 kHz spin-lock was 
used to reduce the protein background signals. STD spectra were obtained by subtracting the 
on-resonance from the off-resonance spectrum. STD intensities were measured comparing 
each STD spectrum with the correspondent off-resonance one and normalizing to the ligand 
peak receiving the highest degree of saturation. The resonances of 3'-sialyllactose or 6'-
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sialyllactose were assigned by standard procedures (1H-1H TOCSY 70 ms, 1H-1H ROESY 600 ms 
and phase-sensitive 1H-13C HSQC), whereas those of nigerose and kojibiose were obtained 
using the reported assignments [19]. Data were analyzed with Bruker TopSpin 3.0 and figures 
were built with MestReNova v.8.0.2. 
DOSY spectra of TAdV-3 fiber head proteins were recorded in a Bruker AVANCE 500 MHz 
spectrometer equipped with a 5 mm inverse probe head, with a diffusion time of 0.5 s and a 
gradient pulse of 1.5 ms, 32 gradient intensity increments and 32 scans per increment. Spectra 
were processed with the standard 2D DOSY procedure included in TOPSPIN 2.1 software 
(Bruker Biospin). 
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CHAPTER 3 
THE INTERACTION PROPERTIES OF A MONOCLONAL ANTIBODY RAISED AGAINST THE 
MYCOBACTERIAL CAPSULE 
3.1 Introduction 
Antibodies, also known as immunoglobulins, are large, Y-shaped molecules synthesized by the 
immune system to identify and neutralize foreign objects, such as viral or bacterial invaders. 
Antibodies are able to recognize their ligands, called antigens, with high affinity and specificity. 
In mammals, five iso-types exist which differ in origin, functionality and quaternary 
arrangement. Depending on the isotype, immunoglobulins (Ig) can be secreted in monomeric 
(IgD, IgE, IgG), dimeric (IgA) and pentameric (IgM) forms, or they can be bound to the surface 
of immune cells. Structurally, antibodies consist of two identical heavy chains accompanied by 
two identical light chains, which are covalently attached by a disulfide bond to each other, 
forming a constant region, which is identical in all antibodies of the same isotype. They play a 
key role in modulating its immune activity. Additionally, a variable region exist, which contains 
the antigen binding site (fig. 1A). 
Although all antibody molecules share the same basic architecture, they display remarkable 
variability in the antigen-binding region, which enables them to potentially bind any possible 
antigen. The size of the human antibody repertoire is potentially as high as 1011 different 
immunoglobulin molecules in every individual [1]. The generation of this diversity is accounted 
for by a complex mechanism involving the rearrangement of the immunoglobulin genes [2], for 
whose elucidation S. Tonegawa received the Nobel Prize for Physiology or Medicine in 1987. 
The recognition of antigens by antibodies involves non-covalent, reversible interactions 
between the variable region of immunoglobulins and conformational epitopes of the antigen, 
particularly of protein or carbohydrate nature.  
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Figure 1: Structure of immunoglobulins. A: Crystallographic structure of an intact IgG antibody (PDB: 1IGT) [3], with 
labels showing the antibody parts. B: Solution synchrotron X-ray scattering structure of a human pentameric IgM 
(PDB: 2RCJ) [4]. 
Carbohydrate antigens are known to act as many disease-causing agents, including cancer and 
infections caused by viruses, bacteria and parasites [5]. In addition to being naturally 
recognized by the immune system, they can be exploited for stimulating the immune system in 
the form of vaccines, [6-7] or being subject to targeting by therapeutic antibodies [8]. Also 
importantly, antibodies are the base for a variety of immunoassays routinely utilized in 
biochemistry and molecular biology labs. Hence, understanding antibody-carbohydrate 
interactions is useful both for the generation of new therapeutic agents and for the 
development of novel analytical techniques.   
The chemistry of carbohydrate-antibody interactions is essentially similar as in other protein-
sugar systems, involving hydrogen bonding, van der Waals contacts and hydrophobic effects 
[9]. Methodologically, antibodies have properties that make them appealing from the NMR 
viewpoint. They are heavy proteins (> 150 kDa), and can be oligomeric, which makes them very 
sensitive to ligand-detected methods. In turn, however, this renders them unapproachable 
using protein-detected techniques. Carbohydrate-antibody interactions have long been 
studied by NMR methods, such as STD to detect and characterize the recognition of glycans 
epitopes by immunoglobins [10-11], including studies to deduce the minimum epitope 
recognized by an antibody [12-13], or trNOESY experiments to study the conformation of 
saccharides in the antibody-bound state [14]. 
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The work presented in this chapter was done in collaboration with the group of Prof. Ben J. 
Appelmelk (University of Amsterdam), with the goal of developing useful antibody-based 
techniques for the investigation of the Mycobacterium capsular -glucan, using a murine IgM 
antibody raised against glycogen [15]. 
Pathogenic mycobacteria are associated to important human diseases such as leprosy and 
tuberculosis (TB). Mycobacterium tuberculosis, the causative agent of TB, has infected one-
third of the worlds population and claims more than 1.4 million lives every year. Thus, insights 
into the molecular mechanisms that allow the tubercle bacillus to occupy the hostile 
environment of the human patient and evade its immune responses, is key to the design of 
novel anti-TB drug therapies that could oppose this pathogen. The tubercle bacillus expresses 
a broad arsenal of immuno-modulatory factors for successful colonization in its host. Many of 
these factors are well-known as outermost surface constituents of the mycobacterial cell 
envelope. The cell envelope of mycobacteria is unique for bearing a characteristic second 
outer membrane of long fatty acids (mycolic acids) and a polysaccharide-rich capsule layer that 
surrounds these species [16-18]. The main polysaccharide of the mycobacterial capsule is -
glucan, which represents up to 80% of its sugar content [19]. Capsular -glucan resembles the 
structure as well as the chemical composition of glycogen, as it is a polymer composed of 
linear -D-(1-4) linked glucose (Glc) units with core substitutions at position 6 every 5 or 6 
residues by -D-(1-4) linked oligoglucosides [20-21]. Today, limited data is available on 
mycobacterial capsular -glucan and its functional role. Some studies suggest that it interacts 
with the complement receptor 3 [22], and that it suppresses the production of interleukin 12 
by blocking CD1 expression in dendritic cells, stimulating the production of anti-inflammatory 
cytokine IL-10 via a CD80-dependent manner [23]. Furthermore, Stokes et al. showed that M. 
tuberculosis capsular components exhibit anti-phagocytic properties against special types of 
macrophages [24]. Finally, the group of Ben J. Appelmelk investigated the role of -glucan in 
dendritic cells and showed that it abolishes dendritic cell function by a mechanism that is 
dependent on the C-type lectin DC-SIGN [25]. Taken together, these studies suggest an 
important role for capsular -glucan in host-pathogen interactions, which merit further 
investigation.
However, gathering deep insights into the host-pathogen interaction mediated by this 
polysaccharide is challenging due to the lack of fast and reliable techniques to qualify and 
quantify capsular -glucan levels. Reasons for these limitations include the absence of specific 
monoclonal antibodies against the mycobacterial capsular -glucan, and the lack of 
comprehensive methodologies for capsular -glucan mutant screening. 
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In the 1990s, Baba and colleagues developed a hybridoma cell-line for the production of a 
murine anti-glycogen monoclonal antibody (mAb) (IV58B6) [15]. Recently, Nakamura-Tsuruta 
analyzed the carbohydrate-binding specificity of this mAb to several natural and enzymatically 
synthesized glycogens [26]. However, the mAb specificity was not elucidated at atomic detail, 
and evidence on its interaction with mycobacterial capsular -glucan was not provided.  
In this chapter, we provide structural details on the epitope-fine specificity of the anti-glycogen 
mAb (IV58B6) toward polyglucosides. In addition, we provide heteronuclear NMR studies on 
the structure of the mycobacterial capsule of both wild-type and mutant strains. 
3.2 Results 
3.2.1 Characterization of the mAb IV58B6/-glucan interaction 
We used saturation transfer difference (STD) experiments to study, from the ligands point of 
view, the recognition of glycogen and a selection of related oligoglucosides by the mAb.  
First, STD experiments were performed on a selection of -Glc-containing oligosaccharides: 
maltotetraose and heptaoses. In particular, the study included linear (1-4) oligosaccharides, 
(1-6)-branched maltotriose and a double (1-6)-branched maltopentose as their respective 
(1-6)-branched analogs, keeping the number of Glc units constant. STD experiments 
performed on these oligosaccharides in the presence of the mAb gave rise to STD peaks (fig. 
4), indicating that these ligands were able to bind to the mAb. However, STD responses were 
rather poor, which is in agreement with this interaction being only very weak. Of note, STD 
experiments are very sensitive, allowing for the detection of very weak interactions even for KD
ca. 10 mM [27]. The high chemical shift monotony of the oligoglucosides signals precluded a 
detailed epitope mapping of the interactions. However, focusing on the anomeric signals, it 
became apparent that the (1-4)-linked H1 protons received a higher amount of 
magnetization than both the reducing and (1-6)-linked H1 protons, in all instances (fig. 2). 
Similar experiments performed on the monosaccharide -methylglucose and the (1-4)-linked 
Glc disaccharide (maltose) did not provide any STD response (not shown). Taken together, 
these results suggest that the tri- or tetrasaccharide is the minimum epitope recognized by the 
mAb, and point towards a recognition of the inner, (1-4)-linked Glc units by the mAb, rather 
than the branching points or the reducing ends. 
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Figure 2: STD experiments performed on a series of -Glc-containing oligosaccharides. A: maltotetraose; B: 
maltoheptaose; C: (1-6)-branched maltotriose; D: a double (1-6) branched maltopentose. In all instances, the 
anomeric proton of the linear (1-4) linkages (highlighted in blue) shows a higher STD response than those of the 
reducing ends (highlighted in orange) and the (1-6)-branches (highlighted in red) (marked with asterisks), suggesting 
that the recognition takes place at the core (1-4)-linked -Glc units preferentially. 
Next, we performed STD experiments on glycogen. Because glycogen itself, owing to its large 
size, also becomes inherently saturated to some extent, a blank STD experiment performed in 
the absence of the mAb was subtracted to the STD spectrum performed on glycogen in the 
presence of the mAb, in order to obtain a saturation transfer double difference (STDD) 
spectrum [28], i.e. a dissected contribution of the saturation of glycogen owed to its binding to 
the mAb. The STDD spectrum (fig. 3A) was analyzed, evidencing that the highest degree of 
saturation was observed at H3, at the (1-4)-linked H1, and at the terminal H4 protons (fig. 
3B). These results suggest that the recognition of glycogen preferentially takes part at the core 
(1-4)-linked H1 protons, as well as at the non-reducing terminal ends. 
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Figure 3: A: STDD experiment on glycogen. Because glycogen itself, as a large molecule, receives inherent 
magnetization in STD experiments, STD spectra of glycogen in the presence of the mAb were subtracted a control 
STD spectrum of glycogen in the absence of the mAb to obtained the STDD spectrum. Labels indicate the 
assignment of the glycogen 1H-NMR signals according to [29]. B: Group epitope mapping as obtained by the relative 
STDD intensities for each glycogen signal in the spectrum shown in A. 
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3.2.2 On-cell NMR studies of M. smegmatis cell wall glucans 
A novel technique for identifying genes involved in the synthesis of the mycobacterial -glucan 
using the mAb IV58B6 was developed by the group of Prof. Appelmelk. Briefly, the method is 
based on the generation of a mutant library through transposon mutagenesis [30], which is 
screened by immunostaining with the mAb , revealing an array of over-producing and under-
producing phenotypes, the genes responsible of which are then identified by ligation-mediated 
polymerase chain reaction (PCR) [31]. One of the mutants identified as an under-producer was 
glgB::Tn (fig. 4). In mycobacteria, the glgB gene codes for a glycosyltransferase which 
introduces (1-6) branches on the (1-4) glucan polymer [32]. Thus, glgB::Tn mutants are 
expected to produce a capsular glucan formed by linear (1-4) chains only. 
Figure 4: Quantification of capsular -glucan levels in M. smegmatis -glucan transposon mutants (courtesy of Ben 
J. Appelmelk). 
We used on-cell NMR to get insight into the structure of the cell wall -glucan envelope of 
both M. smegmatis wild-type and glgB::Tn mutants. Suspensions of killed cells of both 
phenotypes were visible by 1H-NMR in the shape of very broad signals, encompassing chemical 
shift ranges typical for glycans (3.0  5.5 ppm) and lipids (0.8  2.5 ppm), and in DOSY spectra 
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as a single species of  logD = -11.8, in agreement with it being a single entity of very large size 
(fig. 5). 
Figure 5: DOSY spectrum of M. smegmatis cell preparations (in blue, with 1D 1H-NMR spectrum stacked on the top). 
The cells are visible as a single entity diffusing with logD = -11.8 m²/s, and encompassing signals at chemical shifts 
characteristic for glycans (3 to 5.5 ppm) and lipids (0.8-2.5 ppm). In red, a DOSY spectrum of the 67 kDa protein 
bovine serum albumin (BSA) is shown for reference. 
1H-13C heteronuclear single quantum coherence (HSQC) spectra of M. smegmatis cell 
suspensions at 13C natural abundance revealed the presence of a high number of cross-peaks 
in the chemical shift region typical for glycans (fig. 6). This spectral complexity is due to the rich 
variety of components of the mycobacterial envelope, including mycolic acids [33], 
arabinogalactan, peptidoglycan, lipoarabinomannan, phosphatidylinositol mannoside, and 
others [34]. In order to straightforwardly identify the signals belonging to the -glucans, these 
were digested until completion with amyloglucosidase from Aspergillus niger, an enzyme that 
hydrolyzes both Glc(1-4)Glc and Glc(1-6)Glc linkages [35]. The resulting spectrum was 
compared with that of the parent sample, revealing the original signals of the -glucans. 
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Expectedly, these signals were very similar to those of glycogen as can be deduced from 
inspection of the corresponding spectral superimposition (fig. 6A). 
Next, spectra from wild type and glgB::Tn mutant samples were compared. Two signals 
characteristic of (1-6)-linked units were absent in the spectrum of the glgB::Tn mutant, i.e. 
those of 6(6-1) and 4(6-1) (fig. 5B), while those of the linear (1-4) sequence were maintained. 
These results indicate that the -glucan of glgB::Tn mutants is primarily formed by a linear, 
unbranched (1-4)glucose polysaccharide, lacking (1-6) branches. 
Figure 6: On-cell heteronuclear NMR studies on the mycobacterial capsule. Phase-sensitive 1H-13C HSQC spectra of 
M. smegmatis cells acquired at 13C natural abundance, in which negative cross-peaks belonging to CH2 
correlations (e.g. position 6 of -glucans) are shown in lighter colors. A: Identification of the -glucan signals. 
Blue/green: untreated wild-type cells. Red/pink: wild-type cells after complete digestion with amyloglucosidase 
from Aspergillus niger. Orange/yellow: glycogen, for reference. Dashed circles highlight the -glucan signals, which 
do not appear in the spectrum of amyloglucosidase-treated cells and are highly superimposable with glycogen 
signals. B: Wild-type vs. GlgB::Tn mutant. Blue/green: wild-type cells. Red/pink: GlgB::Tn mutant cells. Labels 
indicate signals identified as those of 6(6-1) and 4(6-1), which are characteristic for (6-1) branches and do not 
appear in the spectrum of GlgB::Tn mutant cells. 1H-13C correlations were identified using assignments reported by 
[8] and aided by chemical shift prediction performed with CASPER [36] (figs. S2, S3 in Appendix). 
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Based on the intensity of the signals in the 1H-13C HSQC spectrum (fig. 6B), the levels of (1-4) 
linear glucan present in glgB::Tn mutant cells are only about 50% less in comparison to those 
found in wild-type cells. However, colonies of mutant cells did not show any immunostaining 
using the mAb, a reason why this mutant seemed to not produce -glucan at all (fig. 5). These 
data are in apparent contrast with the ligand epitope mapping deduced from STD data, which 
seem to indicate that recognition of glycogen and related oligosaccharides by this mAb 
preferentially involves the (1-4) linear core (figs. 2-3). This fact raises the question why 
glgB::Tn mutants do not appear to bind the anti-glycogen mAb. 
There are two main reasons that may explain this discrepancy. First, because (1-6) branching 
provides the -glucan with additional (1-4) chains, the capsule of glgB::Tn mutants could 
actually bear lower levels of -glucan epitopes for the mAb. Since the 1H-13C HSQC spectrum 
does not allow to discriminate between signals from intracellular and capsular -glucan, it is 
possible that the greatest portion of the -glucan signals in the spectrum of glgB::Tn mutants 
arise from intracellular -glucan, which is not accessible to the antibody. However, this does 
not appear to be the case, since previous data showed that glgB knockout mutants produced 
57% and 36% of normal capsular and intracellular -glucan levels, respectively [32]. 
Secondly, amylose-like, linear (1-4) linked polymers are known to be largely insoluble in 
hydrophilic conditions and to form aggregates [37]. Therefore, we hypothesize that binding of 
the mAb to glgB::Tn mutants is precluded due to strongly reduced availability of the (1-4) 
linked -glucan epitope caused by insolubility and aggregation of the unbranched -glucan 
polymers. Electron microscopy images of glgB::Tn mutant cells obtained by the group of B. J. 
Appelmelk, showing electron-dense insoluble aggregates not visible in preparations of wild-
type cells provide support to this hypothesis. 
3.3 Methods 
3.3.1 STD experiments 
STD experiments were acquired at 25 ºC in a Bruker AVANCE 600 MHz spectrometer equipped 
with a cryoprobe in fully deuterated Tris-d11 25 mM buffer, pD 8.0, 150 mM NaCl. Samples 
contained 5 mg glycogen from bovine liver (Sigma) or 2 mM of the studied oligosaccharides 
and 0.2 mg/ml of the monoclonal antibody IV58B6 (mAb), kindly ceded by O. Baba [15]. The 
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mAb was saturated on-resonance at 0 ppm and off-resonance at 100 ppm with a train of 
Gaussian-shaped pulses of 50 ms each, totaling an irradiation time of 2 s. STD spectra were 
obtained by subtracting the on-resonance to the off-resonance spectra. In the case of 
glycogen, a separate STD spectrum was acquired in the absence of the mAb and subtracted to 
the STD spectrum in the presence of the mAb to obtain a saturation transfer double difference 
(STDD) spectrum. STD(D) intensities were measured comparing each STD(D) spectrum with the 
correspondent off-resonance spectrum and normalizing to the ligand peak receiving the 
highest degree of saturation. Data were analyzed with Bruker TopSpin 3.0 and figures were 
built with MestReNova v.8.0.2. 
3.3.2 On-cell NMR 
M. smegmatis mc2155 wild-type and glgB::Tn strains were cultured in the laboratory of Ben J. 
Appelmelk (University of Amsterdam). Bacteria were grown for 2 days in 7H9 liquid medium 
supplemented with 10% albumin-dextrose-catalase and tween-80. Then, they were washed 2 
times with PBS, pelleted and heat-killed for 2 hours at 80 ºC. For NMR observarions, they were 
washed (x2) in D2O and resuspended in D2O. 1H-NMR and multiplicity-edited 1H-13C HSQC 
spectra were acquired at 37 ºC in a Bruker AVANCE 700 MHz spectrometer equipped with a 
cryoprobe. For identification of the cell wall -glucan signals, wild-type cell samples were 
incubated with 60 U amyloglucosidase from Aspergillus niger (Sigma, St Louis, MO), in 50 mM 
sodium phosphate buffer, pH 5.6 at 55 ºC until digestion was complete. Next, cells were 
pelleted, washed and spectra were recorded again and compared with those recorded before 
treatment. Diffusion-ordered spectroscopy (DOSY) experiments were run using the standard 
Bruker sequence, in a Bruker AVANCE 500 MHz spectrometer. 32 1H-NMR spectra were 
collected with a diffusion time (big delta) of 1 s for cell samples and 0.4 s for a sample 
containing BSA, and an gradient pulse (little delta) of 3 ms. The 1D spectra were processed and 
baseline-corrected, and the diffusion dimensions were exponentially fitted according to pre-
set windows. 
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CHAPTER 4 
STUDIES ON UDP-GLUCOSE PYROPHOSPHORYLASE OF STREPTOCOCCUS PNEUMONIAE, A 
DRUG TARGET CANDIDATE 
4.1 Introduction 
Carbohydrate-processing enzymes catalyze the synthesis of activated sugar donors [1], as well 
as the transfer of sugar residues from these donors to other carbohydrates or aglycons [2], and 
thus, they are responsible for the genesis of the whole cellular glycan repertoire.  
Glycosyl phosphoesters of nucleoside pyrophosphates, more often referred to as sugar-
nucleotides, occupy a relevant place in carbohydrate metabolism as the activated forms 
serving as glycosyl donors for the synthesis of complex carbohydrates and the sugar moieties 
of glycoconjugates. Among these molecules, UDP-glucose is a highly multifunctional 
metabolite, being essential for a rich variety of processes and a crossroad point in 
carbohydrate metabolism. In animal and fungal metabolism, UDP-glucose is the sugar donor 
for glycogen synthesis and, as in all eukaryotes, in the formation of the carbohydrate moieties 
of glycolipids, glycoproteins and proteoglycans [3]. Besides, it is also required for galactose 
utilization [4]. In plants, UDP-glucose is used for the synthesis of sucrose and cellulose and is 
involved in starch metabolism [5]. In prokaryotes, perhaps the most distinguishing role of UDP-
glucose is its participation in the synthesis of different components of the bacterial envelope, 
particularly the lipopolysaccharide (LPS) and the capsule, structures that represent necessary 
virulence factors of many microorganisms. 
UTP:-D-glucose-1-phosphate uridylyltransferase (EC 2.7.7.9), commonly referred to as 
UDP-glucose pyrophosphorylase, and abbreviated as UGP or by the capitalization of its coding 
gene in E. coli (GalU), catalyzes the reversible formation of UDP-glucose and pyrophosphate 
(PPi) from glucose-1-phosphate and UTP (fig. 1). UGP activity is ubiquitous to all domains of 
life, given the functional importance of its product. However, and interestingly, prokaryotic 
UGPs are evolutionary unrelated to their eukaryotic counterparts [6].  
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Figure 1: Reaction scheme for UDP-glucose pyrophosphorylase 
Given its essential activity for the cell metabolism, UDP-glucose pyrophosphorylases are 
ubiquitously distributed throughout all domains of life. UGPs are, in addition, very well 
conserved proteins: for instance, the sequence of the E. coli UGP bears a 29% identity with 
that from the archean Sulfolobus, and the human and barley enzymes share a 55% identity. 
However, and interestingly, sequence similarities between UGPs of prokaryotic origin and their 
eukaryotic counterparts lie around 8%, which is considered non-significant. For comparison, 
human UDP-galactose-4-epimerase, another enzyme rendering UDP-glucose as product, 
shares an identity of 51% with its E. coli homologue [7]. Thus, the UGPs of prokaryotic and of 
eukaryotic origin are believed to be evolutionarily unrelated [6, 8]. Fittingly, Hartman and 
Fedorov classified the eukaryotic UGP as a eukaryotic signature protein, being itself one of 
only a handful enzymes in a list of 347 proteins that were considered to be genuine eukaryotic 
inventions [9]. 
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In light of these data, a number of authors have underlined the attractiveness of bacterial 
UGPs as potential antimicrobial targets, as a means of selectively inhibit the pathogen enzyme 
without disrupting the host metabolism [6, 8, 10]. 
4.1.1 Structure 
Up to date, the crystallographic structures of four bacterial UGPs have been deposited in the 
Protein Data Bank: those from Escherichia coli (acc.: 2E3D) [11], Corynebacterium glutamicum
(2PA4) [12], Sphingomonas elodea (2UX8) [13] and Helicobacter pylori (3JUJ and 3JUK) [8], all 
of which share a very similar structure. Here, the structure of the H. pylori enzyme is discussed 
as representative of the group. 
All four UGP structures were crystallized as homotetramers (fig. 4), exhibiting mean 
dimensions of 85 Å × 75 Å × 50 Å. Each monomer, of approximately 30-35 kDa, presents a 
characteristic folding, dominated by a central mixed -sheet, reminiscent of the nucleotide-
binding Rossmann fold, but including nine -strands, surrounded by eleven -helices and two 
additional -strands (fig 5). The overall quaternary structure can be understood as a dimer of 
dimers, with tight dimers resulting of extensive interactions established between two 
adjacent subunits, and loose dimers arisen from weaker packing interactions between the 
alternate pairs of subunits (fig. 4). In the H. pylori UGP, the tight dimers result from 
interactions made by residues located mainly in the 1, 4 and 12 helices and the 2-3 
loop, between subunits A and B, and C and D, respectively. In other UGPs (e.g. that of S. 
elodea), an additional helix exists at the C-terminus, which gives rise, together with the 
preceding helix, to a V-shaped domain that further stabilizes the dimer by interacting with its 
homologous in the other monomer. The loose dimers arise from contacts between the  3 
strands from each alternate subunit A and C, and B and D, respectively. 
4.1.1.1 Active center 
As in other pyrophosphorylases, such as thymidylyltransferases, each bacterial UGP subunit 
carries on an active site made up by residues located in the same polypeptide chain [14]. This 
is in contrast with cytidylyltransferases, in which active sites are formed by residues located in 
different subunits [12]. In UGPs, the active center is located in a deep cleft of approximately 20 
Å × 20 Å × 15 Å, delimited by 1, 4, 8, 9, 7, 11 and nearby loops (fig. 5). Residues 
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involved in binding and catalysis are extremely conserved among UGPs of different species. 
These residues are located mainly in loops facing the active site cleft, rather than in the 
neighboring -helices or -strands. 
Figure 2: Tetrameric structure of H. pylori UGP (PDB: 
3JUK) [8]. Subunits A and B (in blue and green, 
respectively) and C and D (in pink and yellow, 
respectively) interact within a region including three -
helices and one loop, forming the respective tight 
dimers. In addition, subunits A and D, and B and C are 
packed, in a weaker manner, with participation of 
residues located in two -strands.  
Figure 3: H. pylori UGPase in its unliganded form (PDB 
code: 3JUJ), with labels indicating the identity of the 
individual alpha helices and beta strands. 
Fig. 6 shows UDP-glucose anchored to the H. pylori UGPase active site, showing key contacts 
between the enzyme atoms and those of its product. In the bound state, both the nucleoside 
and sugar moieties are buried inside the active site pocket, unlike the phosphate groups, which 
remain fully accessible to the solvent. The nucleoside moiety of UDP-glucose interacts with the 
Ala10 and Gly11 backbone NHs from the conserved N-terminal motif, at the level of the O2 
and O2 atoms, respectively. In addition, the Gln102 -amide and the Gly107 NH interact with 
O4 of the uracyl moiety. Negatively charged phosphate groups are docked to the enzyme by 
electrostatic interactions with a pair of conserved lysine residues. The first phosphate interacts 
with the Lys191 side-chain from the VEKP signature motif, whereas the second phosphate 
contacts the Lys25 side-chain. Two phosphoryl oxygens from the phosphate pair are 
coordinated with a Mg2+ ion, whose coordination sphere is completed by the Glu130 
carboxylate and three ordered water molecules. Gly171 can hydrogen-bond to any of both the 
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3- and 4-hydroxyl groups of the glucose moiety, Asp131 contacts the 6-hydroxyl group, and 
Glu190 carboxyl oxygens from the VEKP motif interact with the sugar 2 and 3-hydroxyl 
groups, a bidentate interaction commonly found in other glucose-protein interactions, such as 
those found in lectins [15].  
Figure 4: Diagram of the H. pylori UGP active center, in complex with UDP-glucose [8]. The protein residues 
participating in substrate binding are depicted in yellow, and a magnesium ion, coordinated with Glu130, two 
phosphoryl groups and three water molecules, is shown in green. Black dotted lines represent the inferred 
interactions implicated in substrate binding. Arg15 is located apart from the ligand and is not involved in binding, 
since mutation of this residue has no significant effects on the affinity of the enzyme towards its substrates [8]. 
Instead, it plays an important role in the catalytic activity. 
4.1.2 Mechanism of action 
In UDP-glucose pyrophosphorylases, the reaction is initiated by a nucleophilic attack of the 
glucose-1-P phosphoryl oxygen on the phosphorous atom of the UTP -phosphate. It is 
thought that a Mg2+ ion participates in the catalysis by both stabilizing the excess of negative 
charge and properly positioning the phosphoryl oxygen of glucose-1-phosphate for its 
nucleophilic attack [16]. Indeed, the presence of magnesium has been shown to be absolutely 
required for the catalysis [17], as well as enhancing the binding affinity of UGP towards UTP 
and UDP-glucose [8]. After the reaction takes place, the - and -phosphates are displaced and 
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leave the enzyme/UDP-glucose complex as inorganic pyrophosphate, followed by dissociation 
of UDP-glucose. In the reverse reaction, pyrophosphate nucleophilically attacks UDP-glucose 
and glucose-1-P is displaced, followed by release of UTP. 
4.1.3 Function and value as a therapeutic target 
The relevance of UGPs for bacterial cell physiology is determined by the pivotal role of its 
product UDP-glucose in the bacterial metabolic pathways (Fig. 7). Occupying this central 
position in the bacterial metabolism, UDP-glucose serves both as a signaling molecule and as a 
building block for the synthesis of complex polysaccharide structures. As noted above, one of 
the main functions of UDP-glucose, in prokaryotes is to serve as glucosyl donor for 
carbohydrate biosynthesis. UDP-glucose is required for the synthesis of LPS, cell wall sugar 
moieties, capsular polysaccharides and membrane-derived oligosaccharides, as well as 
exopolysaccharides, either directly or via UDP-galactose. In addition, production of UDP-
glucose has been linked with osmotolerance and the complex coordination of cell size and the 
control of the bacterial cell cycle.  
The central position of UDP-glucose in the bacterial biochemical pathways, very prominently 
those involved in the synthesis of envelope structures, determines that strains defective for 
this enzyme show markedly impaired pathogenic phenotypes. Not unexpectedly, the gene 
galU can be found as an essential gene for one third of all bacteria taxa included in the 
database of essential genes [18]. 
In S. pneumoniae,  ninety different capsular types have been described [19], and the 
organization of the gene cluster responsible for the biosynthesis of several capsular types has 
been analyzed [19-21]. UDP-glucose is needed for the addition of glucose, galactose (via the 
epimerization of the activated sugar), glucuronic and galacturonic acid residues of the 
pneumococcal capsule. Since at least one of these four sugars is found in all capsular 
polysaccharides, pharmacological inhibition of UGP would affect the biosynthesis of the 
pneumococcal capsule, considered a sine qua non component of pathogenicity of this 
microorganism [10, 17]. Figure 8C shows the unencapsulated phenotype of galU-defective 
pneumococci, which is correlated with its apathogenicity.  
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Figure 5: Diagram showing the central position of UDP-glucose in the bacterial biochemical pathways. Arrows 
indicate the enzymatic transformations of UDP-glucose into several metabolites in E. coli, catalyzed by enzymes 
denoted by codes in gray. Gray ovals represent bacterial functions associated with those enzymatic activities. These 
functions, especially the presence of capsule and/or LPS in the bacterial envelope, are related with bacterial 
virulence (represented by a black oval). 
Figure 6: Capsule phenotypes for three pneumococcal strains: A: M23, B: M23c, and C: M23g (GalU), showing the 
non-encapsulated phenotype of the galU mutant (C). Bar, 1 mm. Adapted from [22]. 
In addition to S. pneumoniae, it has been shown that galU mutation produces aberrant 
envelope structures in a large number of organisms. Consequently, the galU UDPG:PP 
enzymatic activity may represent an important target in fighting bacterial infectious diseases 
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[17]. In E. coli, such mutants were reported to produce incomplete LPS, containing only 
heptose and 3-deoxy-D-manooctulosonic acid as sugar moieties. Moreover, these mutants 
showed motility impairment due to lack of functional flagella formation [23]. Loss of motility 
has been also shown to occur in other pathogenic organisms, such as Pseudomonas, upon galU 
mutation [24]. In addition, mutations in genes coding for UGPs have been shown to lead to 
decreased virulence of a number of diverse bacterial pathogens. In Klebsiella pulmoniae, galU 
mutation led to loss of mucoid colony phenotype and virulence in mice and high sensitiveness 
in human serum [25]. galU– Vibrio colerae was defective in colonization and lost its capability 
to synthesize an exopolysaccharide biofilm involved in the formation of a resistant rugose 
variant [26]. Similarly, cornea infecting and systemic spreading capacities of Pseudomonas 
aeruginosa were impeded upon galU mutation [27], while the plant pathogen Xanthomonas 
citri was shown to require UGP activity for in planta growth and pathogenicity [28].  
Considering all above, the advent of new molecules targeted against the activity of bacterial 
UGPs will obviously open new ways for broad applications in biotechnology and biomedicine. 
Specifically, inhibitors of this enzyme would be of great value for the treatment of diseases 
caused by pathogens that are resistant to the current therapeutic arsenal. The promising 
profile of bacterial UGPs as potential target candidates has been referred by many authors, 
given its participation in key metabolic pathways and the synthesis of some of the most 
important bacterial virulence factors, together with the fact that there is no relation, aside 
from the catalytic activity, between bacterial UGPs and their eukaryotic counterparts. This last 
feature very well suits bacterial UGPs to provide the required specificity to avoid undesired 
toxicities, therefore possibly accelerating its development and speeding up its process to 
market. 
The objectives of this chapter are to develop NMR-based procedures useful for mechanistical 
studies on this family of enzymes, using the biomedically relevant UGP from S. pneumoniae as 
a model, which can be used further in the characterization of inhibitory drugs or in the 
exploration of metabolic pathways in which sugar-nucleotides are involved. In addition, we 
present a fragment-based screening against spUGP, which represents the first step toward 
drug targeting of bacterial UGPs.  
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4.2 Results 
4.2.1 Insights into the spUGP reaction mechanism 
To get insight into the mechanism of spUGP by NMR, STD experiments were performed on its 
three ligands that are visible by proton NMR, i.e. UDP-Glc, UTP and Glc-1-P, in the presence of 
the enzyme. The outcome of these experiments can be seen in figs. 7-9. Both UDP-Glc and UTP 
gave rise to STD signals in the presence of spUGP, indicating that its binding can be monitored 
by NMR. Group epitope mapping studies showed that a similar pattern of selective saturation 
was found at the nucleoside part of both substrates, with H1 of uracyl receiving the highest 
degree of saturation, followed by the ribose signals, especially H1 and H4 protons. 
Figure 7: Recognition of UDP-glucose. Off-resonance (A) and STD (B) spectrum of UDP-Glc in the presence of spUGP, 
with labels indicating 1H-NMR assignments. A molecule of UDP-Glc is shown, with labels indicating the STD intensity 
of each signal, relative to the STD intensity of the most saturated signal. Red circles: I > 50%, orange circles: 50% I > 
30%, yellow circles: 30% > I > 10%.
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Figure 8: Recognition of UTP. Off-resonance (A) and STD (B) spectrum of UTP in the presence of spUGP, with labels 
indicating 1H-NMR assignments. A molecule of UTP is shown, with labels indicating the STD intensity of each signal, 
relative to the STD intensity of the most saturated signal. Red circles: I > 50%, orange circles: 50% I > 30%. 
In contrast, STD experiments performed on Glc-1-P in the presence of spUGP were negative 
(fig. 9B). However, addition of UTP to the same samples triggered the rising of signals in the 
STD spectrum not only for the nucleotide, but also for the sugar phosphate (fig. 9D). In those 
instances, signals of UDP-Glc were also observed in the spectra, because co-incubation of UTP 
and Glc-1-P with the enzyme in the NMR tube resulted in their enzymatic transformation into 
UDP-Glc and PPi.  
Lastly, STD signals of the different substrates were abolished upon addition of EDTA to the 
samples (fig. 9E), thus indicating that magnesium is needed not only for catalysis, but also for 
ligand binding. Together, these results can give insight into the reaction mechanism of this 
enzyme. 
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Figure 9: Recognition of glucose-1-P. Off-resonance (A) and STD (B) spectrum of Glc-1-P in the presence of spUGP, 
with labels indicating the 1H-NMR assignments. Off-resonance (C) and STD (D) spectrum of the same sample, after 
addition of 1 equivalent UTP, and STD spectrum (E) of this sample after addition of 5 mM EDTA-d12. A molecule of 
Gcl-1-P is shown, with labels indicating the STD intensity of each signal, relative to the STD intensity of the most 
saturated signal. Red circles: I > 50%, orange circles: 50% I > 30%. These results indicate that Glc-1-P only binds to 
spUGP after UTP, and that Mg2+ is absolutely required for ligand binding. 
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The catalytic mechanism followed by NDP-sugar pyrophosphorylases has historically been a 
subject of controversy. Early insights into the mode of action of a member of the family 
suggested a sequential ordered Bi-Bi mechanism, in which the substrates enter the active site 
in an orderly fashion, react, and depart from the enzyme in a precise order. Nonetheless, it 
was speculated that the phosphorolysis reaction could operate also through a ping-pong 
mechanism, via a covalent intermediate between the nucleotide and the enzyme [29], a 
possibility that was discarded by the absence of 14C incorporation to the enzyme from the 
labeled sugar-phosphate. Speculation persisted, nonetheless, if the second substrate binds and 
simultaneously reacts (the so-called hit and run mechanism) or binds, and then reacts [14]. 
Our results point toward a sequential ordered Bi-Bi catalytic mechanism, in which UTP binds to 
the enzyme first, followed by Glc-1-P binding to the enzyme/nucleotide complex. These results 
are supported by recent findings using isothermal titration calorimetry (ITC) measurements, 
together with crystallographic data for a number of pyrophosphorylases [8, 14]. 
4.2.2 NMR-based enzyme assay 
One of the advantages of NMR spectroscopy is that it allows observing individual nuclei of 
particular molecules, even in complex mixtures of compounds. This feature makes NMR-based 
assays very convenient to monitor chemical reactions in real-time. 
Although most UTP and Glc-1-P signals overlap with those of UDP-Glc, the reaction catalyzed 
by spUGP could be monitored by looking at the interconversion between the glucose-1-P 
proton H1 to the UDP-glucose proton H1 (fig. 10). These signals, which appear as 
characteristic doublets of doublets, due to 3J-coupling with both the glucosyl H2 and the 31P of 
the vicinal phosphate, are around 0.15 ppm apart from each other, and well-isolated in the 
1H-NMR spectrum. 
Focusing on these signals, the reversible interconversion between Glc-1-P and UDP-Glc was 
monitored inside the NMR tube, both in the forward reaction, i.e. formation of UDP-Glc (fig. 
10), and in the reverse reaction, i.e. formation of Glc-1-P and UTP (fig. 11). The NMR-based 
assay consisted in a cascade of 1H-NMR experiments of 30 s each, until the reaction reached a 
steady state (ca. 20 min). To help mix the reactants and minimize precipitation of the insoluble 
magnesium pyrophosphate, the NMR spectra were recorded while spinning the sample at 20 
Hz.  
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Figure 10: NMR-based spUGP activity assay. Monitoring of the forward reaction (UTP + Glc-1-P ® UDP-Glc + PPi). A: 
Stacked 1H-NMR spectra of a reaction mixture at different reaction times (in min), focusing on the UDP-Glc H1 and 
Glc-1-P H1 signals. Reaction mixtures contained 1 mM UTP, 1 mM Glc-1-P, 5 mM MgCl2 and 350 nM spUGP. Spectra 
at t=0 were obtained before enzyme addition. B: Plots showing substrate-product conversion as a function of time. 
The maximum reaction rates for the forward and reverse reactions measured in these assays 
were 16 nmol/min and 48 nmol, respectively. Considering one unit of activity (U) as the 
amount of enzyme required to catalyze 1 mol of substrate per minute, and the amount of 
enzyme used (6 g), these values account for specific activities of 2.7 U/mg and 8 U/mg, 
respectively.  The activity measured in these assays is thus comparable to the reported value 
of 13.6 U/mg for the reverse reaction, using freshly purified spUGP [17].  
This NMR-based assay, used here for the first time for the characterization of enzymes from 
this family, represents a direct approach to monitor their activity, because substrate 
interconversion is directly observed. Thus, this method is advantageous over the currently 
most used one for measuring nucleotidyltransferase activity, which relies on its coupling to 
NADH/NAHD+ conversion by UDP-Glc 6-dehydrogenase [6, 17].  
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Figure 11: NMR-based spUGP activity assay. Monitoring of the reverse reaction (UDP-Glc + PPi ® UTP + Glc-1-P). A: 
Stacked 1H-NMR spectra of a reaction mixture at different reaction times (in min), focusing on the UDP-Glc H1 and 
Glc-1-P H1 signals. Reaction mixtures contained 1 mM UDP-Glc, 1 mM PPi, 5 mM MgCl2 and 350 nM spUGP. Spectra 
at t=0 were obtained before enzyme addition. B: Plots showing substrate-product conversion as a function of time. 
4.2.3 Fragment-based targeting of spUGP 
As already mentioned, the involvement of UGPs in bacterial pathogenicity makes them an 
excellent target for the discovery of new pharmaceuticals, especially against highly resistant 
bacterial species, such as S. pneumoniae. 
 A useful approach to target carbohydrate-processing enzymes is by using non-hydrolyzable 
analogs, such as aza- or carbasugars [30] and exo-glycals [31]. However, since UTP:-D-glucose-
1-phosphate uridylyltransferase activity is key for biological processes also in humans, care 
must be taken when using this strategy, because the enzymatic activity of the host would likely 
be inhibited as well. Instead, the lack of evolutionary relation and sequence homology 
between prokaryotic and eukaryotic UGPs represents an opportunity for lead discovery as 
result of screening programs to selectively inhibit the bacterial enzyme without problems 
derived from promiscuity toward the human protein. 
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We have targeted spUGP through fragment-based drug discovery (FBDD), which represents 
the first reported efforts to target bacterial UGPs.  
In total, 200 molecules were screened against spUGP. Nearly 30% of the tested fragments 
displayed STD signals. This was correlated with the existence of a big binding pocket (that of 
the active center), making it prone for fragments to bind therein. Fig. 12 exemplifies the 
finding of a fragment hit within a mixture. In order to pick only the best performing fragments, 
a cut-off was applied for hit selection, which left fragments showing an STD response below 
12% out of subsequent study. Positive hits satisfying this requirement are shown in Table I. 
All hits had in common an elevated hydrophobicity and a similar scaffold, consisting of two 
non-fused aromatic rings, either five- or six-membered. All of them were shown to interact 
with protein epitopes in or very close to the active site, as inferred from their ability to 
compete with UDP-glucose (fig. 13). Besides, in all instances, UTP was shown to compete with 
these fragments in STD experiments (as exemplified for fragment 275 in fig. 12), indicating that 
fragment binding occurs at the nucleotide subsite of the active center. 
Figure 12: Example of fragment hit occurrence in a mixture targeting spUGP. A: off-resonance spectrum of a 
fragment mixture (scaled 10%); B: STD spectrum of that fragment mixture, with the structure of fragment 275, 
identified as the hit. C: STD spectrum after addition of UTP to the sample. 
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Figure 13: Fragment ranking. Left: STD titration with UDP-Glc. Right: Competition STD experiments with UDP-Glc. 
Green: 3.2 mM UDP-Glc; purple: + 2 mM 209; red: 3.2 mM UDP-Glc; blue: + 2 mM 358.
Table I: List of fragment hits for spUGP and their estimated KD and LE values
ID Structure KD (mM) LE (kcal/mol)
UDP-glc 3.2  ± 0.2 0.09 
209 0.9 0.32 
338 1.2 0.31 
358 1.2 0.33 
355 2.1 0.26 
275 1.1 0.31 
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Dissociation constants (KD) for these fragment hits were estimated through competition 
experiments, using UDP-Glc as a spy molecule (Table I). This procedure was advantageous over 
direct KD calculation for every molecule, not only because it obviated the need to perform 
multiple titrations, but also because they in fact permitted to estimate a KD for such highly 
hydrophobic compounds. Indeed, in some cases, the obtained KDs were higher than their 
solubility limit. 
Because competition experiments are more powerful when using weak-binding spy molecules, 
they were performed with UDP-Glc in the absence of Mg2+ (in fact, with only the amount of 
Mg2+ present in the protein samples, likely coming from the bacterial expression host), which 
lowered the affinity of spUGP toward UDP-Glc down to the mM level, but still permitted to 
observe significant STD signals (fig. 13). 
In agreement with their small size, fragment hits were estimated to bind to spUGP with rather 
low affinities (with KDs in the low mM range), but with high ligand efficiencies. As expected 
from these low affinities, enzymatic assays performed in the presence of these fragments led 
to virtually no difference in the activity profile of the enzyme (fig. 14). However, it is expected 
that larger, more potent inhibitors will lead to a decrease in spUGP activity observable in the 
enzyme assay. 
These studies are the first reported small-molecule screening against a bacterial UGP and 
represent the first step toward the targeting of pneumococcal UGP, a therapeutic target 
candidate. 
Figure 14: NMR-based spUGP activity 
assay. Plot showing Glc-1-P to UDP-Glc 
conversion, as a function of time, by 
spUGP, both in the absence (filled circles 
and solid regression curve) and in the 
presence of 1 mM fragment 275 (open 
circles and dashed regression curve). 
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4.3 Methods 
STD studies on spUGP substrates 
STD experiments were performed on UGP recombinantly produced as previously reported 
[17]. Experiments were run at 298 K in a Bruker Avance 500 MHz spectrometer, using 1 mM of 
each substrate and 5 mM MgCl2 in 25 mM Tris-d6, pH 8.0, 50 mM NaCl in D2O. The protein was 
saturated on resonance at -0.5 ppm and off resonance at 100 ppm with a train of 40 selective 
Gaussian-shaped pulses of 50 ms duration with a 100 s delay between each pulse. Substrates 
were purchased from Sigma (St. Louis, MO, USA). UGP samples were generously provided by 
the laboratory of Prof. Antonio Romero (CIB-CSIC). 
NMR-based enzyme assay
The progress of the reaction catalyzed by spUGP was monitored by NMR. Reaction samples 
within the NMR tubes contained 1 mM of each pair of reactants (UTP and Glc-1-P for the 
forward reaction; UDP-Glc and PPi for the reverse reaction) and 5 mM MgCl2 in 25 mM Tris-d6, 
pH 8.0 in D2O. Reactions were initiated by the addition of 6 g (360 nM) recombinant spUGP 
and subsequently monitored by a cascade of 1H-NMR experiments of 30 s each until reaction 
reached the equilibrium, in a Bruker Avance 500 MHz spectrometer. Substrate to product 
conversion was measured by monitoring the interconversion between the glucose-1-P proton 
H1 to the UDP-glucose proton H1. One unit of activity was defined as the amount of enzyme 
required to catalyze 1 mol of substrate per minute at 25 ºC. 
Fragment screening 
Mixes of 10 chemically diverse fragments were screened through STD experiments against 
spUGP in a Bruker Avance 500 MHz spectrometer. Screening mixtures contained 150 M of 
each fragment and 5 M spUGP. Buffer conditions were 25 mM Tris-d6, pH 8.0, 50 mM NaCl in 
D2O. The protein was saturated on resonance at -0.5 ppm and off resonance at 100 ppm with a 
train of 40 selective Gaussian-shaped pulses of 50 ms duration each. 
STD-positive hits were identified from the reference off-resonance spectra and binding was 
tested independently. Next, they were ranked according to their estimated KDs. 
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KD estimation 
To quantify the affinity of spUGP toward UDP-Glc, a KD was estimated from titration 
measurements of the intensity of its STD signal as a function of its concentration.  
           (1), 
where I is the observed intensity for the H1 peak in the STD spectrum at a concentration c of 
UDP-Glc, Imax is the maximum intensity and KD is the dissociation constant. A set of experiments 
at varying concentrations of UDP-Glc were performed and the KD was estimated by regression 
of these data to eq. 1 using SigmaPlot 12.0. 
For fragments, affinities were estimated based on competition experiments in the presence of 
UDP-Glc as a spy ligand. The decrease in the STD signals of UDP-glucose after the addition of 
each fragment was monitored, and an inhibition constant (KI) was calculated for each fragment 
assuming a competitive inhibition model, where: 
           (2), 
being KDap the apparent dissociation constant of UDP-glucose for spUGP observed after the 
addition of a concentration F of a fragment binding with a dissociation constant KI. Therefore, 
the relation between the observed STD signals of UDP-glucose at a concentration L after and 
before the addition of a fragment could be represented as: 
 (3) 
And, since we used L = KD, 
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 (4) 
 A value for I0 was obtained for UDP-glucose at this concentration in each measure, and a value 
for I was obtained after the addition of each fragment. Next, KIs were calculated from eq. 4. 
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CHAPTER 5 
TARGETING GALECTINS 
5.1 Introduction 
Complex carbohydrates on cell surfaces are increasingly viewed as biochemical messages read 
and translated into effects by endogenous lectins [1]. Among them, the members of the 
galectin family have recently attracted special interest due to their context-dependent 
multifunctionality and involvement in disease processes, [2] and the possibility of being used 
as therapeutic targets.  
Galectins are a family of animal lectins defined by a shared consensus of amino acid sequences 
and a carbohydrate recognition domain (CRD) of around 130 amino acids, with affinity for 
-galactose containing oligosaccharides. Galectins are best known for mediating adhesion and 
regulate cell growth (as mitogens or as anti/pro-apoptotic effectors) through binding to cell 
surface glycoconjugates. However, members of this family are not only expressed 
extracellularly, but also inside the cell and in the nucleus, and they have been often found to 
perform moonlighting functions. 
The galectin CRD fold is comprised of two antiparallel -sheets of five and six -strands, 
arranged in a -sheet sandwich motif with a jelly-roll topology. The carbohydrate binding 
site is located within the six-stranded -sheet face of the -sheet sandwich, and is composed 
of conserved amino acid residues, i.e. two arginines, glutamic acid, histidine, and a tryptophan 
(see fig. 6 in Chapter 1). The -galactose unit of the bound carbohydrate ligand is positioned 
between two loops that essentially fold over it, and is maintained in place by multiple 
hydrogen bonds formed with its O4, O5 and O6 atoms. From one of these loops, the planar 
aromatic side chain of the conserved tryptophan is positioned under the galactose ring to 
provide further stabilization for the bound carbohydrate ligand.  
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Structurally, galectins are divided into three classes. Prototype galectins are composed of a 
single CRD, which can self-associates to form homodimers (gal-1, -2, -5, -7, -10, -11, -13, -14 
and -15. Tandem repeat galectins have two homologous, yet distinct, CRDs that are connected 
to each other via a linker polypeptide chain (galectin-4, -6, -8, -9 and -12). Finally, chimera-type 
galectins (galectin-3) are composed of one CRD attached to a non-lectin part.  
In this chapter, a series of studies combining ligand- and protein-detected NMR methods is 
presented, probing the structure and interacting capabilities of two members of the galectin 
family: galectin-7, a prototype, dimeric galectin, and galectin-3, the only chimera-type galectin 
identified until now. 
5.2 Galectin-7: a prototype galectin 
Galectin-7 (gal-7) is a prototype, dimeric galectin. Also referred to as the p53-induced gene 1 
product based on its up-regulation by the tumor suppressor p53 in human DLD-1 colon cancer 
cells [3], gal-7 is a potent pro-apoptotic effector, e.g. for neuroblastoma cells by binding 
ganglioside GM1 [4]. Gal-7 also plays a key role in the development and differentiation of the 
pluristratified epithelium, and has a complex, dual role in tumor progression [5], depending on 
the tissue type: while gal-7 overexpression in sunburn keratinocytes is co-related with an 
increased apoptosis, gal-7 induces expression of MMP-9 in lymphoma cells [6]. 
Several crystallographic structures have been reported for gal-7 dimers, both unliganded and 
in complex with simple carbohydrates, like lactose and N-acetyl lactosamine. In addition to 
binding glycans, gal-7 can interact with the anti-apoptotic protein bcl-2, a property shared with 
gal-3 [7].  
Studies presented in this section, initiated by full NMR assignment of this galectin, are directed 
toward the characterization of the structure and dynamics of the gal-7 homodimer. These 
results are meant to pave the way for the study of interacting capabilities of this protein, both 
at and beyond the carbohydrate binding site.
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5.2.1 Full NMR assignment of galectin-7 
Complete NMR assignment of human galectin-7 was achieved in collaboration with the group 
of Prof. Kevin H. Mayo (University of Minnesota, MN, USA). Our contribution consisted in the 
collection of backbone and side-chain carbon and proton NMR assignments through a set of 
homo- and heteronuclear 2D experiments, as well as heteronuclear triple resonance 3D 
experiments carried out at 800 MHz. 
Specifically, 13C and 13C resonances were sequentially obtained through 3D HNCACB 
experiments, as exemplified in fig. 1. Their correspondent protons were identified in 1H-13C 
HSQC spectra. In addition, 3D HNCO experiments afforded the assignment of all 13CO 
resonances. Besides, several side-chain resonances were identified based on 1H-1H NOESY 
spectra recorded with different mixing times. 
In total, 1,045 13C, 264 15N and 1,624 1H chemical shifts were unambiguously assigned. 
Backbone resonances (1HN, 15N, 13CO, 13C and 1H) were fully assigned with the exception of 
the first two residues (simply not observed in the 1H-15N HSQC spectrum) and for 1H of Pro15, 
whose signal was completely overlapped with the water signal. In addition, sequential 
connectivity of the Pro26-Pro27 pair could not be established. Furthermore, more than 80% of 
side-chain resonances were assigned, and stereospecific assignments were made for all Val 
and Leu methyl groups. These chemical shift assignments were deposited in the 
BioMagResbank [8] under the accession number 17826, and published in the Biomol NMR 
Assign journal [9]. 
Figure 2 shows a 1H-15N HSQC spectrum of gal-7, in which all cross-peaks are labeled according 
to these NMR assignments. The spectrum shows doubling of several cross-peaks, which are 
due to the co-existence of two distinct conformations of gal-7 in solution, in slow exchange on 
the chemical shift timescale. The nature of this conformational duality will be presented in the 
next section. 
5.2.2 The conformational duality of gal-7 
As seen in the previous section, assignment of the gal-7 resonances revealed the doubling of 
peaks for a number of residues distributed along the whole gal-7 sequence, compatible with 
the presence of two stable conformations in slow exchange on the chemical shift timescale.  
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Figure 1: A series of strip plots from an HNCACB experiment 
taken at the amide 15N and 1H chemical shifts of residues 
E122-V127. Chemical shifts of C (blue cross-peaks) and C
(red cross-peaks) atoms are indicated on the vertical axis. 1H 
chemical shifts are indicated on the horizontal axis. 
Horizontal dotted lines indicate sequential connectivity.
Figure 2: 1H-15N HSQC spectrum of gal-7. The insert 
shows an expansion of a congested region of the 
spectrum. Horizontal lines connect resonances 
arising from side-chain groups of Asn and Gln 
residues. Other lines shown connect cross-peaks 
that are doubled in the spectrum due to the 
presence of two conformations in slow exchange on 
the chemical shift scale.
The number of affected residues is 22, which accounts for 18% of the gal-7 amino acids 
observable in the 1H-15N HSQC spectrum (fig. 3). As shown in fig. 4, these residues cover a large 
portion of the gal-7 surface, and they are distributed all along the gal-7 sequence, although 
they appear mainly concentrated at the N- and C-termini. There are several modifications that 
the N-terminus of even recombinantly expressed proteins can suffer in E. coli, including 
deformylation and enzymatic cleavage of the initiating N-formylmethionine, which can result 
in the presence of a heterogeneous population of the recombinant protein. This may lead to 
spectral changes, including splitting of peaks belonging to the N-terminal amino acids and 
those of nearby regions [10]. To rule out the possibility that doubling of gal-7 peaks might be 
due to a heterogeneous modification of the N-terminus in the bacterial expression system, we 
performed mass spectrometry measurements on our gal-7 samples. The result confirmed the 
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homogeneous presence of a single major species corresponding to a molar mass of 14946.9 Da 
(fig. S4 in Appendix), close to the theoretical value of 14943.8 Da for the gal-7 sequence 
without the initial methionine, thus ruling out the presence of a heterogeneous protein in our 
samples, and confirming that the spectral duality of gal-7 is due to the coexistence of two 
stable conformations of the same protein, in slow exchange on the chemical shift timescale.
Figure 3: 1H-15N HSQC spectrum of human gal-7, with 
connectors and labels indicating the doubled peaks.
Figure 4: Representation of one of the monomers in the 
X-ray structure of lactose-bound gal-7 (PDB: 4GAL). 
Residues with doubled signals are highlighted in green.
5.2.2.1 Pro4 is directly responsible for the conformational duality 
The presence of two populations in slow chemical exchange requires that the energy barrier 
(G) between both conformers is high. The Eyring equation [11] permits to calculate the 
barrier between two species at coalescence: 
   	 
       (1) 
where kc is the coalescence rate, calculated as: 
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being  the frequency separation between the two signals, in Hz. Since, for gal-7, the 
situation is still far from coalescence, application of the Eyring equation provides that the 
energetic barrier between both gal-7 conformers is G > 17 kcal/mol. Such high a barrier 
indicates a slow process, the most typical of which in the realm of proteins is proline cis/trans
isomerization. Indeed, the activation energy for the isomerization of the Xaa-Pro amide is 
about 20 kcal/mol, due to the highly energetic syn-Pro transition state [12]. 
Galectin-7 has 10 prolines scattered all along its sequence, but isomerization of Pro4 is the one 
which would best explain the region affected by doubling of peaks. To test this hypothesis, the 
gal-7 P4L mutant was constructed in the laboratory of Prof. Hans-Joachim Gabius (Ludwig 
Maximilian University, Munich). The 1H-15N HSQC spectrum of the uniformly 15N-labeled 
mutant protein is highly superimposable with that of the wild type, indicating that the overall 
folding of the mutant is maintained, but it completely lacks one set of the doubled peaks (fig. 
5), thus confirming that Pro4 is the direct responsible of the gal-7 conformational duality. 
5.2.2.1 Fine characterization of the gal-7 cis-conformer
The observation that two conformers of gal-7, caused by a switch in the V3-P4 amide bond, 
coexist in solution, is in contrast with the configuration of that peptide bond in both 
monomers of all seven gal-7 dimer X-ray structures released to date (1BKZ, 2GAL, 3GAL, 4GAL, 
5GAL, 3ZXE, 3ZXF). In all crystallographic structures, the gal-7 N-terminus is found in an open 
conformation, protruding from the -sandwich. As a result, there is a spatial proximity 
between the Asn2 sidechain and the -strand 9 that results in the establishment of a hydrogen 
bond between the Asn2 side-chain and the Gly125 backbone NH (fig. 6). 
In order to gain insight into the hydrogen bond pattern of both conformers, the HN 
temperature coefficients were obtained from a temperature titration, by running 1H-15N HSQC 
spectra of gal-7 in a range of temperatures between 292 K and 313 K (fig. 7). Detailed 
quantification of the correlation between amide proton temperature coefficients (HN/T) 
have shown a good prediction value for a hydrogen bond for temperature coefficients smaller 
than 4.6 ppb/K [13]. The titration showed a differential shifting among the cross-peaks, with a 
115 
number of signals showing poor shifting along with the temperature gradient and thus likely 
being involved in hydrogen bonds.  
Figure 5: 1H-15N HSQC spectra of human gal-7. Blue: wild-type. Red: P4L mutant. Some of the doubled peaks in the 
wild-type spectrum are labeled for reference. 
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Figure 6: Detail from the X-ray structure of human gal-7 (PDB: 4GAL), in which the trans-conformation for P4 is 
present. This figure shows the establishment of a hydrogen bond between the G125 amide and the N2 side-chain. 
Focusing on the G125 signal HN pair, the peak belonging to the trans- conformation remained 
stable over the whole temperature range investigated, with HN/T = 2.26 ppb/K, in 
agreement with the hydrogen bond observed in the crystallographic structure. In contrast, the 
peak from the cis- conformation showed a temperature coefficient of 6.63  ppb/K, which 
accounts for the loss of the G125/N2 hydrogen bond in the cis- conformer. No other significant 
differences were found for the other doubled signals. 
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Figure 7: Overlay of 1H-15N HSQC spectra of gal-7 corresponding to a temperature titration. The less shifted are the 
signals, the higher is the probability that NHs are involved in a hydrogen bond, with a good predictive value for a 
hydrogen bond for temperature coefficients less negative than 4.6 ppb/K [13]. Temperature coefficients for the 
trans- and cis- signals of the G125 pair are 2.26 ppb/K and 6.63 ppb/K, respectively, which is in agreement with 
the loss of a hydrogen bond between G125 and N2 in the cis- conformer. 
Further corroboration to this hypothesis was found by probing the gal-7 solvent accessible NH 
groups with dimethyl sulfoxide (DMSO). Those protein NHs that are solvent accessible can 
show spectral shifts upon perturbation of the solvent properties, e.g. its dielectric constant via 
the addition of a small quantity of an organic solvent, such as DMSO [14], while the rest are 
unaffected. Addition of 2.5% to 7.5% DMSO to gal-7 resulted in the shift of a number of peaks, 
which permitted to map the gal-7 NHs exposed to the solvent. Of note, the G125 NH peak of 
the cis-conformation showed a significant shift in the presence of DMSO (fig. 8A), while the 
same peak of the trans-conformation remained unaffected. This is in agreement with the 
burying of G125 by the N2 side-chain, as a result of the hydrogen bond established between 
the two, in the trans-conformation. In contrast, in the cis-conformation, the N-terminus is no 
longer close to the vicinal strand, and the latter becomes solvent-accessible (fig. 8B). 
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Figure 8: Differential solvent-accessibility of the G125 amide pair in either conformer. A: the addition of 7.5% DMSO 
to the sample selectively perturbs the G125 amide signal from the cis- conformation, remaining that from the trans- 
unaffected. B: Accordingly, the G125 amide nitrogen appears capped by the N2 side-chain in the trans- 
conformation present in the crystal (PDB: 4GAL), while in the model for the cis- conformation it becomes fully 
solvent-accessible. 
Next, a new mutant of gal-7 was prepared, by mutating the initial Ser into Ala (Gal-7 S1A). 
Since the orientation of the N-terminus is one of the most distinctive features between both 
conformers of gal-7, a change in the chemical nature of the first amino acid could be useful to 
map the region which this terminus points to in each conformer. Figure 9 shows a 1H-15N HSQC 
spectrum of the S1A mutant. Doubling of peaks persisted in the same manner and extent, with 
no perceptible changes in the ratio between conformers. In addition, the spectrum was 
virtually identical to that of wild type gal-7, with minor shifts for a small number of peaks. With 
the exception of those of N2 and V3, the rest of the shifted peaks belong to amino acids which 
are distant in the gal-7 sequence to the point mutation. Such is the case for R22, L129 and 
V132, which lie in a hydrophobic pocket close to the dimer interface in the gal-7 3D structure. 
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Noteworthy, only the peaks belonging to the cis-conformation are shifted, indicating that, in 
this conformation, the N-terminus is close to those residues.  
A model for the gal-7 cis- conformer was built by a manual 180º torsion of the V3-P4 peptide 
bond in the apo-gal-7 crystal structure (PDB: 1BKZ), followed by an energy minimization in an 
OPLS-2005 force field (fig. 10). This model is in agreement with the experimental data in that, 
upon V3-P4 isomerization, the N-terminus moves away from the vicinity of G125, towards a 
spatial area close to L129 and V132. 
Figure 9: 1H-15N HSQC spectra of human gal-7. Blue: wild-type. 
Red: A1S mutant. Some of the doubled peaks as well as 
significantly perturbed signals (located at a hydrophobic patch 
around L129 and V132) are labeled.
Figure 10: Model for the gal-7 P4 cis conformer, 
generated by a manual 180º torsion of the V3-P4 
bond followed by a MM minimization. The N-
terminus (pink) points toward a hydrophobic 
cluster close to residues L129 and V132 (salmon). 
5.2.2.2 The gal-7 cis-conformation is stabilized by non-polar forces 
For non-proline residues, the overwhelming majority of peptide bonds adopt the trans
configuration, mainly because the steric conflicts between the functional groups attached to 
the C atoms are larger in the cis isomer. For proline residues, however, the cyclic nature of its 
side-chain causes that both conformers are nearly isoenergetic, and it is common for short 
peptides to populate both isomers under unstrained conditions. Still, the trans- isomer is 
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slightly more favorable, and their relative populations tend to favor it.  The exact ratio depends 
on the substituents, especially on the bulkiness of the side-chain of the preceding amino acid, 
with aromatic residues slightly favoring the cis- isomer. Valine, which is the preceding amino 
acid to P4, can be considered rather bulky, with a bulkiness factor (defined as the ratio of the 
side-chain volume to its length [15]) of 21.57 Å2, comparable to that of Trp (21.67 Å2) and 
substantially larger than those of Thr (15.77 Å2) or Pro (17.43 Å2), with similar molecular 
weights. Accordingly, previous data with the model dipeptide Val-Pro [16] showed that, at 
physiological pH, the cis- and trans- isomers were nearly equally populated (40:60, 
respectively). However, the ratios were found to be strongly pH-dependent, with low pH 
favoring the trans- isomer due to stronger steric repulsions between the protonated amino 
group and the carboxylic group in the trans- isoform of the cationic dipeptide. 
In order to evaluate the intrinsic proneness of P4 to populate the cis isomer under unstrained 
conditions, but in a sequence longer than a dipeptide, and in which the rest of the nearby 
substituents could play a role comparable to that in the full protein, a nonapeptide was 
synthesized, corresponding to the most N-terminal portion of gal-7 (SNVPHKSSL). The 
synthesis of this molecule was carried out in the laboratory of Prof. M. Reza Ghadiri, during a 
short stay at The Scripps Research Institute (La Jolla, CA), financed by the FPI Fellowship. The 
aromatic and amide region of the 1H-NMR spectrum of the nonapeptide is shown in fig. 11A. A 
single main set of signals was found, including 7 amide protons (one for each residue with the 
exception of proline), the side-chain amides of N2, the Ser OHs and two sharp singlets 
belonging to the H5 side-chain. Although a second, minor set of signals attributable to a 
second conformer can be seen, its population relative to the major species is < 10%, thus far 
from the 55:45 proportions in the full-length gal-7. Thus, no doubling of peaks as a result of 
Pro isomerization was observed. To determine which isomer (cis or trans) was the one present 
in solution, the NOE pattern of the V3 -proton was analyzed in a ROESY (Rotating frame 
Overhauser Effect Spectroscopy) experiment. As illustrated in fig. 11B, NOE cross-peaks 
between the -proton of the preceding amino acid, and the proline -proton or -protons, are 
diagnostic for the cis- or the trans- configuration, respectively. The ROESY spectrum of the 
synthetic nonapeptide revealed NOE cross-peaks between the V3 -proton and the P4 -
protons (fig. 11C), which are unambiguously indicative for a trans configuration (fig. 11D). 
Taken together, these results indicate that the gal-7 N-terminal sequence has no natural 
tendency to isomerize, and thus the cis-isomer present in the folded protein in solution is the 
result of stabilizing forces in the native-state macromolecule. 
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Figure 11: A synthetic nonapeptide corresponding to the N-terminus of human gal-7 (SNVPHKSSL) does not have a 
natural tendency favorable to yield the cis- isomer. A: 1H-NMR spectrum of the nonapeptide in H2O, revealing the 
existence of only one major conformation. B: Scheme showing the differential NOE pattern (denoted by red arrows) 
for the -proton of the residue preceding proline in each configuration of the peptidyl-prolyl peptide bond. C: 1H-1H 
ROESY spectrum of the synthetic nonapeptide, showing the NOE pattern for the V3 -proton, which is 
unambiguosly indicative for a trans-conformation of the V3-P4 peptide bond. D: Model for the nonapeptide built in 
xleap and subject to an energy minimization, showing the expected NOEs for the V3 -proton in the trans-
conformation, also found in the 1H-1H ROESY spectrum.
However, and since there is a penalty for the intrinsically less favorable cis-isomer, which adds 
to the loss of one hydrogen bond between N2 and G125 in the gal-7 cis-conformer, the 
question arises how it is possible that the latter exists in the protein in solution, or, in other 
words, which are the forces that compensate the added penalties of i) the cis- configuration of 
the V3-P4 peptide bond and ii) the loss of a hydrogen bond between N2 and G125. 
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In agreement with the experimental data, our model for the gal-7 P4 cis conformer missed the 
hydrogen bond between N2 and G125 (fig. 12, left panel), but in turn it gained close contacts 
between the N-terminus and residues from a hydrophobic patch close to the C-terminus (fig. 
12, right panel). Thus, the electrostatic and torsional energy penalties in the P4 cis model are 
compensated by van der Waals interactions, leading to two nearly isoenergetic states that co-
exist in solution. 
5.2.2.3 Functional implications 
Galectin-7 first appeared in mammals, likely as a result of a gene duplication from a common 
ancestor to gal-10, with which gal-7 shares the highest sequence similarity [17]. As can be seen 
in the alignment in fig. 13, the switchable proline is conserved throughout the entire 
mammalian lineage, with the exception of rodents (Rattus norvegicus and Mus musculus). 
Notably, human galectin-10 also possesses the conserved proline residue (P6), which is found 
in the cis- configuration in its X-ray structure (PDB: 1LCL). This configuration shares many 
similarities with our model for the gal-7 P4 cis structure (fig. 14), including the packing of the 
valine residue preceding the conserved proline towards a hydrophobic patch around residues 
126-132. However, and since the N-terminus of gal-10 is a few residues longer than that of 
gal-7, there are further contacts that contribute to stabilize the structure, including one CH- 
interaction between L3 and Y8 and one hydrogen bond between S1 and L132. This could 
explain that the cis- conformer of gal-10 is the energetically most favorable, and thus the one 
found in the crystals. 
The conformational duality of gal-7 could be of functional relevance, since the area affected by 
the proline switch does not lie far from the sugar recognition site: G125 is only 10 Å from the 
galactose residue. More complex oligosaccharides, glycoproteins or even other types of 
protein partners could be selectively recognized by one of the two conformers.  
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Figure 12: Hydrogen bonds and side-chain contacts in the gal-7 P4 trans (upper panel) and P4 cis (lower panel) 
conformers. The loss of a hydrogen bond between N2 and G125 is compensated between close contacts between 
the N-terminus and a hydrophobic cluster of amino acids on the C-terminus.
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Figure 13: Alignment of gal-7 sequences from different mammal species. P4 (indicated by an arrow) is conserved in 
all cases, with the exception of rodents Rattus norvegicus and Mus musculus. 
Figure 14: Superimposition of the gal-10 P6 cis crystal structure (PDB: 1LCL, in blue) and our model for the gal-7 P4 
cis conformer (in orange), with arrows indicating those conserved residues participating in similar interactions in 
both structures. 
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5.2.3 FBDD targeting of gal-7 
The involvement of gal-7 in such heavily-regulated processes as cancer, apoptosis and 
development, is presumably achieved through the establishment of a prolific interactive 
network with effector proteins. Being the exact role of gal-7 in most of these processes still 
poorly understood, physical interactions have been demonstrated between gal-7 and at least 
two non-glycosylated partners: the apoptotic regulator Bcl-2 [7] and the transcription factor 
Smad2/3 [18]. Of note, the gal-7/Bcl-2 interaction was shown to be independent of 
carbohydrate binding. Furthermore, non-glycosylated protein partners are also known to other 
galectins, such as Bcl-2 itself for gal-3 [19] and farnesyl-Ras for gal-1 [20]. In the latter case, the 
binding epitope on gal-1 was delineated by the construction of a mutant (gal-1 L11A) which 
retained normal carbohydrate-binding abilities, but inhibited Ras-GTP, giving rise to an 
attenuated pro-oncogenic activity of H-Ras(G12V) [21]. Taken together, all these data evidence 
the interacting capabilities of galectins beyond the carbohydrate recognition site. 
Fragment-based drug discovery (FBDD) is a powerful approach for the identification of novel 
inhibitor scaffolds as well as novel binding pockets on protein targets [22]. It involves the 
screening of small libraries of low molecular weight compounds (typically <300 Da), whose 
small size and low chemical complexity results in low-affinity binders, thus requiring sensitive 
methods such as NMR for detection. Subsequently, fragment hits are developed or merged to 
yield inhibitors of higher potency. 
Targeting gal-7 through FBDD, we found a set of compounds that weakly bind to gal-7, as 
screened by using saturation transfer difference (STD) experiments performed on fragment 
mixtures from a commercial library of 1,000 small organic compounds. Characterization of 
their binding epitopes on the gal-7 surface in 1H-15N HSQC experiments revealed that all 
fragment hits targeted either of two protein epitopes, none of which is the sugar binding site. 
These novel binding sites are the gal-7 dimerization interface, and a previously unreported site 
located at a shallow groove in a lateral face of the lectin (fig. 15). 
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Figure 15: Left: Monomer of the X-ray structure of lactose-bound gal-7 (PDB: 4GAL) with fragments 245 and 549 
bound in their respective sites (the dimer interface and the PPBS, respectively) as calculated with AutoDock. Several 
gal-7 residues important for fragment binding are labeled. Right: scheme of the different binding sites on the gal-7 
dimer structure. 
The latter binding site was targeted by hits bearing a phenoxyphenyl scaffold (fig. 16). This 
region, which we subsequently called the phenoxyphenyl-binding site (PPBS), is located at a 
shallow cleft near a larger groove close to the dimer interface. NMR titrations (fig. S5 in 
Appendix) revealed fragment 549 as the most potent of the series, with a KD of 1.27 ± 0.09 
mM. Docking calculations positioned 549's hydroxyl group at hydrogen bond distance of the 
Q128 side-chain, and a phenyl ring well-positioned to establish a CH- interaction with the L24 
side chain (fig. 15). Although the role of the PPBS on the gal-7 surface, if any, is unknown, the 
size of its adjacent groove, added to the performance of phenoxyphenyls as -turn mimics [23-
24] suggest that the PPBS could be involved in gal-7/protein interactions. Of note, the PPBS in 
gal-7 is structurally and sequence-homologous to an epitope of galectin-1 encompassing F30, 
L32 and I128. This region of gal-1 overlaps to the putative binding site of farnesyl-Ras [20-21], 
whose association to gal-1 is necessary for H-Ras and K-Ras activation [21].  
A second set of fragments, exemplified by 245 (fig. 17), gave rise to STD signals, indicating 
binding to gal-7. However, and interestingly, no changes in the 1H-15N HSQC spectrum of gal-7 
were detected upon addition of 245 (fig. S6 in Appendix). This was suggestive that its binding 
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site was hidden under those experimental conditions. Particularly, and since the only 
difference between the experimental setup for STD and HSQC experiments was the employed 
protein concentration (15 M and 250 M, respectively), we guessed that 245 bound to the 
dimer interface, an event that would be precluded by the dimerization process that takes place 
for higher gal-7 concentrations.  
Figure 16: Details of the 1H-15N HSQC spectra of gal-7 in the absence (blue) and in the presence of 549 (red), 
showing selective perturbation of a number of peaks corresponding to residues located at the PPBS. 
Figure 17: Details of the 1H-15N HSQC spectra of gal-3 CRD monomer in the absence (blue) and in the presence of 
245 (red), showing perturbation of a number of peaks located at a region which is structurally homologous to the 
gal-7 dimer interface. On the left, the X-ray structure of LacNAc-loaded gal-3 CRD (PDB: 1A3K) is shown, highlighting 
the residues corresponding to the most perturbed peaks by 245 addition. 
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To corroborate this hypothesis, we used the CRD of gal-3 (gal-3 CRD), a monomer homolog of 
gal-7, obtained by truncation of the chimera-type full-length gal-3 [25]. 1H-15N experiments 
performed with 15N-labeled gal-3 CRD revealed selective chemical shift perturbations of a 
number of peaks when 245 was added. The most shifted signals corresponded to amino acids 
located at a hydrophobic patch of the protein surrounding the K103 side chain, at the opposite 
face of the sugar binding site (fig. 17). This region is structurally homologous to that at the gal-
7 dimer interface. Accordingly, docking calculations using the gal-7 dimer interface as input 
positioned 245's benzotiophene rings at CH- distance of the A99 side-chain methyl, and its 
negatively charged carboxylate in contact with the K98 side-chain (figs. 15, 19B). This pose is in 
agreement with the ligand epitope mapping of 245 obtained by diffusion-ordered 
spectroscopy (DOSY) [26] (fig. 18), which indicates that protons adjacent to the carboxylic 
group are in tighter contact with the protein. 
Importantly, binding of 245 at the dimer interface of gal-7 showed disruptive effects for 
dimerization. By performing DOSY experiments, we obtained direct evidence that fragment 
245 disrupts gal-7 self-association, as shown by a significant change in the diffusion coefficient 
(D) of gal-7 in the presence of 245. By adding the fragment to a sample containing 15 M gal-7, 
a concentration where it is predominantly dimeric, given its dimerization KD of around 1.7 M 
[27], the D value of the gal-7 signals shifted from -10.07 to -9.95 (fig. 18). Extrapolation of 
these values in a calibration line [28] (fig. S1 in Appendix) gave apparent molecular weights of 
27 kDa and 13 kDa for gal-7 in the absence and in the presence of 245, respectively, which is in 
agreement with dimer dissociation of gal-7 upon addition of 245. 
In addition, STD experiments showed that binding of 245 promoted the access of other small 
molecules to the interface (fig. 19A), where there is enough room for at least one additional 
fragment (fig. 19B). Similarly, binding of 245 to gal-7 enhanced further binding of 245 itself, as 
shown by STD response curves as a function of fragment concentration (fig. 20).  These results 
not only confirm the ability of 245 to disrupt gal-7 dimerization, but also give good 
perspectives about the feasibility of obtaining stronger binders to the gal-7 dimer interface 
following a fragment merging approach. Looking at this possibility into detail, selective inter-
ligand NOEs (iLOEs) [29] were detected between 205 and 245 (fig. 19B), thus providing 
information on the relative orientation of these fragments, when bound at the gal-7 dimer 
interface. 
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Figure 18: DOSY spectra of gal-7/245 samples, showing disruption of gal-7 dimerization upon addition of 245. Blue: 
gal-7; green: 245; red: gal-7 + 245. An epitope mapping effect [26] is observed at the 245 signals. 
Figure 19: Simultaneous binding of multiple fragments to the gal-7 dimer interface. A: STD spectra of 500 M (1) 
205, (2) 205 + 245, (3) 235, (4) 235 + 245, in the presence of 15 M gal-7; and (5) 235 + 245 in the absence of gal-7. 
B: NOESY experiment showing selective cross-peaks between the 205 methyl signals and two protons of 245 
(iLOEs). Overlaid, docking structure of the gal-7 monomer with 245, highlighting a hydrophobic space belonging to 
the gal-7 dimer interface that could be accessed by additional fragments when gal-7 is found as a monomer. 
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Figure 20: STD response curves as a function of fragment concentration. While it is expected that increasing ligand 
molar excesses result in diminished STD response ratios (calculated as ISTD/IOff-resonance), the %STD grows at growing 
concentrations of 245 (A) up to 300 M, when it starts to drop. This also gives support to the notion that binding of 
245 inhibits gal-7 dimerization, subsequently triggering the binding of small molecules to secondary sites at the 
hydrophobic gal-7 dimer interface. In contrast, the STD rate of 549 (B), a fragment that binds at the phenoxyphenyl 
binding site on gal-7 dimers, diminishes as a function of the fragment's concentration. 
To the best of our knowledge, these results represent the first example of disruption of the 
oligomeric state of a protein achieved through a fragment-based approach. This success could 
be due to the intrinsic nature of lectins as proteins recognizing highly polar molecules, and 
thus devoid of large hydrophobic clefts other than interfaces for oligomerization and other 
protein/protein interactions, and will inspire future approaches with other members of the 
lectin family. 
It is known that the galectin oligomer state can drastically impact function [30]. For example, 
while both gal-1 dimers and monomers can bind glycans on various cells, only the Gal-1 
dimeric form can induce signaling and promote macrophage-mediated phagocytosis vis-à-vis 
cell apoptosis [31]. In another study, it was shown that only a dimeric form of Gal-1 could 
potently induce apoptosis in murine thymocytes and mature T cells, whereas a monomer form 
of Gal-1 could not [32]. In addition, Miura et al. reported that while both dimer and monomer 
forms can promote axonal regeneration, only dimer gal-1 could effectively induce Jurkat cell 
death [33]. Other studies have reported galectin oligomer-mediated effects in cell 
agglutination studies [34-35]. These facts invite to use 245, or a more potent derivative 
thereof, to explore the possible biological effects of inhibiting dimerization of gal-7. 
At the same time, phenoxyphenyl derivatives emerge as scaffolds for disrupting any potential, 
yet to be discovered gal-7/protein interactions taking place at the PPBS.  
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5.2.4 Lactose binding enhances the stability of the gal-7 homodimer 
Although the binding site of fragment 245 was identified at the gal-7 dimerization interface, 
initial attempts to determine it yielded contradictory results. 
Competition experiments using STD showed that addition of lactose to samples containing 
gal-7 and fragment 245 resulted in an apparent displacement of 245 by the disaccharide 
(fig. 21). While this was suggestive that lactose and 245 competed for the same binding site, 
the absence of perturbations in the gal-7 1H-15N HSQC spectrum exerted by 245, and 
subsequent evidences for binding at the dimer interface ruled out this possibility. Instead, 
these observations, supported by other data, indicated that lactose allosterically competed 
with 245 by promoting dimerization of gal-7. 
Figure 21: 1H-NMR spectra of samples containing 500 µM 245 in the presence of 1.5 uM Gal-7. A: Reference 
spectrum (scaled 25%) with labels indicating the assignment of proton resonances. B: STD spectrum. C: STD 
spectrum in the presence of 8 mM lactose. D: Plots showing STD responses for 500 µM 245 vs. the concentration of 
gal-7, before (filled circles) and after (open circles) addition of lactose to reach the concentration of 8 mM. 
Figure 21 shows a series of STD experiments performed using fragment 245 as a spy molecule, 
at four different gal-7 concentrations ranging from 500 nM to 5 µM, i.e. around its 
dimerization KD, of 1.7, µM. In all instances, the addition of lactose to the analyzed samples 
significantly reduced the STD signal intensities of 245. Since the actual amount of monomer in 
fact increases as the total concentration of Gal-7 increases, the STD effect also increases with 
the Gal-7 concentration. Because STD signals are significantly reduced in the presence of 
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lactose at any concentration of gal-7, these data were interpreted in terms of an indirect 
competition over 245 exerted by carbohydrate binding, as shown in the scheme of fig. 22. In 
this model, the binding of sugar stabilizes the gal-7 dimer state, promoting dimerization of the 
lectin, and thus the dimer interface becomes no longer exposed, effectively preventing the spy 
molecule to access its binding site.  
These observations, in concert with data from FPLC, circular dichroism, and molecular 
dynamics studies, revealed that carbohydrate binding to gal-7 induces long-range effects 
throughout the protein, consisting in minor conformational shifts and changes in structural 
dynamics, which result in stabilization of the dimer state [27]. 
Figure 22: Model of allosteric competition exerted by lactose on 5-chloro-benzo[b]thiophene-3-carboxylic acid 
(fragment 245). At low gal-7 concentrations, the protein is predominantly found as a monomer, and the dimer 
interface is exposed. Under such condition, the probe molecule is able to access its binding site and becomes 
saturated in the STD experiments. When lactose binds to the lectin, dimerization is promoted and the dimer 
interface is no longer accessible. As a result, access of the probe molecule to its binding site is impaired, and its STD 
signal decreases. 
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5.3 Galectin-3: a chimera-type galectin 
Gal-3 is structurally unique among galectins. Aside from its pan-galectin-conserved CRD, gal-3, 
the only chimera-type galectin, has an extended N-terminal domain (ND) of 115 residues 
composed of a 20 amino acid-long N-terminal peptide, followed by tandem repeats of short 
segments (mostly collagen-like, rich in Pro and Gly) connected to its C-terminal CRD (~135 
residues) [36]. Sequence conservation of ND repeat units is strong among mammals, extending 
to homologues in fish, frog and chicken, that developed phylogenetically with a conserved 
structural design [37].   
Although the gal-3 CRD -sandwich structure binds glycans like other galectins, its unique N-
terminal domain plays a significant role in gal-3 function. For example, it modulates sugar 
binding to its CRD, mediates cell signaling, and interacts with lipopolysaccharide (LPS) lipid A 
moiety to enhance LPS-mediated neutrophil activation. In addition, the N-terminal domain has 
three post-translational phosphorylation sites (Ser6, S12, Y107) with functional consequences.  
Functionally, gal-3 is anti-apoptotic in various cells and against a diverse array of apoptotic 
stimuli [38-39], being involved in immune and inflammatory responses, and in tumor 
development and progression. [40-42]. Gal-3 is highly expressed in macrophages and 
immature dendritic cells, and its expression is up-regulated in activated macrophages and is 
down-regulated during dendritic cell maturation [43-44]. Gal-3 is also expressed in many types 
of epithelial and stromal cells, including fibroblasts [45-46]. Gal-3 is also heavily involved in 
innate immunity, by binding glycans at the surface of different types of pathogens. In addition 
to its aforementioned reactivity towards LPS, gal-3 can bind to Gal-(1-3)-Gal, a Leishmania
virulence factor [47-48], to Gal- xenoantigen [49-50], and to LacdiNAc-glycans, which 
constitute a parasite pattern for gal-3-mediated immune recognition [51]. 
Although extracellular functions of gal-3, like galectins in general, mediate most of their known 
activities by binding to saccharide ligands on cells and extracellular matrix [30, 52-55], gal-3 
can also function intracellularly [56] by e.g. inducing pre-mRNA splicing and regulating 
expression of certain genes like cancer-related genes cyclin D1, thyroid transcription factor 1 
and mucin 2 [57], as well as regulating JNK1 [58] and directly binding to intracellular proteins 
like Bcl-2 [59]. 
Although the structure of the gal-3 CRD has been elucidated [60-61], that of full length gal-3 
with its CRD and ND remains unknown. However, it has been suggested that residues 94-113 
of the relatively flexible ND interact with the CRD [62-63]. A number of reports have 
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demonstrated that the ND is crucial to gal-3 function. For example, the presence of the ND 
enhances CRD binding to carbohydrates [64-65], and while the gal-3 CRD alone can bind cell 
surface glycans (albeit relatively weakly), it is otherwise functionally inactive without the ND 
[66]. 
The work presented in this unit addresses both the interaction properties of the gal-3 CRD with 
functionally relevant glycans, as well as structural aspects of its ND in the context of the full-
length protein. 
5.3.1 Full NMR assignment of galectin-3 
Sequence specific NMR assignments for the gal-3 CRD had been previously reported [67]. 
However, emerging evidence on the broad physiological significance of the full-length protein, 
well beyond glycan binding, emphasized the need for NMR assignment of full-length gal-3. 
To allow for detailed studies on gal-3 at atomic resolution, the 1H, 13C and 15N resonances of 
the full-length protein were assigned, also as a joint effort with the laboratory of Prof. Mayo 
(University of Minnesota).  
Most resonances in native gal-3 exhibit nearly the same chemical shifts as those in gal-3 CRD, 
thus facilitating the assignment of this domain in the full-length protein. The real challenge 
was assigning resonances from the ND, which has 115 residues, with about 20 from a short 
N-terminal segment and about 95 in the collagen -like domain. This domain is PG-rich (26 Pro 
and 26 Gly residues), and has a number of repeat sequences. Most of the resonances of the 
ND fall within a narrow 1H spectral region coincident with that for random coil sequences. 
To aid in the assignment process, several truncation variants of the protein were made by 
permutationally removing tandem repeats. In addition, a series of peptides derived from the 
ND were chemically synthesized and their NMR resonances were assigned. Our contribution 
consisted in the full assignment of 1H, 13C and 15N resonances of the 20-residues long 
N-terminal peptide (fig 23A), both unphosphorylated, and with biologically relevant 
phosphorylations on Ser6 and/or Ser12. To this end, homonuclear TOCSY and NOESY 
experiments were performed, in combination with heteronuclear 1H-13 HSQC and 1H-15N HSQC 
experiments at natural isotopic abundance. 
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Figure 23: Assignment of full-length gal-3. A: Detail of the 1H-1H TOCSY of the 20 amino acids-long gal-3 N-terminal 
peptide. B: 1H-15N HSQC spectrum of full-length gal-3. Signals from the ND are poorly dispersed within a narrow 1H 
spectral region coincident with that for random coil sequences (ca. 7.8-8.3 ppm). 
In total, backbone resonances (1HN, 15N, 13CO, 13C and 1H) for all residues within the CRD and 
N-terminal tail were fully assigned (fig. 23B), with the exception of the fast exchangeable HN 
amides H64, G93, G152, N153, N166, S188, and K226, as well as CO of residues preceding 
prolines in the CRD. In contrast, resonances within the tandem-repeat section of the ND were 
difficult to uniquely assign, because most resonances have near-identical proton and backbone 
carbon chemical shifts. For example, the segment 67PGAY70 could not be uniquely assigned. 
Similarly, 42PGAYPGQAPP51 has the same amino acid sequence as segment 51PGAYPGQAPP60, 
leading to indistinguishable chemical shifts for resonances of each equivalent amino acid 
residue.  
Overall, greater than 90% of side-chain resonances were assigned in both the CRD and N-
terminal tail. Chemical shift assignments were deposited in the BioMagRes-Bank [8] under 
accession number 19491 and published in the Biomol NMR Assign journal [68]. 
This assignment report also represents the first step toward the 3D structural elucidation of 
native, full-length gal-3 in solution.  
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5.3.1 The interaction of oligosaccharides at the gal-3 CRD 
Assignment of the full length protein allowed for the study of ligand-binding to the full, 
chimeric protein. Figure 24 shows a titration of lactose, the pan-galectin ligand, against full 
length gal-3. The largest chemical shift differences are concentrated in the CRD part of the 
protein. In contrast, signals from the ND remained essentially unaffected upon binding of the 
disaccharide. Accordingly, in many of our studies with small oligosaccharides, we made use of 
the truncated protein, i.e. the gal-3 CRD. As a first approach, we investigated the binding of 
this protein to several oligosaccharide ligands of relevance for innate immunity. 
Figure 24: Lactose-binding titration on full-length gal-3. A: Overlaid 1H-15N HSQC spectra of full length gal-3 acquired 
at 800 MHz in the presence of lactose at different concentrations up to 100 mM, with labels indicating some of the 
most affected residues upon lactose binding. B: 1H-15N-weighted chemical shift differences for full-length gal-3 
backbone NH signals upon addition of a saturating concentration of lactose. The largest chemical shift differences 
are concentrated in the CRD (residues 107-250), with changes in the resonances of the ND (residues 1-106) virtually 
non-existent. C: Structure of LacNAc-loaded gal-3 CRD (PDB: 1A3k), with residues highlighted in red for the most 
shifted resonances upon lactose binding, followed by orange and yellow. 
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5.3.1.1 The recognition of lacdiNAc by gal-3 
LacdiNAc (GalNAc-(1-4)GlcNAc) is structurally very similar to lactose, only differing in that it 
incorporates an N-acetyl group at 2-OH of both sugar rings of the disaccharide. LacdiNAc is 
present in vertebrates as constituents of N-glycans. Besides, it is highly abundant in helminths, 
and it has been proposed as a parasite pattern for gal-3- mediated immune response [51]. 
The interaction between lacdiNAc and gal-3 was studied by NMR. The addition of 10 
equivalents of lacdiNAc to 15N-labeled gal-3 CRD produced a very similar profile of the 
backbone chemical shift variations to those produced by lactose (fig. 25). In addition, a region 
of gal-3 comprising residues Arg162-Phe163-Asn164 became differentially perturbed by 
lacdiNAc. Docking calculations showed a pose of lacdiNAc very similar to that of lactose. The 
differential perturbation of residues 162-164 can be explained by their proximity to the 
additional N-acetyl group of lacdiNAc at the galactose residue (fig. 25D).
Figure 25: The interaction of lacdiNAc with gal-3. A: Chemical shift differences for backbone amides of gal-3 CRD 
upon addition of 10 equivalents lacdiNAc. B. Overlaid 1H-15N HSQC spectra of gal-3 CRD (black) and in the presence 
of 20 equivalents lacdiNAc (red). C: Comparison between chemical shift differences for lacdiNAc (red) and lactose 
(black), highlighting a group of residues differentially perturbed by lacdiNAc (Arg162-Phe163-Asn164). D: Docked 
structure of lacdiNAc (green) to gal-3, superimposed to the X-ray structure of LacNAc-bound gal-3 (white). The 
additional N-acetyl of lacdiNAc is shown as mesh. Residues differently perturbed by lacdiNAc are highlighted in red.
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5.3.1.2 The recognition of the -Gal epitope by gal-3 
The -Gal epitope (Gal-1,3-Gal-1,4-GlcNAc-R) is a major xenoantigen expressed on 
glycoconjugates of non-primate mammals. In turn, apes and humans produce a natural 
antibody (anti-Gal), which specifically binds the -Gal epitope. Anti-Gal  is produced as the 
most abundant antibody (1% of immunoglobulins) in all individuals, and represents an 
important barrier for xenotransplantation [69]. However, this antibody is not the only 
responsible for the rejection of pig xenograft organs in humans, since lectins have also been 
shown to be involved in that process. Specifically, gal-3 has been identified as the receptor for 
monocyte-dependent recognition of porcine endothelium via binding to the -Gal epitope 
[49], playing an important role in delayed xenograft rejection [70]. 
Using NMR, we studied the interaction between gal-3 and two oligosaccharides containing the 
-Gal epitope: the Gal-1,3-Gal-1,4-GlcNAc trisaccharide, i.e. the minimal structure 
containing the -Gal epitope, and a tetrasaccharide derivative thereof, namely Gal-1,3-Gal-
1,4-GlcNAc-1,3-Gal. STD spectra of these oligosaccharides in the presence of gal-3 (figs. 26-
27) show a differential saturation response for several ligand nuclei. Specifically, in the case of 
the trisaccharide, those of the galactose residues showed higher STD responses that of the 
glucosamine residue (fig.26). This result is similar to analogous experiments previously 
reported on lactose [71], in the sense that the glucosyl moiety receives less saturation than the 
galactose unit. This, in turn, is in agreement with the binding mode of this disaccharide to the 
CRD of gal-3, which exposes the glucose residue toward the solvent, as demonstrated both by 
X-ray crystallography [60] and NMR studies [72]. For the tetrasaccharide, the STD pattern of 
the digalactose portion was very similar to that obtained with the trisaccharide. However, 
slightly higher degrees of saturation were found at the GlcNAc moiety. Besides, the additional 
(1-3)-linked galactosyl moiety also received some degree of saturation (fig. 27). This seems 
rather surprising, since the expected binding mode for the tetrasaccharide would leave this 
galactose residue as the one most exposed to the solvent. Thus, it is possible that transient 
interactions occur between this -galactose residue and the canonical galactose-binding site of 
gal-3, explaining this phenomenon. 
The addition of 10 equivalents of either molecule to 15N-labeled gal-3 produced a similar 
profile of the backbone chemical shift variations to those exerted by lactose (fig. 28). This 
indicates that the binding mode of these molecules closely resembles that of lactose. Besides, 
the differential shifting of residues 148-149 in the presence of both sugars (and not with 
lactose) suggest that this region is proximal to the additional, (1-3)linked galactosyl moiety.  
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Figure 26: A: STD experiment on Gal-1,3-Gal-1,4-
GlcNAc in the presence of gal-3. Top spectrum: Off-
resonance. Bottom: STD (up-scaled). B: Epitope mapping 
deduced from STD data, with colors showing relative 
STD intensities to the most saturated signal.
Figure 27: A: STD experiment on Gal-1,3-Gal-1,4-
GlcNAc-1,3-Gal in the presence of gal-3. Top: Off-
resonance. Bottom: STD (up-scaled). B: Epitope mapping 
deduced from STD data, with colors showing relative 
STD intensities to the most saturated signal. 
Figure 28: Interaction of -Gal tri- and tetrasaccharide with gal-3. A: Comparison between chemical shift differences 
for the trisaccharide (orange) and lactose (black). B. Overlaid 1H-15N HSQC spectra of gal-3 (black) and with 10 eq. 
trisaccharide (orange). C: Comparison between chemical shift differences for the tetrasaccharide (purple) and 
lactose (black). B. Overlaid 1H-15N HSQC spectra of gal-3 CRD (black) and with 10 eq. tetrasaccharide (purple).
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In order to obtain a 3D view on the interaction, docking calculations were performed on the 
gal-3 CRD and the -Gal trisaccharide. As experimental constraints, taking into account the STD 
results and the protein chemical shift perturbation analyses, we assumed that the lactose 
moiety of the tetrasaccharide was located at the lactose binding site. A structure from the 
most populated cluster of this docking analysis is shown in fig. 29. The predicted binding mode 
indicates that the interactions with the lactosyl moiety are kept, i.e. hydrogen bonds involving 
side chains of aminoacids His158, Arg162, Arg186 and Glu184, and a CH- interaction between 
the Trp181 indole ring and the -face of GalNAc. Besides, the docked structure predicts the 
positioning of the additional, (1-3)-linked galactose moiety onto the vicinal strand, 
hydrogen-bonding with the Arg144 and Asp148 side-chains. These putative interactions are in 
good agreement with the selective chemical shift perturbations of these residue peaks, 
occurring in the presence of the tri- and the tetrasaccharide, but not with lactose. 
Figure 29: Docked structure from the 
most populated cluster of an AutoDock 
4.2 calculation, using the gal-3 X-ray 
structure (PDB: 1A3K) treated as rigid 
and a flexible Gal-1,3-Gal-1,4-GlcNAc 
molecule. The predicted binding pose of 
the LacNAc moiety closely resembles 
that of the crystallographic structure. 
Besides, new hydrogen bonding 
interactions putatively arise between the 
additional, (1-3)-linked galactose 
moiety at the non-reducing terminus and 
the Arg144 and Asp148 side-chains. 
As a general conclusion, the recognition of both lacdiNAc and -Gal epitope-derived 
oligosaccharides, all of which can be essentially understood as substituted lactose molecules, 
show the same recognition features of the disaccharide. In addition, selective local 
perturbations detected by NMR, and interpreted by molecular modeling, permit to map the 
location of the additional substitution moieties. 
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5.3.1.4 The recognition of GAGs at the gal-3 CRD 
Although the previous sections have focused on the interaction between gal-3 and small 
oligosaccharides, galectins perform many of their important biological functions by binding to 
macromolecular receptors. 
Even though the recognition between galectins and higher molecular weight glycans has been 
extensively documented, attempts of exploring these interactions at atomic resolution have 
not been yet reported. As shown in this unit, we investigated the binding of two large 
glycosaminoglycans (GAGs) to full-length gal-3 by using protein-detected NMR experiments.  
GAGs are a class of polysaccharides encompassing a variety of sulfated carbohydrates. They 
include heparin, heparan sulfate, hyaluronic acid and keratan sulfate, which perform 
important structural functions, and whose recognition by different receptors triggers a 
plethora of biological responses, such as inflammation, cell adhesion, and regulation of cell 
growth and proliferation [73-74]. Since some types of GAGs contain poly-LacNAc sequences, 
they are regarded as potential ligands for galectins.   
In a previous work, the interaction of galectins with several types of GAGs was analyzed by 
frontal affinity chromatography [75]. Results showed that their interaction with keratan sulfate 
was strong if the galactose residue(s) remained unsulfated, while GlcNAc sulfation had 
relatively little effect. Gal-3, -7, and -9 also exerted significant affinity to desulfated, GalNAc-
containing GAGs, i.e., chondroitin and dermatan, but not at all to hyaluronan and N-
acetylheparosan. Together, these observations revealed that the integrity of the 6-OH group of 
-Gal is important for galectin recognition of GAGs. 
GAGs used in this study were keratan sulfate (KS) and desulfated keratan (K), which were 
produced from bovine cornea in the laboratory of Prof. Robert Linhardt (Rensselaer 
Polytechnic Institute, Troy, NY, USA). Both polymers bear 1,3-linked LacNAc repeats, which in 
the case of KS can be sulfated at 6-OH of galactose, GlcNAc residues, both, or none. 
As can be seen in the DOSY spectrum of fig. 30, the size of the K and KS samples used in this 
study were rather large. As estimated through their diffusion coefficients, they behaved as 
particles of mean sizes 15 kDa and 145 kDa, respectively. 
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Figure 30: Overlaid DOSY spectra of glycans of different size. Orange: keratan sulfate; red: desulfated keratan; 
green: a gal-3 CRD/lactose mixture. A molecular weight estimate based on a calibration curve is indicated in blue.
Addition of these glycans to 15N-labeled gal-3 samples caused a dramatic loss of the gal-3 HN 
signals. This was attributed to a sharp decrease in the correlation time of the protein upon 
binding to the heavy polysaccharide chains. As seen in fig. 31A, there is a selective 
perturbation of the CRD signals upon addition of KS, which broadens them beyond detection, 
leaving the signals from the ND comparatively much less affected. In principle, this permits to 
deduce that binding occurs at the CRD. When lactose is added to gal-3/KS mixtures, the CRD 
signals are recovered (fig. 31B), which indicates that the recognition of KS by gal-3 takes place 
at the canonical sugar binding site of its CRD.
Analogous studies were performed on the less heavy desulfated keratan polysaccharide. These 
analyses showed that, although the selective broadening of the CRD signals was still apparent, 
signals were still visible, which permitted to monitor chemical shifts perturbations to map the 
gal-3 regions involved in the interaction. Again, competition with lactose was shown to revert 
the CRD signals to a chemical shift pattern characteristic of lactose-bound gal-3 (fig. 32A). As 
seen in fig. 32C, the gal-3 interface of binding to K includes a large area of the concave face of 
the -sandwich, as well as the most C-terminal -strand in the opposite face. Computational 
studies with high order oligosaccharides are currently underway to provide a 3D view of the 
forces involved in these interactions. 
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Figure 31: The interaction of the gal-3 CRD with KS. A: 1H-15N HSQC spectra of full length gal-3 before (blue) and 
after addition of KS (red). The CRD signals are selectively broadened beyond detection upon binding to the 
polysaccharide. B: 1H-15N HSQC spectra of a gal-3/KS mixture before (red) and after addition of a lactose excess. 
Addition of the disaccharide recovers the signals of the CRD, thus confirming that binding of gal-3 to KS takes place 
at the canonical sugar binding site of the gal-3 CRD. 
Figure 32: The interaction of gal-3 CRD with desulfated keratan (K). A: 1H-15N HSQC spectra of full length gal-3 alone 
(blue), after addition of K (red), in the presence of K and a lactose excess (green). B: Comparison between chemical 
shift differences exerted by K (blue) and those by lactose (red). C: Structures of LacNAc-loaded gal-3 CRD (PDB: 
1A3K), with residues highlighted in red for the most shifted resonances upon ligand binding, followed by orange and 
yellow. Left: shifts in the presence of lactose; right: shifts in the presence of K. 
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5.3.2 The interaction of the ND of gal-3 with its CRD 
In structural aspects, the modular design of galectin-3 (gal-3) is unique. It is composed of the 
common -sandwich-type carbohydrate recognition domain (CRD) linked to collagen-like 
repeats (nine in human gal-3) and one N-terminal peptide with two sites for serine 
phosphorylation, the explanation why gal-3 is called a chimera-type galectin [37]. Since every 
animal species studied so far harbors gal-3 despite marked inter-species differences in the 
total number of galectin genes and the sequences in the two non-CRD regions appear 
conserved [2, 37, 76], the trimodular structure likely bears special physiological significance. 
At present, the non-CRD portion is implicated in non-classical secretion [59, 77-78]; serine 
phosphorylation of the starting peptide (at S6 and S12 [78-80]) is known to play a role in 
nuclear export [59, 81-82]. Although an impact on binding lactose, ganglioside GM1 and 
N-glycans was excluded [12, 15, 16], this phosphorylation reduced gal-3 reactivity to laminin 
and asialomucin but enhanced both complex formation with the cell adhesion molecule L1 and 
its association with Thy-1-rich microdomains in neurons [83-84]. Equally intriguing, tyrosine 
phosphorylation by non-receptor kinases cAbl/Arg (at Y79, Y107 and Y118 [84-86]) appears to 
be a signal for gal-3 to reach the cell periphery with ensuing secretion in mouse embryonic 
fibroblasts [87]. It is an open question whether intramolecular recognition, influenced by 
phosphorylation status, may contribute to the structural basis of these processes. 
Of note, the N-terminal portion appears to be rather flexible, although the transition 
temperature at 39 °C during thermal denaturation and the bimodal charge distribution in 
nano-ESI mass spectrometry provide evidence for an interconverting mixture of conformers, 
tentatively between extended and compact forms [4, 88]. Importantly, chemical shift analysis 
of hamster gal-3 suggested the presence of transient contacts with the CRD, for residues in the 
first part of the N-terminal tail (F5, W22, W26) and L109 [62]. The delineation of a nuclear 
export signal, probably interacting with a transporter such as nucleoporin Nup98 [89], in the 
distal section of the CRD, i.e. around 240-255 in murine gal-3 [90], in conjunction with these 
NMR-based observations and the switch-like impact of serine phosphorylation on nuclear 
export noted above, raises the intriguing possibility that serine phosphorylation can trigger so 
far unknown structural consequences, directly and/or indirectly. 
As noted in previous sections, the assignments for the CRD part of full-length gal-3 were 
essentially the same as for the truncated protein, indicating that, in the overall structure, the 
CRD is folded in a very similar way as when truncated. 
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However, close inspection of a spectral overlay of both protein variants reveals selective 
differences in the chemical shifts of a number of signals. Among these, the most shifted ones 
correspond to residues covering a large area located on the convex side of the CRD 
-sandwich, at the opposite face of the sugar binding site (fig. 33).  These observations were 
strongly suggestive that, in the full-length protein, the ND establishes interactions with this 
region of the CRD, and motivated an investigation to unveil the structural details of this 
interaction by dissecting the contribution of each ND part.  
Figure 33: Bottom panel: superimposition of 1H-15N HSQC spectra of the gal-3 CRD (blue) and hGal-3 full-length 
(red), with labels indicating some of the most perturbed signals. Top panel: structure of the LacNAc-loaded gal-3 
CRD (PDB: 1a3k), with residues highlighted in red for the most shifted resonances, followed by orange and yellow. 
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On this basis, we tested the hypothesis of the existence of interactions with synthetic peptides 
and 15N-labeled CRD. Looking at secretion, tyrosine phosphorylation may play into this process 
by favoring a conformer, most suitably in extended form to make the tail fully accessible. 
Testing potential for peptide-CRD interactions followed the described strategy. To complete 
this study line, we also examined the chemical shift properties of the CRD in the presence of 
peptides comprising one and two collagen-like repeats. Peptides were synthesized in the 
laboratory of Prof. Dieter Kübler (German Cancer Research Center, Heidelberg, Germany).  
5.3.2.1 Definition of peptides 
To assess interactions between the gal-3 CRD and N-terminal tail, we used 1H-15N HSQC 
experiments and three sets of structurally-relevant tail-derived peptides as shown in Figure 34. 
The first set (P1-P3) represents the N-terminal peptide with and without Ser phosphorylation. 
The second set (P4-P7) encompasses sequences from the C-terminal part of the tail that 
contains phosphorylation sites Y107 and Y118. In the third set, we tested two peptides (P8, P9) 
from the collagen-like part of the tail.
5.3.2.2 N-terminal peptides 
Although peptide P1 failed to show significant interactions with the CRD (fig. S7 in Appendix), 
its phosphorylated counterparts did (fig. 35). Here, the most markedly shifted resonances 
belonged to residues located at the backside of the lectin, opposite to the canonical sugar-
binding site (fig. 36), which in turn leaves the -galactoside (e.g. lactose) binding site 
unaffected. Significant chemical shift perturbations of NH cross peaks belonging to residues 
207-211 suggests that K210 is likely the contact site for phosphate groups within the tail.  
The use of two scrambled control phosphopeptides (SCR1 and SCR2) allowed us to conclude 
that these effects were specific. Despite the presence of two phosphate groups in SCR2, the 
NMR spectra of gal-3 CRD showed only very small chemical shift perturbations (fig. S9 in 
Appendix). When the distance between the two phosphates was maintained, as in SCR1, some 
minor chemical shift perturbations were observed (fig. S8 in Appendix), but not to the extent 
observed with the non-scrambled peptide. Overall, these results strongly suggest that the N-
terminal peptide of human gal-3 can specifically interact with the CRD in a phosphorylation-
dependent and sequence-specific manner. 
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Figure 34: Top panel: sequence of the synthetic peptides used in this study, with phosphoserine (pS) and 
phosphotyrosine (pY) residues highlighted in red. Bottom panel: location of the peptides in the whole protein 
sequence. Red: peptides P1-P4; orange: peptides P5 and P6; blue: peptides P7-P9. The sequence of the CRD is 
indicated on a green background. On the right, a schematic representation of the crystal structure of the gal-3 CRD 
(green), with the ND (at scale) is shown. 
5.3.2.3 Tyr-P peptides 
Phosphorylation of Tyr107 and Tyr118 had the opposite effect. Whereas peptides P4-P7 
elicited significant chemical shift perturbations of resonances from the CRD, their 
phosphorylated counterparts actually attenuated interactions with the CRD (figs. 37, 38). Once 
again, the most highly shifted signals belonged to residues located at the backside of the -
sandwich structure (fig. 36), and chemical shift differences were generally greater with the 
longer peptides P6 and P7. In any event, phosphorylation decreased the extent of chemical 
shift perturbations in the gal-3 CRD, indicating that affinity of these phosphorylated peptides 
towards the CRD is significantly reduced. Thus, phosphorylation of serine and tyrosine resiudes 
within the N-terminal tail appears to differentially modulate the interactions with the CRD.  
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Figure 35: A: Top panel: superimposition of 1H-15N HSQC spectra of the gal-3 CRD, in the absence (blue) and in the 
presence of ten equivalents of P2 (green) or P3 (red), with labels indicating some of the most perturbed signals. 
Bottom panel: 1H-15N-weighted chemical shift differences () for gal-3 CRD backbone NH signals upon addition of 
10 equivalents P1 (yellow), P2 (red) or P3 (blue). B: Superimposition of 1H-15N HSQC spectra of the gal-3 CRD with 
different P9/P3 ratios. Blue: gal-3 alone; black: in the presence of ten equivalents of P9; orange: after the addition 
of 3.3 equivalents P3; green: after the addition of 5 equivalents P3; red: in the presence of ten equivalents P3. 
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Figure 36: Mapping of the gal-3 CRD residues with the most shifted signals for a number of peptides. In all cases, the 
structure of the LacNAc-loaded human gal-3 CRD (PDB: 1A3K) is shown, with residues highlighted in red for the 
most shifted resonances, followed by orange and yellow. 
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Figure 37: Top panel: superimposition of 1H-15N HSQC spectra of the gal-3 CRD, in the absence (blue) and in the 
presence of ten equivalents of P4 (red) or P5 (green). Bottom panel: 1H-15N-weighted chemical shift differences () 
for gal-3 CRD backbone NH signals upon addition of 10 equivalents P4 (blue) or P5 (red). 
5.3.2.4 Pro/Gly-rich tandem-repeat peptides 
To complete this study, we tested peptides containing one and two repeat sequences derived 
also from the tail, specifically one peptide comprising residues 42-50 (P8) and another one 
comprising residues 42-59 (P9). The observed chemical shift perturbations within the CRD 
were rather similar, compared to those exerted by peptides P4-P7, consistent with their 
sequence similarity (fig. 38, fig. 36). The profile of apparent contacts suggests that the region 
of interaction is somewhat larger for P9 than for the single-repeat variant peptide P8.  
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Figure 38: Top panel: superimposition of 1H-15N HSQC spectra of the gal-3 CRD, in the absence (blue) and in the 
presence of ten equivalents of P6 (red) or P7 (green). Bottom panel: 1H-15N-weighted chemical shift differences () 
for gal-3 CRD backbone NH signals upon addition of 10 equivalents P6 (blue) or P7 (red). 
Because many of these peptides appeared to interact with the same region of the Gal-3 CRD, a 
competition experiment was performed to verify whether the phosphorylated N-terminal 
peptide P3 could displace peptide P9 from the CRD. The results of this experiment are 
illustrated in fig. 35B. Three signals (L203, A212 and L219) are significantly perturbed by the 
presence of P9, but not by that of P3. Addition of increasing amounts of P3 to the sample of 
gal-3 CRD + P9 reversed the chemical shift changes induced by P9, thus indicating that N-
terminal phosphopeptide P3 can compete with the two tandem-repeat peptide P9 for binding 
to the CRD. These evidences suggest that phosphorylation of gal-3 at the N-terminus may alter 
the Gal-3 structure, potentially with recognition and/or functional consequences. 
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Figure 39: Top panel: superimposition of 1H-15N HSQC spectra of the Gal-3 CRD, in the absence (blue) and in the 
presence of ten equivalents of P8 (green) or P9 (red). Bottom panel: 1H-15N-weighted chemical shift differences () 
for Gal-3 CRD backbone NH signals upon addition of 10 equivalents P8 (blue) or P9 (red). 
5.3.2.5 Conclusions 
Interaction of the gal-3 CRD with synthetic (phospho)peptides derived from the gal-3 N-
terminal tail was assessed using NMR HSQC experiments with 15N-labeled CRD. Results show 
that distinct N-terminal peptides can interact at specific sites within the gal-3 CRD, suggesting 
that a similar behavior may take place in full length gal-3. Thus, the reported data can be 
relevant for association of tail-derived peptides (by proteolytic truncation of gal-3) with the 
lectin, as well as for intra- and intermolecular interactions, the latter in gal-3 aggregates 
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formed with multivalent ligands. Moreover, while phosphorylation of Ser6 and Ser12 in 
specific N-terminal peptides promotes association with the CRD, phosphorylation of Tyr107 
and Tyr118 in other peptides attenuates this association. In this regard, serine and tyrosine 
phosphorylation of the N-terminal tail may act as on/off switches or modulators for various 
functions of Gal-3. 
5.4 Methods 
Section 5.2:  
Protein assignment: 3D experiments for assignment of gal-7 were acquired in a Bruker AVANCE 
800 MHz equipped with a cryoprobe. NMR data were processed in TopSpin 3.0. and analyzed 
with CARA. 
Protein sequencing: the N-terminus of gal-7 was sequenced by standard Edman degradation 
chemistry in an Applied Biosystems 494 protein sequencer. 
NMR experiments: 1H-15N HSQC spectra were recorded on gal-7 samples contained 0.2 mM 
uniformly 15N-labeled gal-7 in 20 mM PBS buffer, pH 7.4 in H2O, plus 10% D2O for field-
frequency lock. Data were collected at 298 K in a Bruker Avance 600 MHz spectrometer 
equipped with a cryogenically cooled HCN probe with z-axis gradients. 
Peptide synthesis: A nonapeptide corresponding to the N-terminal sequence of human gal-7 
(SNVPHKSSL) was synthesized using standard Fmoc solid phase synthesis in an Advanced 
Chemtech Peptide Synthesizer Model 348  following manual attachment of the protected 
first amino acid (Leu-Fmoc) to 2-Cl-trityl chloride resin macrobeads (Peptides International, 
Louisville, KY). 
Sequence alignment: Sequences of galectin-7 from different species were downloaded from 
the NCBI protein database and aligned with Clustal Omega. Alignments were manually edited 
with JalView to eliminate gaps and loaded with ClustalW2 to build the figures. 
In silico modeling: A peptide model for the nonapeptide was built in xleap and subject to an 
energy minimization in Macromodel in the OPLS_2005 force field. A model for the gal-7 P4 cis
conformer was generated by a manual 180º torsion of the V3-P4 peptide bond in the apo-gal-7 
crystal structure (PDB: 1BKZ-A), followed by an energy minimization with Macromodel in the 
OPLS_2005 force field. 
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Fragment-based drug discovery: The Maybridge Ro3 fragment library (1000 compounds) was 
screened against gal-7. Mixes of 5 fragments (150 M each) were screened by STD in the 
presence of 15 M gal-7 in Tris-d11 buffer, p2H 7.5, in a Bruker 500 MHz spectrometer. 1H-15N 
HSQC experiments were performed at 600 MHz, on 250 M 15N-labeled gal-7 or gal-3 CRD, 
using Tris buffer, pH 7.5 plus 10% D2O at 298 K. Chemical shift perturbations were monitored, 
using the gal-7 and gal-3 1H and 15N assignments. To obtain iLOEs, a NOESY 500 ms experiment 
was performed with 30 M gal-7 plus 500 M of fragments 205 and 245. Computational 
docking was performed with AutoDock 4.2 [91], treating gal-7 and gal-3 CRD X-ray structures 
(4GAL and 1A3K, respectively) as rigid. Ligand structures were retrieved from the 
manufacturer's database and treated as flexible. 
Gal-7 dimer probing: Gal-7 dimer STD experiments were performed using 5-chloro-
benzo[b]thiophene-3-carboxylic acid (i.e. fragment 245) as a spy molecule, at four different 
gal-7 concentrations around its dimerization KD, ranging from 500 nM to 5 µM, in fully 
deuterated 20 mM phosphate buffer at pD 7.4. The effect of lactose was analyzed by repeating 
the experiments after the addition of 8 mM lactose to the samples. 
Section 5.3 
Protein assignment: Assignment of the gal-3-derived peptides was done by a combination of 
TOCSY, NOESY, and HSQC experiments performed in a Bruker AVANCE 600 MHz equipped with 
a cryoprobe.  
NMR spectroscopy: All experiments were performed at 298 K in a Bruker AVANCE 600 MHz 
spectrometer equipped with a cryogenically-cooled z-gradient triple resonance probe. Samples 
for 1H-15N HSQC experiments contained 15N-labeled human gal-3 (full length or CRD) at a 
concentration of 100 to 200 M, with or without ten to 20 equivalents of the tested ligands. 
STD experiments were performed with 30-100 equivalents of ligands and 15 to 30 M gal-3. 
Samples were dissolved in phosphate buffer in 90% H2O/10% D2O. Chemical shift 
perturbations were monitored using the sequence-specificassignments for the human gal-3 1H 
and 15N resonances. 
Modeling: The starting geometry for gal-3 CRD was the pdb 1A3K. The initial structure for the 
docking was built by manually docking the oligosaccharide structures into the lactose binding 
site. The docking was run in Autodock 4.2, with selective active torsions of the ligand, a grid 
box of 64×64×64 with a 0.375 Å spacing, maximum number of evaluations 25×107, maximum 
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number of generation 30000, 150 individual populations, using a Lamarckian genetic algorithm 
with 50 runs, and a clustering with an rms tolerance of 2.0 Å.    
All proteins were produced in the laboratory of Prof. H.-J. Gabius (Ludwig Maximilian 
University of Munich, Germany). 
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CHAPTER 6 
NEW DEVELOPMENTS: APPLICATION OF PARAMAGNETISM TO PROBE SUGAR 
CONFORMATION AND INTERACTION WITH RECEPTORS 
6.1 Introduction 
Currently, conformational analyses of carbohydrates by NMR make extensive use of nuclear 
Overhauser enhancements (NOE) and scalar couplings. However, despite the important 
information that can be extracted from these sources of information, additional parameters 
are usually required to define the global shape and the dynamics of complex glycans [1-3]. 
Indeed, NOEs and J-couplings only provide local information, and it is common to find 
oligosaccharides in extended shapes, with no long-range NOE contacts. Also, the flexibility of 
glycans often precludes the detection of NOEs with structural information [4]. This is 
aggravated by the inherent difficulty of carbohydrates due to signal overlapping problems.  
In addition, studies on protein-carbohydrate interactions by NMR from the receptor 
perspective are often hampered by the weak signal perturbations that weakly-binding, neuter 
sugars exert on protein NMR spectra, and the scarcity of intermolecular NOE information. For 
these reasons, new tools are needed that boost the effect of sugar binding on the protein 
signals and introduce additional restraints for structural elucidation of protein-carbohydrate 
complexes by NMR.  
The exploitation of paramagnetic effects, especially those exerted by lanthanide ions, offers a 
potential to tackle these challenges, thanks to a rich source of long-range structural restraints 
that they provide, including residual dipolar couplings, relaxation enhancement and 
pseudocontact shifts. The use of paramagnetic restraints has traditionally been restricted to 
proteins and nucleic acids [5-6]. In this chapter, we show how they can be used as key 
parameters in the structural characterization of carbohydrates and carbohydrate-protein 
complexes.  
160 
The work presented in this chapter was done in close collaboration with Dr. Angeles Canales 
(Complutense University of Madrid and CIB-CSIC), and Dr. Alvaro Mallagaray of Prof. Javier 
Pérez-Castells lab (University San Pablo CEU, Madrid). 
6.1.1 Theoretical background 
Paramagnetism arises from the presence of unpaired electrons in atomic or molecular orbitals 
of certain chemical species, notably metal ions and organic radicals. Among the latter, 
nitroxide spin labels are notable due to their stability in aqueous solutions. For their part, 
metal ions with paramagnetic properties include Mn2+, Fe2+, Co2+, Ni2+, Cu2+ and most 
lanthanide (III) cations (Ln3+). 
6.1.1.1 Isotropic and anisotropic magnetic susceptibility 
The paramagnetism that is originated in a paramagnetic center can be described by its 
magnetic susceptibility tensor , which in turn can be expanded in its three spatial 
components  x, y and z. 
The  tensor is anisotropic if the magnetic moment of the paramagnetic center varies as a 
function of the orientation of the molecule inside the main magnetic field, B0; otherwise, the 
tensor is defined as isotropic. Gd3+ is the only lanthanide ion with an isotropic  tensor, while 
the rest of paramagnetic lanthanide (III) ions possess strongly anisotropic  tensors. 
Since the major part of paramagnetic effects is accounted for by the deviation of the  tensor 
from spherical symmetry only, this tensor is usually decomposed in its isotropic (iso) and 
anisotropic (the  tensor) components. The latter is in turn characterized by its axial and 
rhombic components: 
(1)
(2)
Thus, the  tensor is null when x = y = z. The  tensor anisotropy depends on the 
coordination environment. 
yxrh  
2
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zax
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6.1.1.2 Types of paramagnetic effects 
While unpaired electron spins of nitroxide radicals and some cations (e.g. Gd3+, Mn2+ and Cu2+) 
are characterized by long relaxation times (in the nanosecond range), metals with strongly 
anisotropic  tensors (most lanthanide ions) display very short (sub-picosecond) relaxation 
times [7]. This difference is accounted for by different relaxation mechanisms, which are 
ultimately responsible for the different types of paramagnetic effects observed by NMR [5]. 
6.1.1.2.1 Paramagnetic relaxation enhancement (PRE) 
PREs arise from dipolar interactions between the unpaired electrons and the nuclei in its 
vicinity. Thus, they are dependent on the nuclear spin (I) and its distance to the paramagnetic 
center (r). Specifically, PREs due to dipolar relaxations operating via the Solomon mechanism 
(long relaxation times, like in nitroxide radicals, Mn2+ and Gd3+ ions) or the Curie mechanism 
(short relaxation times, like in most Ln3+ ions) show the same r-6 dependence. For dipolar 
relaxation: 
(3)
Where 1/c=1/r + 1/e (r being rotational correlation time and e the electron spin state 
halftime), and S is the electron spin. For Curie-spin relaxation: 
 (4) 
Where ge and Se are the electronic factor g and the spin, respectively, T is temperature and B0
is the strength of the main magnetic field. The inverse sixth power distance dependence 
means that PREs are strong close to the paramagnetic center, where they cause severe 
broadening of the NMR signals beyond its detection limit, but are minimized at long distances. 
Thus, their study is suitable around regions close enough to the paramagnetic center to be 
measured, but where they are not too strong to not be detected.  
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Today, the use of PREs is widely extended in structural studies of biological macromolecules 
[8]. In the context of carbohydrate-protein interactions, it is worth mentioning the application 
of nitroxide spin-labels for mapping the carbohydrate binding sites on protein surfaces, thanks 
to PREs arisen from the nitroxide moiety. Perturbations in the 1H-15N HSQC spectrum of 
galectin-3 (gal-3) were monitored and used to identify protein residues proximate to the 
binding site for N-acetyllactosamine [9]. 
6.1.1.2.2 Paramagnetic shifts 
NMR signals affected by the presence of unpaired electrons in its vicinity can experience an 
external net contribution to their chemical shift called hyperfine shift. This contribution can be 
due to two different mechanisms: 
6.1.1.2.2.1 Contact shifts 
If the unpaired electrons are delocalized over the resonant nucleus due to chemical bonding, 
the NMR signal of the latter will experience a shift called Fermi contact shift (c). The 
magnitude of c contains structural information, but it is very difficult to extract, although 
successful attempts to use them in structural calculations have been reported [10-12].  
6.1.1.2.2.2 Pseudo-contact shifts (PCS)
If the magnetic moment of the unpaired electrons is anisotropic, there is an additional spatial 
dipolar coupling causing a hyperfine shift on vicinal nuclei called pseudo-contact shift (PCS). 
The net hyperfine shift of every nucleus in a paramagnetic molecule is a sum of contact and 
pseudo-contact shifts. However, in the practice, when the number of chemical bonds between 
the resonant nucleus and the paramagnetic center is above four, and none of them are 
-bonds, hyperfine shifts can be considered as entirely caused by PCS. 
PCSs are proportional to the anisotropy of the  tensor () and independent of the isotropic 
component of the  tensor. It is therefore sufficient to describe the PCS as a function of the 
axial and rhombic components of the  tensor, ax and rh, as seen in eq. 5, [13] where 
PCS is the difference in chemical shifts measured between diamagnetic and paramagnetic 
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samples, r is the distance between the metal ion and the nuclear spin, and and  are the 
polar coordinates describing the position of the nuclear spin with respect to the principal axes 
of the  tensor.  
(5) 
PCS give rise to large changes in chemical shifts that decrease with the distance between the 
metal ion and the nuclear spin with a r-3 dependence. Therefore, PCS can provide long-range 
structural information. PCSs were first described in 1958 [14] and successfully used for 
structural studies on small nucleotides in 1971 [15]. Today, PCSs are widely used for 
calculation and refinement of the structure of biomolecules, especially proteins [5-6].  
As shown in fig. 1, PCSs are usually represented as isosurfaces superimposed to the 3D 
structure of the paramagnetic molecule. These isosurfaces represent the spatial coordinates 
for which eq. 5 predicts the same PCS values. 
Figure 1: Pseudo-contact shifts 
(PCSs). A: An electron-proton 
system showing the definition 
of r and angular parameters 
and . B: PCS isosurfaces 
plotted on a paramagnetic-
labeled protein. Figure from 
[16]. 
6.1.1.2.3 Residual dipolar couplings (RDC) 
The 1-bond scalar coupling costant 1J of a given nuclear pair (e.g. 1H-13C, 1H-1H, 1H-15N) may 
have a dipolar contribution (D) due to partial alignment of the biomolecule in the presence of 
     2cos231cos3121 223 senr rhaxPCS
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the external magnetic field B0. This contribution, called residual dipolar coupling (RDC), causes 
splitting in the signal of each nucleus involved. The magnitude of this splitting depends on two 
geometrical parameters: the distance r between both nuclei and the angle  between the 
vector connecting these nuclei and the direction of B0. For a given pair of nuclei, for instance a 
1H-13C pair in a carbohydrate, the dipolar interaction is given by: 
                     (6) 
Where the terms enclosed in brackets correspond to time-averaged distance <rHC-3> and time- 
averaged angle <cos2 >. Normally, solutes tumble isotropically; thus, <cos2> is zero, leading 
to null dipolar splitting. In contrast, when a solute is weakly oriented in an alignment medium, 
there is a net dipolar contribution D to 1J. For this reason, RDC measurement requires partial 
alignment of the molecules under study [17-18]. Several alignment media have been tested for 
carbohydrates, using both external alignment systems [18-20] and paramagnetic tags [21].  
From the experimental viewpoint, RDCs simply add to splitting due to J-coupling. Thus, for a 
given NMR signal, the magnitude of the RDC is determined from the difference in splitting 
between the sample under alignment (RDC + J) and the isotropic non-aligned sample (J).  
The great advantage of RDCs is that they permit to correlate the geometrical orientation 
between structural fragments (e.g. pyranose rings in the carbohydrate field) no matter how 
apart they are in the molecule [22]. Thus, RDCs are particularly useful to deduce the geometry 
of the glycosidic linkages, which has a major influence on the conformation of carbohydrates 
and their overall shape [23].  
RDCs have also been successfully employed for the study of protein-carbohydrate complexes. 
In this regard, RDCs have been used to determine the carbohydrate conformation in the bound 
state [24], the location of the carbohydrate binding site and the structure of the complex, in 
combination with PCS-derived information [25]. 
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6.1.2 Paramagnetic labeling of biomolecules 
Paramagnetic effects have been extensively exploited for structural characterization of 
biological macromolecules, mainly proteins [6, 26]. Since most biological molecules lack 
natural paramagnetic centers, these must be artificially incorporated. 
A possible strategy consists in the replacement of naturally binding ions (e.g. in calcium-
binding proteins) by paramagnetic (e.g. lanthanide) ions [27-28]. However, since Ln3+ ions have 
an additional charge and a higher coordination number than Ca2+, this method does not always 
provide satisfactory results. Similar approaches have been reported with proteins that bind 
Mg2+ or Mn2+ [16, 29-30].  
However, since a majority of proteins do not bind metals, the most extended strategy involves 
covalent labeling of biomolecules with paramagnetic tags. Labeling is selectively done at 
reactive functional groups of proteins (e.g. solvent-accessible cysteine thiols or lysine amines), 
which can exist in the natural molecule or be mutagenically incorporated. Paramagnetic tags 
can incorporate either nitroxide radicals or lanthanide chelators (fig. 2), and many of them are 
available in a commercial basis [8]. 
Figure 2: Two examples of cysteine-reactive paramagnetic tags, one incorporating a nitroxide spin label (left), and 
one incorporating a metal chelator (right).
6.1.2.1 Lanthanide ions 
In lanthanide ions (Ln3+), unpaired electrons are located in the non-reactive f orbitals. Since 
interactions involving these metals and their ligands are generally ionic in nature, these 
electrons do not tend to delocalize by forming chemical bonds, as it is usual, for instance, in 
hemo-iron paramagnetic complexes. As a result, contact shifts (the paramagnetic equivalents 
of scalar couplings) are restricted to nuclei in direct contact with the lanthanide ion, and the 
majority of paramagnetic effects that they exert can be explained by PREs and PCSs.  
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Trivalent cations of the different lanthanide elements differ substantially in their paramagnetic 
properties (fig. 3), namely their  tensor values and their associated anisotropy. Looking at 
their  tensors, lanthanide ions can be classified as strongly paramagnetic (Dy3+, Tb3+), 
moderately paramagnetic (e.g. Er3+, Yb3+), and weakly paramagnetic (e.g. Eu3+, Ce3+, Sm3+). Gd3+
represents a special case, because it has an isotropic  tensor. In addition, it induces strong 
PREs without detectable PCSs. Of note, there also exist diamagnetic lanthanides (La3+, Lu3+), 
which are used as diamagnetic references for their paramagnetic counterparts, together with 
other diamagnetic trivalent cations of similar radii like Y3+ and Sc3+. 
Figure 3: Paramagnetic properties of Ln3+ ions, including  tensors and the axial and rhombic components of their 
anisotropic  tensors, magnitude of PRE and isosurface representation of their PCSs, and typical electronic 
relaxation times (e) at 800 MHz (figure from [31]).
6.2 Results 
6.2.1 Assessing sugar conformation in solution by PCS measurement 
The synthesis and evaluation of a molecule of chitobiose covalently attached to a lanthanide 
binding tag was previously reported by our laboratory, in collaboration with that of Prof. 
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Pérez-Castells [32], as the first lanthanide-chelating molecule in the realm of carbohydrates. Its 
design consisted in a 1--aminochitobiose derivative connected to an ethylenediamine-
tetraacetic acid (EDTA) chelator unit by a rigid biphenyl linker. The role of the linker was to 
position the sugar nuclei beyond the distance range at which PREs lead nuclear signals to 
became broadened beyond detection. Large PCSs (of up to 0.22 ppm) were measured in the 
sugar moiety [32].  
Next, a second generation of lanthanide binding tags (LBT) was designed, incorporating a 
phenylendiaminetetraacetic acid (PhDTA)-based chelator, which presented multiple 
advantages. First, it lacked stereogenic centers, thus facilitating its synthesis. Second, its 
structure gained in rigidity, boosting paramagnetic effects thanks to minimizing structure 
averaging in solution.  
Using a lactose derivative bound to a biphenyl-DTA (Lac-biPhDTA), PCSs of the lactose moiety 
were measured by comparing the 13C and 1H-NMR chemical shifts in the presence of the 
diamagnetic reference (La3+) and two different paramagnetic ions (Tb3+, Dy3+) through standard 
1H-13C HSQC experiments. All sugar signals were detected in the spectrum, and only one set 
NMR of signals was observed for the molecule in the presence of stoichiometric amounts of 
these metals. 
A comparison of the spectra of Lac-biPhDTA coordinated with either La3+ or Tb3+ is shown in 
fig. 4, with very large PCSs in the sugar moiety in the presence of the paramagnetic ion. These 
satisfactory results prompted us to explore the use of this molecule to assess the conformation 
of lactose by PCS measurement. 
The goal was two-fold: first, to demonstrate that the shape of the molecule was not affected 
by the presence of both the biphenyl linker and the DTA chelator unit. Second, to provide a 
proof-of-principle example that these derivatives can be useful to determine carbohydrate 
conformation in solution. 
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Figure 4: Formula and 1H-13C HSQC spectra of lac-biPhDTA complexed with a diamagnetic lanthanide ion (La3+, 
blue/green) and a paramagnetic lanthanide ion (Tb3+, red/pink). 
The conformation of lactose has been previously studied in detail, using NMR and molecular 
mechanics [23, 33-34]. These studies have shown that lactose exists in an ensemble of 
conformations in solution, with a predominance of the typical 4C1 chair pucker in both 
pyranose rings, with a major conformation (> 95%) around the glycosidic bond (synF/synY) in 
coexistence with two other minor conformations (synF/antiYand antiF/synY, > 5%). 
Calculations were performed with MSpin [35] software to deduce the theoretical PCS values 
using the geometries of these three lactose conformations. PCSs predicted for the major 
conformer (synF/synY) were in excellent agreement with the experimental data (fig. 5). The 
Cornilescus quality factor Q was 0.050 for Tb3+ and 0.006 for Dy3+, for 1H PCSs (the closer 
the Q factor to zero, the better the given trial structure fits the empirical data). The 
corresponding data for both anti conformers were much worse, (Q = 3.727 for the synF/antiY
conformer and Q = 1.859 for the antiF/synY conformer).   
These results show that PCS measurement is a valid approach to probe carbohydrate 
conformation in solution, paving the way for analogous analyses using larger, more complex 
glycans. In this regard, a similar approach has recently afforded the determination, for the first 
time, of the conformation of a biantennary N-glycan nonasaccharide by our group [36]. 
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Figure 5: Plots correlating experimentally obtained and back-calculated 1H and 13C PCSs for the geometry of 
Lac-biPhDTA in the major lactose conformation, in the presence of either Tb3+ or Dy3+. 
6.2.2 Application to molecular recognition 
The detection of large PCSs in the sugar moiety of Lac-biPhDTA prompted us to explore the 
applications of this technology to molecular recognition.  
Since PCSs are originated by dipolar interactions which depend on distance, such effects could, 
in principle, be detected at the receptor signals, transferred through-space from the non-
covalently binding paramagnetic sugar, to the protein nuclei. We looked into this using a well-
known example of biomedical interest: carbohydrate binding to human gal-3, using Lac-
biPhDTA and 15N-labeled gal-3 CRD. 
First, a control 1H-15N HSQC experiment with Lac-biPhDTA loaded with La3+ was performed, 
indicating the chemical shift perturbations induced in the gal-3 signals were basically identical 
to those obtained in the presence of just lactose, without the LBT moiety. (fig. 6). These 
observations were supported by the assessment that the modified ligand was equally 
recognized as lactose, using epitope mapping by STD (fig. 7). Thus, the binding modes of Lac-
biPhDTA and lactose to gal-3 are equivalent. 
Next, we compared 1H-15N HSQC spectra of gal-3 in the presence of Lac-biPhDTA loaded with 
La3+ (i.e. in diamagnetic conditions) and loaded with different paramagnetic lanthanides: Dy3+, 
Tb3+ and Tm3+. In all cases, PCSs were observed for many protein signals, as a result of the 
interaction between the protein and the carbohydrate analogue (fig. 8). Both positive and 
negative chemical shift changes were observed in the 1H-15N signals of gal-3 upon addition of 
Lac-biPhDTA loaded with the different paramagnetic metals, compared with the control 
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experiment in the presence of Lac-biPhDTA:La3+ (fig. 9). In addition, depending on the 
employed metal, some 1H-15N cross peaks became severely broadened, with some of them 
even disappearing, probably due to PREs. This effect was especially apparent in the case of 
Dy3+, as expected from its stronger paramagnetic properties (fig., 3).  
Figure 6: Right panels: 1H-15N HSQC 
(acquired at 700 MHz) for the gal-
3:lactose (molar ratio 1:12) sample. Left 
panels: 1H-15N HSQC (acquired at 600 
MHz) for the sample containing gal-3 and 
the lactose derivative 5, loaded with La3+
(molar ratio 1:12). 
Figure 7: Lower panel: STD experiments 
performed on either Lac-biPhDTA or 
lactose in the presence of gal-3 CRD. A: 
Lac-biPhDTA, with labels (off-resonance); 
B: Lac-biPhDTA (STD); c: lactose (STD).  
Upper panel: ligand epitope mapping of 
the recognition of Lac-biPhDTA by human 
gal-3 CRD as inferred from STD 
experiments. Protons from the biPhDTA 
linker (labelled with asterisks, i.e. 
biphenyl protons and those of the 
chelating arms) give rise to much weaker 
STD responses than those of the lactose 
moiety, thus indicating that the 
recognition takes place at the level of the 
sugar.  
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Figure 8: Superimposition of 1H-15N HSQC 
spectra of gal-3 in complex with 2.5 eq. 
Lac-biPhDTA acquired under isotropic 
conditions (red, loaded with La3+) and 
anisotropic conditions (blue, loaded with 
Tb3+). Some of the residues directly 
involved in the lactose-gal-3 interaction or 
in close proximity have been highlighted.
These results were analyzed on the basis of a three-dimensional model of the complex using 
the X-ray coordinates of lactose-bound gal-3 (PDB: 2NN8) [37]. This structure was used as a 
template to generate the putative complex with compound Lac-biPhDTA, by attaching the 
biPhDTA fragment to the lactose moiety, as described in the experimental section. Plot in fig. 9 
shows the gal-3 residues experiencing significant low field and high field PCSs, as well as those 
broadening beyond detection. The latter always correspond to NH pairs located at closer 
distance from the metal (around 30.0 Å for both Dy3+ and Tb3+). However, in the case of Tm3+
no signal was broadened beyond detection. PCSs were measured in most gal-3 NH signals, 
even in residues further than 40 Å apart from the Ln3+ metal core.  
Looking at the effects of each individual metal, PCS data obtained for Dy3+ and Tb3+ showed the 
same pattern of positive and negative values, as expected from the corresponding isosurface 
shapes. In addition, the spectrum of the sample loaded with Tm3+ (with the lowest PRE of the 
three paramagnetic metals employed) proved very valuable to extract additional information. 
In this case, it was possible to observe NH cross-peaks belonging to residues lying 38.6 Å apart 
from the metal. These signals disappeared when Lac-biPhDTA was loaded with the other 
metals (fig. 9, e.g. around 163-169). Thus, the combination of data with different metals allows 
for the gathering of complementary information. 
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Figure 9: Plot of the positive and negative variations of PCSs along the same complex, loaded with three different 
lanthanide metals (brown for Dy3+, green for Tb3+ and blue for Tm3+), taking as blank the corresponding data 
obtained with La3+. 
Figure 10: Structures of gal-3 complexed with Lac-biPhDTA, showing PCSs isosurfaces calculated from combined -
tensors of Dy3+ (A), and Tm3+ (B), obtained through PCS data on the protein signals (figs. 8-9). Figures were built 
using Numbat [38]. 
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6.2.3 Disulfide-based sugar-lanthanide conjugates 
The synthetic route to Lac-biPhDTA took 10 steps in total [39]. Its synthesis, carried out at the 
laboratory of Prof. Pérez-Castells, was planned in a convergent way, with a final amide ligation 
between 1--aminolactose and the biPhDTA fragment. Although the synthesis is 
straightforward and provides the final product in good yields, it is out of the synthetic 
capabilities of most NMR groups. 
In order to provide an alternative solution with less synthetic requirements, we conceived a 
strategy for the synthesis of sugar-paramagnetic derivatives via a disulfide linkage. This 
procedure allows for the exploitation of a diversity of thiol-targeting tags originally conceived 
for proteins, which are commercially available. In addition, one can take advantage of the 
many thio-saccharides available in the market. Altogether, this strategy can be practiced 
without complex synthetic requirements, since the final disulfide coupling between the 
thiosugar and the paramagnetic tag occurs instantaneously and stoichiometrically in water.  
Coupling of 1--thiogalactose (Gal-1S) with a biPhDTA tag activated as a methanethiosulfonate 
proceeded and stoichiometricly in water. Large PCS were detected in the sugar signals (fig. 11). 
Of note, the non-planarity of the disulfide bond yielded a different PCS pattern from that 
obtained from the rigid conjugate Lac-biPhDTA. In Gal-1S-biPhDTA, H6 protons were the ones 
displaying the largest PCSs. 
Another difference is that two distinct conformers of Gal-1S-biPhDTA arise from the two 
possible CSSC torsion angles about the disulfide bond of +90 and -90 [40] (fig. 12). In our 
conjugate, PCSs predicted for the +90 conformer in the presence of Tb3+ were in better 
agreement with the experimental data (fig. 12), with Q = 0.122, in contrast with the value of Q
= 0.225 obtained for the -90 conformer. This seems to indicate that the +90 conformer is the 
major species in solution. Nevertheless, Q factors obtained with this molecule were worse 
than those obtained with the rigid conjugates. This is probably accounted for by the 
coexistence of these two conformers, and the greater conformational freedom around the 
disulfide linkage vis-à-vis the amide bond. 
Next, we also explored the application of these disulfide-based conjugates for the detection 
and study of their recognition by macromolecular receptors. Since the minimal recognition 
unit for galectins is the residue of galactose in its -configuration, Gal-1()S-biPhDTA is also a 
valid tool to probe its binding to galectins through monitoring of paramagnetic effects from 
the protein perspective. 
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Figure 11: Gal-1S-biPhDTA. Upper panel: synthesis. Lower panel: overlaid 1H-13C HSQC spectra of Gal-1S-biPhDTA 
loaded with a diamagnetic lanthanide (La3+, blue) and a paramagnetic lanthanide (Tb3+, red).  
1H-15N HSQC spectra of gal-3 recorded in the presence of 1 equivalent Gal-1S-biPhDTA loaded 
with Tb3+ showed dramatic effects in terms of PCSs and signal broadening beyond detection 
(fig. 13). These effects were in fact superior to those exerted by Lac-biPhDTA (fig. 8), if one 
takes into account the lower excess of ligand used in the case of the galactose derivative and 
its poorer affinity (in the mM range [41]) compared with the disaccharide. This is likely due to 
the fact that the paramagnetic center of Gal-1S-PhDTA is bent toward the protein surface, 
owing to the non-planarity of the disulphide bond. These results underline the sensitiveness of 
disulfide-based paramagnetic ligand derivatives for the detection of protein-binding events. 
Of note, the -90 conformer of Gal-1S-PhDTA is the only one possible in the galectin-bound 
state, given the steric clashes that would arise between the +90 conformer and the loop 
encompassing residues R162-V170. Thus, there is a conformational selection of the minor 
conformer by protein binding. This fact is supported by the absence of signal loss, due to PREs, 
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around that region of the protein in the presence of Tb3+ and other paramagnetic lanthanides 
(fig. 13B, 13C). 
Figure 12: Upper panel: two possible conformers of Gal-1S-biPhDTA by rotation of the angle around the disulfide 
bond. Lower panel: Plots correlating experimentally obtained and back-calculated 1H and 13C PCSs for the geometry 
of Gal-1S-biPhDTA in the +90 conformation, in the presence of either Tm3+, Er3+ or Tb3+. 
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Figure 13: A: 1H-15N HSQC spectra of gal-3 in complex with 1 eq. Gal-1S-biPhDTA loaded with La3+ (blue) or Tb3+
(red). B: Plot showing PCSs for the same complex, when loaded with three different metals (brown: Tb3+, green: 
Tm3+; blue: Yb3+). C: Model of the gal-3/Gal-1S-biPhDTA complex highlighting residues whose cross-peaks show 
positive (green), negative (red) PCSs or become broadened beyond detection (orange) in the presence of Tb3+. 
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6.2.4 Fluorine-detected paramagnetism 
It has previously been explained (Chapter 1) how the virtues of fluorine-19 have prompted the 
development of a wide variety of 19F-detected NMR experiments devoted to study ligand-
receptor interactions. Among them, we should emphasize the good sensitivity of 19F by NMR 
and the lack of fluorine in virtually all biological molecules. 
Obviously, a requisite is that the studied species contain at least one atom of fluorine. In the 
case of fluoroproteins, and since natural amino acids involved in protein synthesis of course 
lack fluorine, two different approaches have been used to circumvent this issue: i) biosynthetic 
introduction of fluorinated amino acid analogs in the expression systems and ii) post-
translational labeling at reactive amino acids with fluorine-containing reagents. The first 
approach is much more work-consuming, and is susceptible to a number of challenges. Thus, 
the facile incorporation of fluorine tags via directed labeling is often regarded as more 
convenient, and allows for the use of a large number of commercially available fluorine-
containing probes. 
In this section, we show the application of a rationally designed 19F-spin label of proteins to 
paramagnetic-detection of molecular recognition processes, which can also be employed for a 
number of other potential applications. 
6.2.4.1 Design rationale of a trifluoroacetylcysteine methanethiosulfonate (TFAM) tag 
Most protein-targeting tags are directed toward reactive amino acids, such as Cys, Lys, Arg 
and, to a lesser extent, Ser and Thr. We designed our tag as a methanethiosulfonate for highly 
reactive targeting of Cys residues, since there are usually only a few reactive Cys residues per 
molecule, thus rendering simplified 19F-NMR spectra and minimize spectral overlapping in 
protein mixtures. As it is common among fluorine probes, a trifluoromethyl (CF3) group was 
chosen as the fluorine carrier, in order to maximize sensitivity and take advantage of its 
relatively narrow peaks due to rapid rotation along the methyl axis. The CF3 group was 
separated from the rest of the tag by an amide bond, in order to avoid 19F-1H cross-relaxation 
pathways leading to signal broadening, and to contribute to overall rigidity needed for high 
sensitivity to paramagnetic effects. Finally, and in order to overcome solubility problems often 
associated with fluorine-containing probes, the design of the tag was based on a cysteine 
backbone, in order to attain the polarity needed to work at high concentrations. 
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The synthesis of TFAM was carried out at the CIB-CSIC, by trifluoroacetylation of L-cysteine 
methanethiosulfonate with trifluoroacetic anhydride in CF3COOH (fig. 14). 
Figure 14: Synthesis and design rationale of the trifluoroacetylcysteine methanethiosulfonate (TFAM) protein-
binding tag.
6.2.4.2 Labeling of gal-7 with TFAM
We deliberately chose to test this approach using Lac-PhDTA and gal-7, which has a single Cys 
residue (Cys38). Although, in all crystallographic structures solved, the C38 sulfhydryl group 
appears buried by R117, the flexibility of its side-chain allows for the tagging with TFAM. 
Tagging proceeded instantaneously and stoichiometrically in water. Completeness of the 
reaction could be monitored by 1H-NMR, by the shifting of the methanethiosulfonate signal 
from around 3 ppm (when bound to the rest of the molecule) to around 2.1 ppm (when 
released upon protein tagging) (fig. S10 in Appendix).  
Fig. 15 shows the overlay of 1H-15N HSQC spectra of gal-7 before and after tagging with TFAM. 
Several peaks corresponding to residues located in the vicinity of the modified sulfhydryl, such 
as C38 itself, G39, Q66, R117 and V118 showed considerable shifting. Covalent attachment of 
the tag was also confirmed by mass spectrometry (fig. 15B). Lactose binding to the labeled 
protein was confirmed by 1H-15N HSQC (fig. S11 in Appendix), thus excluding that tagging with 
TFAM would lead to loss of ligand recognition by gal-7. 
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Figure 15: Labeling of gal-7 by TFAM at Cys38, as monitored by 1H-15N HSQC (A) and MALDI (B). 
6.2.4.3 Detection of PCS in TFAM-labeled proteins 
Addition of four equivalents Lac-PhDTA loaded with Tb3+ to a sample of TFAM-labeled gal-7 
induced PCS of around 0.04 ppm at the 19F signal of the labeled protein (fig. 16). According to 
the model shown in fig. 16B, the paramagnetic center lied around 27 Å apart from the fluorine 
nuclei. The measured PCSs are thus comparable with those obtained in previous studies using 
1H-15N HSQC experiments.  
Similar results were obtained using a system involving bovine serum albumin (BSA) and a 
paramagnetic derivative of tryptophan, a natural ligand thereof [42]. BSA is a 67 kDa protein, 
which has 35 Cys residues in total, of which 34 form intrachain disulfide bonds, and only one 
(Cys34) is reduced and solvent-accessible [42-43]. In this case, addition of two equivalents 
L-Trp-PhDTA:Dy3+ to TFAM-labeled BSA at C34 produced a 19F-PCS of around -0.034 ppm, with 
the distance between the paramagnetic center and the fluorine nuclei estimated around 37.6 
Å (fig. 17B). 
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Figure 16: A: structures of Lac-PhDTA and TFAM. B: 19F-NMR spectra of TFAM-labeled gal-7, in the presence of 4 
equivalents Lac-PhDTA:La3+ (diamagnetic, blue) or Lac-PhDTA:Tb3+ (paramagnetic, red). The excess of TFAM is 
shown as an internal chemical shift reference. On top, a model of TFAM-labeled gal-7 complexed with Lac-PhDTA is 
shown, highlighting the distance measured between the paramagnetic center and the CF3 moiety (blue balls). 
Figure 17: A: structure of Trp-PhDTA and 19F-NMR spectra of TFAM-labeled BSA, in the presence of 2 eq. Trp-
PhDTA:La3+ (diamagnetic, red) or Trp-PhDTA:Dy3+ (paramagnetic, blue). B: Model of TFAM-labeled BSA complexed 
with L-Trp-PhDTA, highlighting the distance between the paramagnetic center and the CF3 moiety (blue balls).
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In previous sections, we have shown how paramagnetic ligands can be used as tools for the 
study of structural aspects of their recognition by macromolecular receptors. Using uniformly 
15N-labeled galectin, we detected and measured specific perturbation of proton NH signals 
beyond the binding site to a distance up to 40 Å from the ligand. 
Of course, the latter approach is only possible if recombinant production, isotopic labeling and 
acquisition of high-resolution 2D spectra of the protein of interest can be done. Thus, tagging 
of the protein by a fluorine-containing probe such as TFAM and monitoring of paramagnetic 
perturbations, exerted by ligands or other modified proteins, of the fluoroprotein signals in 1D 
19F-NMR spectra can be a useful way to deal with those instances where the latter approach is 
not possible (e.g., proteins isolated from natural sources or of very high molecular weight). 
6.3 Methods 
Experimental PCSs for lanthanide-chelating carbohydrate derivatives were calculated as the 
difference between the chemical shift of each signal in an 1H-13C HSQC spectrum acquired in 
the presence of a diamagnetic metal ion (La3+) and one spectrum acquired in the presence of a 
paramagnetic metal ion (e.g. Tb3+, Dy3+). Spectra were acquired at 600 MHz and 298 K. Samples 
were prepared in deuterated Tris buffer (D2O, Tris-d6, 50 mM, pH 7.8) at a final concentration 
of the carbohydrate derivative 5 of 2.5 mM. CH3CN was added as chemical shift reference.  
Once the experimental values were obtained, MSpin [35] software was used to back-calculate 
the expected PCSs from the different lactose conformations. The quality of the fitting between 
experimental and back-calculated values is given by the Q factor, which is defined by the 
following expression: 
(7)[35] 
For molecular recognition applications, gal-3 PCSs were measured from 1H-15N HSQC 
experiments acquired in the presence of the lanthanide chelating carbohydrate conjugates 
loaded either with diamagnetic (La3+) or with paramagnetic ions (Tm3+, Tb3+, Dy3+). Spectra 
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were recorded at 700 MHz and 298 K. For experiments involving disulfide-based conjugates, 
samples were prepared in sodium acetate buffer (100 mM in H2O/10% D2O) at pH 6.5, because 
the tag activated as a methanethiosulfonate readily decomposed at basic pH. Protein 
concentration was 270 M and the lactose derivative/protein molar ratio was set to 2.5:1 with 
Lac-biPhDTA, and 1:1 with Gal-1S-biPhDTA. Gal-1S was purchased from Sigma (St. Louis, MO). 
For the analysis of protein PCSs, Numbat (New Userfriendly Method Built for Automatic -
Tensor determination) [38] was used to back-calculate the expected PCSs for the geometry 
reported in the X-ray crystallographic structure of the galectin-3/lactose complex (PDB: 2NN8) 
[37]. The lactose molecule of the X-ray structure was replaced by the lactose conjugate bearing 
the lanthanide-binding tag. The geometry of the PhDTA unit was taken from the reported 
coordinates of this moiety crystallized in the presence of Fe(III) [44]. 
Synthesis of TFAM was done by trifluoroacetylation of L-cysteine methanethiosulfonate with 
trifluoroacetic anhydride in CF3COOH. The reaction was carried out at 278 K and real-time 
monitored by 1H-NMR and 19F-NMR until completion. The product, obtained in excellent yields 
(98%) was isolated by coevaporation of the solvent with toluene under vacuum. Proteins were 
labeled with TFAM in water, using 1:1 proportions. PCSs were measured at the 19F-NMR signals 
upon addition of paramagnetic ligands at different proportions, using a 500 MHz spectrometer 
equipped with a 19F probe.
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CONCLUSIONS 
Carbohydrate-protein systems of biological relevance have been studied using nuclear 
magnetic resonance (NMR) spectroscopy. 
- The interacting capabilities of a set of viral protein fibers toward small oligosaccharides have 
been studied, at atomic scale, by using STD experiments. 
- The interaction features of a monoclonal antibody toward glycogen have been characterized, 
from the ligands perspective, using STD and STDD experiments glycogen and a few related 
oligosaccharides. Our results point towards a recognition of the inner, (1-4)-linked Glc units 
by the antibody, rather than the branching points or the reducing ends. 
- On-cell NMR experiments were performed on both a wild-type and a glgB::Tn mutant strain 
of Mycobacterium smegmatis. Results indicate that the -glucan of the glgB::Tn mutant is 
primarily formed by a linear, unbranched (1-4)glucose polysaccharide, lacking (1-6) 
branches. We hypothesize that binding of the mAb to glgB::Tn mutants is precluded due to 
strongly reduced availability of the (1-4) linked -glucan epitope caused by insolubility and 
aggregation of the unbranched -glucan polymers. 
- Using STD experiments, we have gained insight into the catalytic mechanism of the UDP-
glucose pyrophosphorylase (UGP) of Streptococcus pneumoniae. Our results point toward a 
sequential ordered Bi-Bi catalytic mechanism, in which UTP binds to the enzyme first, followed 
by Glc-1-P binding to the enzyme/nucleotide complex. 
- An NMR-based assay has been developed to measure UGP activity. This assay represents a 
direct approach to monitor their activity, because substrate interconversion is directly 
observed. Thus, it is advantageous over the currently most used one for measuring 
nucleotidyltransferase activity, which relies on its coupling to NADH/NAHD+ conversion by 
UDP-Glc 6-dehydrogenase. 
- Targeting of the UGP of S. pneumoniae trough fragment-based drug discovery has provided a 
set of structurally similar small molecules binding with mM affinities to the enzyme. These 
studies represent the first step toward the targeting of pneumococcal UGP, a therapeutic 
target candidate. 
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- Full NMR assignment of galectin-7 (gal-7) has been accomplished, which revealed the 
coexistence of two conformations of gal-7. The origin of this conformational duality was found 
to be the cis-trans isomerization equilibrium of the Val3-Pro4 peptide bond. 
- A fragment-based screening was done targeting gal-7. A set of fragment hits were found to 
bind with moderate affinities to two distinct epitopes of gal-7 involved, or presumably involved 
in protein-protein interactions, rather than the sugar recognition site: a previously unreported 
binding site targeted by phenoxyphenyl-derivatives, and the gal-7 dimerization interface. 
Fragment binding to the latter site was shown to disrupt self-association of gal-7 monomers. 
- Allosteric competition between lactose and fragments binding to the gal-7 dimer interface 
has shown that sugar binding to gal-7 results in stabilization of the gal-7 dimer state. 
- Complete NMR assignment of full-length galectin-3 (gal-3) has been done.  
- The interaction features of a series of glycan ligands by the gal-3 carbohydrate recognition 
domain (CRD) have been studied by both ligand- and protein-detected NMR methods, in 
combination with molecular modeling. 
- The Interaction of the gal-3 CRD with synthetic (phospho)peptides derived from the gal-3 N-
terminal tail was assessed. Results show that distinct N-terminal peptides can interact at 
specific sites within the gal-3 CRD, suggesting that a similar behavior may take place in the full-
length protein. Specifically, phosphorylation of Ser6 and Ser12 in specific N-terminal peptides 
was shown to promote association with the CRD, while phosphorylation of Tyr107 and Tyr118 
was shown to attenuate this association. 
- A novel strategy has been developed for the application of paramagnetic sugar conjugates to 
the study of carbohydrate conformation and recognition features with receptors. As a proof-
of-principle example, the conformation of lactose has been assessed using pseudo-contact 
shift (PCS) information. In addition, these conjugates have been shown to be useful for the 
detection and characterization of recognition events by receptors. 
- A method for facile synthesis of disulfide-based paramagnetic sugar derivatives has been 
proposed, also with applications to the study of molecular recognition processes. 
- A fluorine-spin label reagent targeted to protein thiols has been synthesized. The application 
of this reagent to paramagnetism-based detection of ligand binding has been studied, using 
paramagnetic ligand derivatives. 
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CONCLUSIONS 
Carbohydrate-protein systems of biological relevance have been studied using nuclear 
magnetic resonance (NMR) spectroscopy. 
- The interacting capabilities of a set of viral protein fibers toward small oligosaccharides have 
been studied, at atomic scale, by using STD experiments.  
- The interaction features of a monoclonal antibody toward glycogen have been characterized, 
from the ligands perspective, using STD and STDD experiments glycogen and a few related 
oligosaccharides. Our results point towards a recognition of the inner, (1-4)-linked Glc units 
by the antibody, rather than the branching points or the reducing ends. 
- On-cell NMR experiments were performed on both a wild-type and a glgB::Tn mutant strain 
of Mycobacterium smegmatis. Results indicate that the -glucan of the glgB::Tn mutant is 
primarily formed by a linear, unbranched (1-4)glucose polysaccharide, lacking (1-6) 
branches. We hypothesize that binding of the mAb to glgB::Tn mutants is precluded due to 
strongly reduced availability of the (1-4) linked -glucan epitope caused by insolubility and 
aggregation of the unbranched -glucan polymers. 
- Using STD experiments, we have gained insight into the catalytic mechanism of the UDP-
glucose pyrophosphorylase (UGP) of Streptococcus pneumoniae. Our results point toward a 
sequential ordered Bi-Bi catalytic mechanism, in which UTP binds to the enzyme first, followed 
by Glc-1-P binding to the enzyme/nucleotide complex. 
- An NMR-based assay has been developed to measure UGP activity. This assay represents a 
direct approach to monitor their activity, because substrate interconversion is directly 
observed. Thus, it is advantageous over the currently most used one for measuring 
nucleotidyltransferase activity, which relies on its coupling to NADH/NAD+ conversion by UDP-
Glc 6-dehydrogenase. 
- Targeting of the UGP of S. pneumoniae trough fragment-based drug discovery has provided a 
set of structurally similar small molecules binding with mM affinities to the enzyme. These 
studies represent the first step toward the targeting of pneumococcal UGP, a therapeutic 
target candidate. 
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- Full NMR assignment of galectin-7 (gal-7) has been accomplished, which revealed the 
coexistence of two conformations of gal-7. The origin of this conformational duality was found 
to be the cis-trans isomerization equilibrium of the Val3-Pro4 peptide bond. 
- A fragment-based screening was done targeting gal-7. A set of fragment hits were found to 
bind with moderate affinities to two distinct epitopes of gal-7 involved, or presumably involved 
in protein-protein interactions, rather than the sugar recognition site: a previously unreported 
binding site targeted by phenoxyphenyl-derivatives, and the gal-7 dimerization interface. 
Fragment binding to the latter site was shown to disrupt self-association of gal-7 monomers. 
- Allosteric competition between lactose and fragments binding to the gal-7 dimer interface 
has shown that sugar binding to gal-7 results in stabilization of the gal-7 dimer state. 
- Complete NMR assignment of full-length galectin-3 (gal-3) has been done.  
- The interaction features of a series of glycan ligands by the gal-3 carbohydrate recognition 
domain (CRD) have been studied by both ligand- and protein-detected NMR methods, in 
combination with molecular modeling. 
- The Interaction of the gal-3 CRD with synthetic (phospho)peptides derived from the gal-3 N-
terminal tail was assessed. Results show that distinct N-terminal peptides can interact at 
specific sites within the gal-3 CRD, suggesting that a similar behavior may take place in the full-
length protein. Specifically, phosphorylation of Ser6 and Ser12 in specific N-terminal peptides 
was shown to promote association with the CRD, while phosphorylation of Tyr107 and Tyr118 
was shown to attenuate this association. 
- A novel strategy has been developed for the application of paramagnetic sugar conjugates to 
the study of carbohydrate conformation and recognition features with receptors. As a proof-
of-principle example, the conformation of lactose has been assessed using pseudo-contact 
shift (PCS) information. In addition, these conjugates have been shown to be useful for the 
detection and characterization of recognition events by receptors. 
- A method for facile synthesis of disulfide-based paramagnetic sugar derivatives has been 
proposed, also with applications to the study of molecular recognition processes. 
- A fluorine-spin label reagent targeted to protein thiols has been synthesized. The application 
of this reagent to paramagnetism-based detection of ligand binding has been studied, using 
paramagnetic ligand derivatives. 
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CONCLUSIONS 
Se ha estudiado una serie de sistemas carbohidrato-proteína de interés biológico mediante 
espectroscopía por resonancia magnética nuclear (RMN). 
- Se ha estudiado, a escala atómica, las capacidades de interacción de un conjunto de 
proteínas fibrilares virales con oligosacáridos pequeños. 
- Se ha estudiado la interacción de un anticuerpo monoclonal con glucógeno y una serie de 
oligosacáridos relacionados, desde el punto de vista del ligando, mediante experimentos STD y 
STDD. Los resultados apuntan a un reconocimiento preferente de las unidades internas de 
glucosa en cadenas lineales (1-4)-enlazadas, frente a las ramificaciones (1-6) o los extremos 
reductores. 
- Se han llevado a cabo experimentos de RMN en células de Mycobacterium smegmatis
procedentes de cepas silvestres y mutantes glgB::Tn. Los resultados indican que el -glucano 
del mutante glgB::Tn está formado principalmente por un polisacárido de glucosa lineal unido 
mediante enlaces (1-4), carente de ramificaciones (1-6). Se ha hipotetizado que el 
reconocimiento del -glucano del mutante glgB::Tn por parte del anticuerpo monoclonal se ve 
impedido por la insolubilidad y agregación de los polímeros lineales de (1-4)-glucosa. 
- Utilizando experimentos STD, se ha obtenido información sobre el mecanismo catalítico de la 
UDP-glucosa pirofosforilasa (UGP) de Streptococcus pneumoniae. Los resultados apuntan a un 
mecanismo catalítico secuencial ordenado Bi-Bi, en el que el UTP se une a la enzima primero, 
seguido de la unión de Glc-1-P al complejo enzima/nucleótido. 
- Se ha desarrollado un ensayo basado en RMN para medir la actividad UGP. Este ensayo 
representa una estrategia directa para el seguimiento de la actividad UGP, y es ventajoso 
sobre el método más utilizado actualmente, basado en la medición indirecta de la actividad 
UGP mediante su acoplamiento con la oxidación de la UDP-glucosa seguida por 
procedimientos espectrofotométricos. 
- Se ha llevado a cabo un cribado de fragmentos contra spUGP, encontrándose una serie de 
compuestos estructuralmente relacionados que se unían con moderada afinidad al subsitio de 
unión de UTP de spUGP. 
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- Se ha llevado a cabo la asignación completa de las señales de RMN de galectina-7 (gal-7). 
Dicha asignación reveló la coexistencia de dos conformaciones de gal-7. Se ha determinado 
que el origen de esta dualidad conformacional reside en la isomerización cis-trans del enlace 
peptídico Val3-Pro4. 
- Se ha llevado a cabo un cribado de fragmentos contra gal-7, hallándose una serie de 
fragmentos que se unen con moderadas afinidades a dos epítopos distintos de gal-7 
involucrados, o presumiblemente involucrados en interacciones proteína-proteína, y distintos 
del sitio de unión a carbohidratos: un sitio de unión previamente desconocido hacia el que 
tienen afinidad derivados de fenoxifenilo, y la interfaz de dimerización de gal-7. La unión de 
fragmentos a dicha interfaz es capaz de competir con la autoasociación de los monómeros de 
gal-7. 
- La competición alostérica entre lactosa y fragmentos con afinidad por la interfaz de 
dimerización de gal-7 ha puesto de manifiesto que la unión de azúcar a gal-7 resulta en la 
estabilización del estado dimérico de gal-7. 
- Se ha llevado a cabo la asignación completa de las señales de RMN de galectina-3 (gal-3). 
- Se ha estudiado la interacción de una serie de ligandos sacarídicos con el dominio de 
reconocimiento de carbohidratos (CRD) de gal-3, mediante experimentos de RMN basados en 
la observación de ligando y métodos basados en la observación de las señales de la proteína, 
en combinación con modelado molecular. 
- Se ha estudiado la interacción del CRD de gal-3 con (fosfo)péptidos sintéticos derivados del 
dominio N-terminal de gal-3. Los resultados muestran la capacidad de distintos péptidos de 
interaccionar con el CRD de gal-3, lo que sugiere que en la proteína nativa podrían darse 
análogos contactos de manera intramolecular. La fosforilación de Ser6 y Ser12 en péptidos N-
terminales mostró ser esencial para la interacción con el CRD, mientras que la fosforilación de 
Tyr107 y Tyr118 reveló atenuar dicha asociación. 
- Se ha desarrollado una nueva estrategia basada en la aplicación de conjugados 
paramagnéticos sacarídicos para estudiar la conformación de los carbohidratos y su 
interacción con receptores. Como prueba de concepto, se ha comprobado la conformación de 
lactosa mediante información procedente de desplazamientos de pseudo-contacto (PCSs). 
Además, estos conjugados han revelado ser útiles para la detección y caracterización de su 
reconocimiento por receptores. 
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- Se ha propuesto un método para la síntesis sencilla de derivados sacarídicos paramagnéticos 
basados en enlaces disulfuro. Dichos derivados también han mostrado utilidad para el estudio 
de procesos de reconocimiento molecular. 
- Se ha sintetizado un reactivo de tioles etiquetado con flúor-19. Se ha estudiado la aplicación 
de este reactivo a la detección de eventos de reconocimiento basada en efectos 
paramagnéticos, utilizando derivados paramagnéticos de distintos ligandos. 
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APPENDIX 
SUPPLEMENTARY FIGURES 
Figure S1: DOSY calibration line [1]built with 6 proteins with molecular weights ranging from 6.5 kDa to 120 kDa. 
Patterns were: aprotinin (6.5 kDa), -lactalbumin (14.2 kDa), carbonic anhydrase (30 kDa), ovoalbumin (44.3 kDa), 
bovine albumin (66 kDa) and viscumin (120 kDa).
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Figure S2: Chemical shift prediction of a glycogen-related oligosaccharide model (sequence shown on top) using 
CASPER [2].
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Figure S3: 1H-13C chemical shift prediction for an (1-6)-branched, (1-4) linear oligosaccharide using CASPER [2]. 
Plot built with the predicted chemical shifts shown in fig. S2, akin to a simulated 1H-13C HSQC spectrum. 
Figure S4: MALDI spectrum of gal-7, showing a single major species corresponding to a molar mass of 14946.9 Da, in 
good agreement with the predicted molar mass of the native sequence without the initial methionine (14943.8 Da). 
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Figure S5: 1H-NMR titration of phenoxyphenyl-based fragments with gal-7. Strong shielding of the gal-7 L24 -
protons was observed upon addition of these compounds. Being this signal reasonably isolated at around 0.53 ppm 
in the gal-7 1H-NMR spectrum [3], a KD for their binding to gal-7 could be determined by monitoring its chemical 
shift displacement at increasing concentrations of the titrated compounds (A), being compound 549 the most 
potent of the series, with a KD of 1.27 ± 0.09 mM (B).
Figure S6: Superimposition of 1H-15N HSQC spectra of 250 M Gal-7, in the absence (blue) and in the presence of 
fragment 245 (red). 
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Figure S7: Superimposition of 1H-15N HSQC spectra of the Gal-3 CRD, in the absence (blue) and in the presence of 
ten equivalents of P1 (red). 
Figure S8: Superimposition of 1H-15N HSQC spectra of the Gal-3 CRD, in the absence (blue) and in the presence of 
ten equivalents of SCR1 (red).
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Figure S9: Superimposition of 1H-15N HSQC spectra of the Gal-3 CRD, in the absence (blue) and in the presence of 
ten equivalents of SCR2 (red). 
Figure S10: 1H-NMR spectra of TFAM, in the absence (lower spectrum) and in the presence of 1 eq gal-7 (upper 
spectrum), showing the release of CH3SO3H from the tag upon disulfide-bond formation with the gal-7 Cys38.  
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Figure S11: 1H-15N HSQC of TFAM-labeled gal-7, in the absence (blue) and in the presence of 1 mM lactose, showing 
selective cross-peak perturbation upon addition of lactose to the protein after TFAM labeling.
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